Synergistic	O
interactions	O
between	O
overlapping	B-DNA
binding	I-DNA
sites	I-DNA
for	O
the	O
serum	B-protein
response	I-protein
factor	I-protein
and	O
ELK-1	B-protein
proteins	I-protein
mediate	O
both	O
basal	O
enhancement	O
and	O
phorbol	O
ester	O
responsiveness	O
of	O
primate	B-DNA
cytomegalovirus	I-DNA
major	I-DNA
immediate-early	I-DNA
promoters	I-DNA
in	O
monocyte	O
and	O
T-lymphocyte	B-cell_type
cell	O
types	O
.	O

Cytomegalovirus	O
(	O
CMV	O
)	O
infection	O
is	O
nonpermissive	O
or	O
persistent	O
in	O
many	O
lymphoid	B-cell_type
and	I-cell_type
myeloid	I-cell_type
cell	I-cell_type
types	I-cell_type
but	O
can	O
be	O
activated	O
in	O
differentiated	B-cell_type
macrophages	I-cell_type
.	O

We	O
have	O
shown	O
elsewhere	O
that	O
both	O
the	O
major	B-DNA
immediate-early	I-DNA
gene	I-DNA
(	O
MIE	B-DNA
)	O
and	O
lytic	O
cycle	O
infectious	O
progeny	O
virus	O
expression	O
can	O
be	O
induced	O
in	O
otherwise	O
nonpermissive	O
monocyte-like	B-cell_line
U-937	I-cell_line
cell	I-cell_line
cultures	I-cell_line
infected	O
with	O
either	O
human	O
CMV	O
(	O
HCMV	O
)	O
or	O
simian	O
CMV	O
(	O
SCMV	O
)	O
by	O
treatment	O
with	O
the	O
phorbol	O
ester	O
12-O-tetradecanoylphorbol-13-acetate	O
(	O
TPA	O
)	O
.	O

Two	O
multicopy	B-DNA
basal	I-DNA
enhancer	I-DNA
motifs	I-DNA
within	O
the	O
SCMV	O
MIE	B-DNA
enhancer	I-DNA
,	O
namely	O
,	O
11	O
copies	O
of	O
the	O
16-bp	O
cyclic	B-DNA
AMP	I-DNA
response	I-DNA
element	I-DNA
(	O
CRE	B-DNA
)	O
and	O
3	O
copies	O
of	O
novel	O
17-bp	O
serum	B-DNA
response	I-DNA
factor	I-DNA
(	I-DNA
SRF	I-DNA
)	I-DNA
binding	I-DNA
sites	I-DNA
referred	O
to	O
as	O
the	O
SNE	B-DNA
(	O
SRF/NFkappaB-like	B-DNA
element	I-DNA
)	O
,	O
as	O
well	O
as	O
four	O
classical	O
NFkappaB	B-DNA
sites	I-DNA
within	O
the	O
HCMV	O
version	O
,	O
contribute	O
to	O
TPA	O
responsiveness	O
in	O
transient	O
assays	O
in	O
monocyte	B-cell_type
and	I-cell_type
T-cell	I-cell_type
types	I-cell_type
.	O

The	O
SCMV	B-DNA
SNE	I-DNA
sites	I-DNA
contain	O
potential	O
overlapping	O
core	O
recognition	O
binding	O
motifs	O
for	O
SRF	B-protein
,	O
Rel/NFkappaB	B-protein
,	O
ETS	B-protein
,	O
and	O
YY1	B-protein
class	I-protein
transcription	I-protein
factors	I-protein
but	O
fail	O
to	O
respond	O
to	O
either	O
serum	B-protein
or	I-protein
tumor	I-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
.	O

Therefore	O
,	O
to	O
evaluate	O
the	O
mechanism	O
of	O
TPA	O
responsiveness	O
of	O
the	O
SNE	B-DNA
motifs	I-DNA
and	O
of	O
a	O
related	O
16-bp	O
SEE	B-DNA
(	O
SRF/ETS	B-DNA
element	I-DNA
)	O
motif	O
found	O
in	O
the	O
HCMV	B-DNA
and	I-DNA
chimpanzee	I-DNA
CMV	I-DNA
MIE	I-DNA
enhancers	I-DNA
,	O
we	O
have	O
examined	O
the	O
functional	O
responses	O
and	O
protein	O
binding	O
properties	O
of	O
multimerized	B-DNA
wild-type	I-DNA
and	I-DNA
mutant	I-DNA
elements	I-DNA
added	O
upstream	O
to	O
the	O
SCMV	B-DNA
MIE	I-DNA
or	O
simian	B-DNA
virus	I-DNA
40	I-DNA
minimal	I-DNA
promoter	I-DNA
regions	I-DNA
in	O
the	O
U-937	B-cell_line
,	O
K-562	B-cell_line
,	O
HL-60	B-cell_line
,	O
THP-1	B-cell_line
,	O
and	O
Jurkat	B-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

Unlike	O
classical	O
NFkappaB	B-DNA
sites	I-DNA
,	O
neither	O
the	O
SNE	B-DNA
nor	O
the	O
SEE	B-DNA
motif	I-DNA
responded	O
to	O
phosphatase	O
inhibition	O
by	O
okadaic	O
acid	O
.	O

However	O
,	O
the	O
TPA	O
responsiveness	O
of	O
both	O
CMV	B-DNA
elements	I-DNA
proved	O
to	O
involve	O
synergistic	O
interactions	O
between	O
the	O
core	O
SRF	B-DNA
binding	I-DNA
site	I-DNA
(	O
CCATATATGG	O
)	O
and	O
the	O
adjacent	O
inverted	O
ETS	B-DNA
binding	I-DNA
motifs	I-DNA
(	O
TTCC	O
)	O
,	O
which	O
correlated	O
directly	O
with	O
formation	O
of	O
a	O
bound	O
tripartite	B-protein
complex	I-protein
containing	O
both	O
the	O
cellular	O
SRF	B-protein
and	O
ELK-1	B-protein
proteins	I-protein
.	O

This	O
protein	B-protein
complex	I-protein
was	O
more	O
abundant	O
in	O
U-937	O
,	O
K-562	O
,	O
and	O
HeLa	O
cell	O
extracts	O
than	O
in	O
Raji	B-cell_line
,	O
HF	B-cell_line
,	O
BALB/c	B-cell_line
3T3	I-cell_line
,	O
or	O
HL-60	B-cell_line
cells	I-cell_line
,	O
but	O
the	O
binding	O
activity	O
was	O
altered	O
only	O
twofold	O
after	O
TPA	O
treatment	O
.	O

A	O
40-fold	O
stimulation	O
of	O
chloramphenicol	B-protein
acetyltransferase	I-protein
activity	O
mediated	O
by	O
four	O
tandem	B-DNA
repeats	I-DNA
of	O
the	O
SNE	B-DNA
could	O
be	O
induced	O
within	O
2	O
h	O
(	O
and	O
up	O
to	O
250-fold	O
within	O
6	O
h	O
)	O
after	O
addition	O
of	O
TPA	O
in	O
DNA-transfected	B-cell_line
U-937	I-cell_line
cells	I-cell_line
,	O
indicating	O
that	O
the	O
stimulation	O
appeared	O
likely	O
to	O
be	O
a	O
true	O
protein	B-protein
kinase	I-protein
C	I-protein
-mediated	O
signal	O
transduction	O
event	O
rather	O
than	O
a	O
differentiation	O
response	O
.	O

Slight	O
differences	O
in	O
the	O
sequence	O
of	O
the	O
core	B-DNA
SRF	I-DNA
binding	I-DNA
site	I-DNA
compared	O
with	O
that	O
of	O
the	O
classical	O
c-Fos	B-DNA
promoter	I-DNA
serum	I-DNA
response	I-DNA
element	I-DNA
,	O
together	O
with	O
differences	O
in	O
the	O
spacing	O
between	O
the	O
SRF	B-DNA
and	I-DNA
ETS	I-DNA
motifs	I-DNA
,	O
appear	O
to	O
account	O
for	O
the	O
inability	O
of	O
the	O
SCMV	B-DNA
SNEs	I-DNA
to	O
respond	O
to	O
serum	O
induction	O
.	O

JOURNAL	NULL
OF	NULL
VirRoLOGY	NULL
,	NULL
Dec.	NULL
1996	NULL
,	NULL
p.	NULL
8590-8605	NULL
0022-538X	NULL
,	NULL
/96/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
Â©	NULL
1996	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

70	NULL
,	NULL
No	NULL
.	NULL

12	NULL
Synergistic	NULL
Interactions	NULL
between	NULL
Overlapping	NULL
Binding	NULL
Sites	NULL
for	NULL
the	NULL
Serum	NULL
Response	NULL
Factor	NULL
and	NULL
ELK-1	NULL
Proteins	NULL
Mediate	NULL
both	NULL
Basal	NULL
Enhancement	NULL
and	NULL
Phorbol	NULL
Ester	NULL
Responsiveness	NULL
of	NULL
Primate	NULL
Cytomegalovirus	NULL
Major	NULL
Immediate-Early	NULL
Promoters	NULL
in	NULL
Monocyte	NULL
and	NULL
T-Lymphocyte	NULL
Cell	NULL
Types	NULL
YU-JIUN	NULL
CHAN	NULL
,	NULL
CHUANG-JIUN	NULL
CHIOU	NULL
,	NULL
``	NULL
QI	NULL
HUANG	NULL
,	NULL
'	NULL
anp	NULL
GARY	NULL
S.	NULL
The	NULL
Molecular	NULL
Virology	NULL
Laboratories	NULL
,	NULL
Departments	NULL
of	NULL
Pharmacology	NULL
and	NULL
Molecular	NULL
Sciences	NULL
'	NULL
and	NULL
Oncology	NULL
,	NULL
``	NULL
Johns	NULL
Hopkins	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Baltimore	NULL
,	NULL
Maryland	NULL
21205	NULL
Received	NULL
20	NULL
May	NULL
1996/Accepted	NULL
21	NULL
August	NULL
1996	NULL
Cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
infection	NULL
is	NULL
nonpermissive	NULL
or	NULL
persistent	NULL
in	NULL
many	NULL
lymphoid	NULL
and	NULL
myeloid	NULL
cell	NULL
types	NULL
but	NULL
can	NULL
be	NULL
activated	NULL
in	NULL
differentiated	NULL
macrophages	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
elsewhere	NULL
that	NULL
both	NULL
the	NULL
major	NULL
immediate-early	NULL
gene	NULL
(	NULL
MIE	NULL
)	NULL
and	NULL
lytic	NULL
cycle	NULL
infectious	NULL
progeny	NULL
virus	NULL
expression	NULL
can	NULL
be	NULL
induced	NULL
in	NULL
otherwise	NULL
nonpermissive	NULL
monocyte-like	NULL
U-937	NULL
cell	NULL
cultures	NULL
infected	NULL
with	NULL
either	NULL
human	NULL
CMV	NULL
(	NULL
HCMV	NULL
)	NULL
or	NULL
simian	NULL
CMV	NULL
(	NULL
SCMV	NULL
)	NULL
by	NULL
treatment	NULL
with	NULL
the	NULL
phorbol	NULL
ester	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
.	NULL

Two	NULL
multicopy	NULL
basal	NULL
enhancer	NULL
motifs	NULL
within	NULL
the	NULL
SCMV	NULL
MIE	NULL
enhancer	NULL
,	NULL
namely	NULL
,	NULL
11	NULL
copies	NULL
of	NULL
the	NULL
16-bp	NULL
cyclic	NULL
AMP	NULL
response	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
and	NULL
3	NULL
copies	NULL
of	NULL
novel	NULL
17-bp	NULL
serum	NULL
response	NULL
factor	NULL
(	NULL
SRF	NULL
)	NULL
binding	NULL
sites	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
SNE	NULL
(	NULL
SRFE/NFKB-like	NULL
element	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
four	NULL
classical	NULL
NFKB	NULL
sites	NULL
within	NULL
the	NULL
HCMV	NULL
version	NULL
,	NULL
contribute	NULL
to	NULL
TPA	NULL
responsiveness	NULL
in	NULL
transient	NULL
assays	NULL
in	NULL
monocyte	NULL
and	NULL
T-cell	NULL
types	NULL
.	NULL

The	NULL
SCMV	NULL
SNE	NULL
sites	NULL
contain	NULL
potential	NULL
overlapping	NULL
core	NULL
recognition	NULL
binding	NULL
motifs	NULL
for	NULL
SRF	NULL
,	NULL
Rel/NFxB	NULL
,	NULL
ETS	NULL
,	NULL
and	NULL
YY1	NULL
class	NULL
transcription	NULL
factors	NULL
but	NULL
fail	NULL
to	NULL
respond	NULL
to	NULL
either	NULL
serum	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
.	NULL

Therefore	NULL
,	NULL
to	NULL
evaluate	NULL
the	NULL
mechanism	NULL
of	NULL
TPA	NULL
responsiveness	NULL
of	NULL
the	NULL
SNE	NULL
motifs	NULL
and	NULL
of	NULL
a	NULL
related	NULL
16-bp	NULL
SEE	NULL
(	NULL
SRF/ETS	NULL
element	NULL
)	NULL
motif	NULL
found	NULL
in	NULL
the	NULL
HCMV	NULL
and	NULL
chimpanzee	NULL
CMV	NULL
MIE	NULL
enhancers	NULL
,	NULL
we	NULL
have	NULL
examined	NULL
the	NULL
functional	NULL
responses	NULL
and	NULL
protein	NULL
binding	NULL
properties	NULL
of	NULL
multimerized	NULL
wild-type	NULL
and	NULL
mutant	NULL
elements	NULL
added	NULL
upstream	NULL
to	NULL
the	NULL
SCMV	NULL
MIE	NULL
or	NULL
simian	NULL
virus	NULL
40	NULL
minimal	NULL
promoter	NULL
regions	NULL
in	NULL
the	NULL
U-937	NULL
,	NULL
K-562	NULL
,	NULL
HL-60	NULL
,	NULL
THP-1	NULL
,	NULL
and	NULL
Jurkat	NULL
cell	NULL
lines	NULL
.	NULL

Unlike	NULL
classical	NULL
NFKB	NULL
sites	NULL
,	NULL
neither	NULL
the	NULL
SNE	NULL
nor	NULL
the	NULL
SEE	NULL
motif	NULL
responded	NULL
to	NULL
phosphatase	NULL
inhibition	NULL
by	NULL
okadaic	NULL
acid	NULL
.	NULL

However	NULL
,	NULL
the	NULL
TPA	NULL
responsiveness	NULL
of	NULL
both	NULL
CMV	NULL
elements	NULL
proved	NULL
to	NULL
involve	NULL
synergistic	NULL
interactions	NULL
between	NULL
the	NULL
core	NULL
SRF	NULL
binding	NULL
site	NULL
(	NULL
CCATATATGG	NULL
)	NULL
and	NULL
the	NULL
adjacent	NULL
inverted	NULL
ETS	NULL
binding	NULL
motifs	NULL
(	NULL
TTCC	NULL
)	NULL
,	NULL
which	NULL
correlated	NULL
directly	NULL
with	NULL
formation	NULL
of	NULL
a	NULL
bound	NULL
tripartite	NULL
complex	NULL
containing	NULL
both	NULL
the	NULL
cellular	NULL
SRF	NULL
and	NULL
ELK-1	NULL
proteins	NULL
.	NULL

This	NULL
protein	NULL
complex	NULL
was	NULL
more	NULL
abundant	NULL
in	NULL
U-937	NULL
,	NULL
K-562	NULL
,	NULL
and	NULL
HeLa	NULL
cell	NULL
extracts	NULL
than	NULL
in	NULL
Raji	NULL
,	NULL
HF	NULL
,	NULL
BALB/c	NULL
3T3	NULL
,	NULL
or	NULL
HL-60	NULL
cells	NULL
,	NULL
but	NULL
the	NULL
binding	NULL
activity	NULL
was	NULL
altered	NULL
only	NULL
twofold	NULL
after	NULL
TPA	NULL
treatment	NULL
.	NULL

A	NULL
40-fold	NULL
stimulation	NULL
of	NULL
chloramphenicol	NULL
acetyltransferase	NULL
activity	NULL
mediated	NULL
by	NULL
four	NULL
tandem	NULL
repeats	NULL
of	NULL
the	NULL
SNE	NULL
could	NULL
be	NULL
induced	NULL
within	NULL
2	NULL
h	NULL
(	NULL
and	NULL
up	NULL
to	NULL
250-fold	NULL
within	NULL
6	NULL
h	NULL
)	NULL
after	NULL
addition	NULL
of	NULL
TPA	NULL
in	NULL
DNA-transfected	NULL
U-937	NULL
cells	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
stimulation	NULL
appeared	NULL
likely	NULL
to	NULL
be	NULL
a	NULL
true	NULL
protein	NULL
kinase	NULL
C-mediated	NULL
signal	NULL
transduction	NULL
event	NULL
rather	NULL
than	NULL
a	NULL
differentiation	NULL
response	NULL
.	NULL

Slight	NULL
differences	NULL
in	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
core	NULL
SRF	NULL
binding	NULL
site	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
the	NULL
classical	NULL
c-Fos	NULL
promoter	NULL
serum	NULL
response	NULL
element	NULL
,	NULL
together	NULL
with	NULL
differences	NULL
in	NULL
the	NULL
spacing	NULL
between	NULL
the	NULL
SRF	NULL
and	NULL
ETS	NULL
motifs	NULL
,	NULL
appear	NULL
to	NULL
account	NULL
for	NULL
the	NULL
inability	NULL
of	NULL
the	NULL
SCMV	NULL
SNEs	NULL
to	NULL
respond	NULL
to	NULL
serum	NULL
induction	NULL
.	NULL

The	NULL
mechanisms	NULL
controlling	NULL
immediate-early	NULL
(	NULL
IE	NULL
)	NULL
gene	NULL
regulation	NULL
in	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
are	NULL
of	NULL
crucial	NULL
importance	NULL
for	NULL
understanding	NULL
cell	NULL
type	NULL
specificity	NULL
,	NULL
progression	NULL
of	NULL
the	NULL
lytic	NULL
cycle	NULL
cascade	NULL
,	NULL
and	NULL
the	NULL
outcome	NULL
of	NULL
host-virus	NULL
interactions	NULL
,	NULL
as	NULL
well	NULL
as	NULL
for	NULL
defining	NULL
how	NULL
the	NULL
virus	NULL
reactivates	NULL
from	NULL
a	NULL
persistent	NULL
or	NULL
latent	NULL
state	NULL
,	NULL
which	NULL
is	NULL
believed	NULL
to	NULL
occur	NULL
predominantly	NULL
in	NULL
monocytes	NULL
,	NULL
myeloid	NULL
stem	NULL
cells	NULL
,	NULL
and	NULL
perhaps	NULL
T	NULL
cells	NULL
(	NULL
20	NULL
,	NULL
31	NULL
,	NULL
39	NULL
,	NULL
61	NULL
,	NULL
64	NULL
,	NULL
78	NULL
,	NULL
79	NULL
,	NULL
86	NULL
)	NULL
.	NULL

The	NULL
major	NULL
IE	NULL
(	NULL
MIE	NULL
)	NULL
gene	NULL
products	NULL
,	NULL
which	NULL
are	NULL
autoregulatory	NULL
transactivators	NULL
that	NULL
trigger	NULL
the	NULL
expression	NULL
of	NULL
downstream	NULL
viral	NULL
genes	NULL
in	NULL
transient	NULL
assays	NULL
,	NULL
are	NULL
expected	NULL
to	NULL
be	NULL
key	NULL
players	NULL
governing	NULL
the	NULL
productive	NULL
cycle	NULL
and	NULL
are	NULL
often	NULL
found	NULL
to	NULL
be	NULL
repressed	NULL
in	NULL
nonpermissive	NULL
or	NULL
latent	NULL
infections	NULL
(	NULL
40	NULL
,	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Pharmacology	NULL
and	NULL
Molecular	NULL
Sciences	NULL
,	NULL
Johns	NULL
Hopkins	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
725	NULL
N.	NULL
Wolfe	NULL
St.	NULL
,	NULL
WBSB	NULL
317	NULL
,	NULL
Baltimore	NULL
,	NULL
MD	NULL
21205	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
410	NULL
)	NULL
955-8684	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
410	NULL
)	NULL
955-8685	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
Gary.Hayward	NULL
@	NULL
qmail.bs.jhu.edu	NULL
.	NULL

8590	NULL
41	NULL
,	NULL
50	NULL
,	NULL
54	NULL
,	NULL
65	NULL
,	NULL
71	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
to	NULL
explore	NULL
the	NULL
mechanism	NULL
of	NULL
CMV	NULL
reactivation	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
determine	NULL
how	NULL
the	NULL
virus	NULL
detects	NULL
and	NULL
responds	NULL
to	NULL
changes	NULL
in	NULL
the	NULL
differentiation	NULL
or	NULL
activation	NULL
state	NULL
of	NULL
host	NULL
cells	NULL
that	NULL
have	NULL
the	NULL
potential	NULL
to	NULL
control	NULL
viral	NULL
MIE	NULL
gene	NULL
expression	NULL
.	NULL

Although	NULL
in	NULL
primary	NULL
infections	NULL
,	NULL
the	NULL
choice	NULL
between	NULL
lytic	NULL
or	NULL
inapparent	NULL
infection	NULL
is	NULL
probably	NULL
influenced	NULL
by	NULL
incoming	NULL
virion	NULL
factors	NULL
(	NULL
49	NULL
)	NULL
as	NULL
well	NULL
as	NULL
by	NULL
preexisting	NULL
cellular	NULL
transcription	NULL
factors	NULL
,	NULL
reactivation	NULL
from	NULL
the	NULL
latent	NULL
state	NULL
must	NULL
be	NULL
mediated	NULL
first	NULL
by	NULL
inducible	NULL
host	NULL
cell	NULL
factors	NULL
acting	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
on	NULL
the	NULL
MIE	NULL
enhancer	NULL
.	NULL

Several	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
agents	NULL
that	NULL
alter	NULL
either	NULL
the	NULL
differentiation	NULL
or	NULL
activated	NULL
states	NULL
of	NULL
monocyte	NULL
or	NULL
myeloid	NULL
lineage	NULL
cells	NULL
in	NULL
culture	NULL
can	NULL
alter	NULL
the	NULL
degree	NULL
of	NULL
permissivity	NULL
to	NULL
CMV	NULL
(	NULL
17	NULL
,	NULL
18	NULL
,	NULL
73	NULL
,	NULL
79	NULL
,	NULL
86	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
have	NULL
recently	NULL
demonstrated	NULL
that	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
phorbol	NULL
ester	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
to	NULL
otherwise	NULL
completely	NULL
nonpermissive	NULL
U-937	NULL
cells	NULL
,	NULL
even	NULL
at	NULL
up	NULL
to	NULL
12	NULL
days	NULL
after	NULL
infection	NULL
by	NULL
either	NULL
human	NULL
CMV	NULL
(	NULL
HCMV	NULL
)	NULL
or	NULL
simian	NULL
CMV	NULL
(	NULL
SCMV	NULL
)	NULL
,	NULL
can	NULL
lead	NULL
both	NULL
to	NULL
increased	NULL
MIE	NULL
mRNA	NULL
and	NULL
protein	NULL
expression	NULL
and	NULL
to	NULL
induction	NULL
of	NULL
low	NULL
Vor	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
TPA	NULL
RESPONSES	NULL
OF	NULL
SRF/ETS	NULL
ELEMENTS	NULL
IN	NULL
CMV	NULL
8591	NULL
A	NULL
B	NULL
SRE	NULL
Ets	NULL
c	NULL
ShEc	NULL
ETS	NULL
-_	NULL
\	NULL
0	NULL
law	NULL
a	NULL
000	NULL
(	NULL
ls	NULL
,	NULL
css	NULL
0	NULL
SBE	NULL
0	NULL
~	NULL
aow	NULL
3	NULL
-s	NULL
sre	NULL
CATCTACcACATCTCCTAATATG	NULL
Â«	NULL
2500	NULL
-	NULL
-2000	NULL
-	NULL
1500	NULL
_	NULL
1000	NULL
_	NULL
-500	NULL
+1000	NULL
+800	NULL
+1000	NULL
bp	NULL
h	NULL
RC	NULL
arced	NULL
acu	NULL
2	NULL
Â«	NULL
si	NULL
ks	NULL
a	NULL
!	NULL

a	NULL
aem	NULL
1	NULL
case	NULL
gree	NULL
(	NULL
ac	NULL
)	NULL
-	NULL
fess	NULL
I	NULL
I	NULL
B20	NULL
Bio	NULL
A	NULL
p	NULL
seeee	NULL
e	NULL
eae	NULL
-	NULL
SREc	NULL
(	NULL
aF	NULL
)	NULL
[	NULL
-Nere	NULL
-peajeent_mn	NULL
[	NULL
inthon	NULL
nHesus	NULL
|	NULL
RHESUS	NULL
1	NULL
-	NULL
-s	NULL
>	NULL
ckÂ®	NULL
|	NULL
\	NULL
&	NULL
:	NULL
``	NULL
1280	NULL
seee	NULL
aer	NULL
70110	NULL
+588	NULL
BABOON	NULL
3	NULL
.-	NULL
-aso	NULL
SEE	NULL
GATCC	NULL
â	NULL
I'AGCFZCATA	NULL
â	NULL
I	NULL
â	NULL
A	NULL
â	NULL
I	NULL
â	NULL
GqAT	NULL
â	NULL
I	NULL
â	NULL
A	NULL
BABOON	NULL
2	NULL
-402	NULL
|	NULL
|	NULL
a	NULL
BABOON	NULL
1.	NULL
ss	NULL
Kim	NULL
camecacramTccatatatecorn	NULL
@	NULL
@	NULL
@	NULL
e	NULL
@	NULL
ra	NULL
c	NULL
B2	NULL
B1	NULL
A2	NULL
A1	NULL
p	NULL
I	NULL
L	NULL
mses	NULL
Bent	NULL
[	NULL
~~	NULL
NFIB	NULL
-|	NULL
kee	NULL
min	NULL
]	NULL
INTRON	NULL
AGM	NULL
HUMAN	NULL
1	NULL
-s3e	NULL
Sgï¬g	NULL
â	NULL
)	NULL
2400	NULL
1400	NULL
+70	NULL
+110	NULL
+587	NULL
I	NULL
sae	NULL
I	NULL
cHrMP	NULL
1	NULL
-s22	NULL
SNE	NULL
$	NULL
5	NULL
)	NULL
GATCCAGTATTFCAGCCGTGqGTWA	NULL
C	NULL
Â«	NULL
+1	NULL
Fos	NULL
SREB	NULL
5:15	NULL
A	NULL
â	NULL
s/AN	NULL
)	NULL
GATCCAGTATT	NULL
â	NULL
FCMSEEÃ©TGCkiTWI	NULL
â	NULL
A	NULL
cFos	NULL
~203	NULL
c	NULL
B2	NULL
BiA2	NULL
A1	NULL
p	NULL
(	NULL
Inv	NULL
.	NULL
)	NULL

E6	NULL
|	NULL
1	NULL
Bent	NULL
[	NULL
~	NULL
NFIB	NULL
_|	NULL
kesENHJan|_INTRON	NULL
BABOON	NULL
s/	NULL
NFkB	NULL
carccactamtccarataTeagacrferseh	NULL
2190	NULL
Â«	NULL
1150	NULL
-Â§73-489-328	NULL
70	NULL
+110	NULL
+621	NULL
|	NULL
|	NULL
$	NULL
/	NULL
Ins	NULL
.	NULL

N	NULL
+1	NULL
TOC	NULL
EoB	NULL
A	NULL
p	NULL
NFkB	NULL
(	NULL
1g	NULL
)	NULL
GATCCAGTATTCCAGCAGGGGACTTTCCAA	NULL
[	NULL
Mob	NULL
NF	NULL
]	NULL
e	NULL
ENH	NULL
_	NULL
jin|	NULL
INT	NULL
]	NULL
HUMAN	NULL
NFKB	NULL
(	NULL
HIV	NULL
)	NULL
catomeecactmTccocrecceactTreca	NULL
Â«	NULL
1125	NULL
.	NULL

772-613	NULL
Â«	NULL
TO-120	NULL
+350	NULL
oon	NULL
CC	NULL
sssse	NULL
Â«	NULL
see	NULL
ANFKA	NULL
(	NULL
Hiv	NULL
)	NULL
-	NULL
catcoofofopprccecmeacroropprcca	NULL
+1	NULL
E	NULL
B	NULL
__	NULL
A	NULL
t	NULL
CRE	NULL
CATCCCATTGACGTCAATEGCGTCAGCTCA	NULL
[	NULL
_	NULL
Mob	NULL
_	NULL
F	NULL
's	NULL
ENH	NULL
CHIMP	NULL
seee	NULL
Â«	NULL
1075	NULL
Â«	NULL
2r512	NULL
Â«	NULL
701120	NULL
+350	NULL
ACRE	NULL
GATCCCATTGGGCCCAATGGGGTCAGCTCA	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Organization	NULL
of	NULL
the	NULL
MIE	NULL
gene	NULL
control	NULL
regions	NULL
in	NULL
five	NULL
Old	NULL
World	NULL
primate	NULL
CMVs	NULL
.	NULL

The	NULL
diagram	NULL
represents	NULL
a	NULL
simplified	NULL
summary	NULL
of	NULL
data	NULL
compiled	NULL
by	NULL
Alcendor	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1	NULL
)	NULL
.	NULL

Position	NULL
+1	NULL
represents	NULL
the	NULL
start	NULL
site	NULL
for	NULL
all	NULL
IE	NULL
class	NULL
transcripts	NULL
encoding	NULL
both	NULL
IE1	NULL
and	NULL
IE2	NULL
proteins	NULL
.	NULL

Each	NULL
control	NULL
region	NULL
is	NULL
considered	NULL
to	NULL
have	NULL
a	NULL
minimal	NULL
promoter	NULL
and	NULL
leader	NULL
region	NULL
(	NULL
MIN	NULL
)	NULL
between	NULL
positions	NULL
-70	NULL
to	NULL
+110	NULL
encompassing	NULL
several	NULL
ATF	NULL
and	NULL
SP-1	NULL
sites	NULL
,	NULL
the	NULL
TATATAA	NULL
box	NULL
,	NULL
and	NULL
the	NULL
highly	NULL
conserved	NULL
first	NULL
noncoding	NULL
exon	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
fully	NULL
conserved	NULL
cis	NULL
repression	NULL
sequence	NULL
(	NULL
CRS	NULL
)	NULL
at	NULL
the	NULL
cap	NULL
site	NULL
,	NULL
which	NULL
represents	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
viral	NULL
IE2	NULL
protein	NULL
and	NULL
correlates	NULL
with	NULL
negative	NULL
autoregulation	NULL
.	NULL

Regulatory	NULL
domain	NULL
ENH-A1	NULL
contains	NULL
multicopy	NULL
CRE	NULL
,	NULL
NFB	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
series	NULL
II	NULL
and	NULL
IV	NULL
motifs	NULL
and	NULL
behaves	NULL
as	NULL
a	NULL
high	NULL
basal	NULL
plus	NULL
cAMP-and	NULL
TPA-inducible	NULL
enhancer	NULL
.	NULL

Domain	NULL
ENH-A2	NULL
contains	NULL
multiple	NULL
SRF	NULL
binding	NULL
sites	NULL
,	NULL
including	NULL
the	NULL
SNE	NULL
and	NULL
SEE	NULL
motifs	NULL
examined	NULL
in	NULL
this	NULL
study	NULL
(	NULL
solid	NULL
circles	NULL
)	NULL
.	NULL

Domain	NULL
B	NULL
represents	NULL
a	NULL
cluster	NULL
of	NULL
overlapping	NULL
palindromic	NULL
high-affinity	NULL
NF-1	NULL
and	NULL
YY1	NULL
binding	NULL
sites	NULL
that	NULL
includes	NULL
up	NULL
to	NULL
23	NULL
copies	NULL
of	NULL
30-bp	NULL
tandem	NULL
repeats	NULL
in	NULL
all	NULL
three	NULL
circopithecoid	NULL
SCMV	NULL
species	NULL
(	NULL
NF1-B	NULL
)	NULL
,	NULL
and	NULL
16-	NULL
to	NULL
21-bp	NULL
tandem	NULL
repeats	NULL
in	NULL
the	NULL
NF1-A	NULL
region	NULL
of	NULL
rhesus	NULL
SCMV	NULL
,	NULL
but	NULL
only	NULL
three	NULL
to	NULL
four	NULL
sites	NULL
in	NULL
HCMV	NULL
and	NULL
chimpanzee	NULL
SCMV	NULL
.	NULL

Domain	NULL
C	NULL
represents	NULL
a	NULL
large	NULL
intrinsically	NULL
bent	NULL
DNA	NULL
domain	NULL
in	NULL
AGM	NULL
and	NULL
baboon	NULL
SCMV	NULL
but	NULL
is	NULL
absent	NULL
in	NULL
the	NULL
others	NULL
.	NULL

Domain	NULL
D	NULL
includes	NULL
clustered	NULL
NF1	NULL
and	NULL
series	NULL
VII	NULL
repeats	NULL
plus	NULL
isolated	NULL
YY1	NULL
,	NULL
SP-1	NULL
,	NULL
SRE	NULL
,	NULL
and	NULL
other	NULL
motifs	NULL
within	NULL
the	NULL
large	NULL
first	NULL
intron	NULL
regions	NULL
.	NULL

Domain	NULL
E	NULL
denotes	NULL
the	NULL
negatively	NULL
acting	NULL
MOD	NULL
domain	NULL
encompassing	NULL
several	NULL
YY1	NULL
sites	NULL
and	NULL
a	NULL
cluster	NULL
of	NULL
approximately	NULL
20	NULL
CGATA	NULL
interspersed	NULL
repeats	NULL
in	NULL
both	NULL
HCMV	NULL
and	NULL
chimpanzee	NULL
SCMV	NULL
.	NULL

(	NULL
B	NULL
)	NULL
DNA	NULL
sequences	NULL
of	NULL
all	NULL
nine	NULL
known	NULL
series	NULL
V	NULL
and	NULL
III	NULL
SNE	NULL
or	NULL
SEE	NULL
motifs	NULL
from	NULL
within	NULL
the	NULL
primate	NULL
CMV	NULL
MIE	NULL
enhancer	NULL
regions	NULL
.	NULL

These	NULL
are	NULL
aligned	NULL
with	NULL
the	NULL
inverted	NULL
(	NULL
INV	NULL
.	NULL
)	NULL

orientation	NULL
of	NULL
the	NULL
SRE	NULL
from	NULL
the	NULL
c-Fos	NULL
promoter	NULL
.	NULL

The	NULL
core	NULL
10-bp	NULL
SRF	NULL
binding	NULL
sites	NULL
(	NULL
SRF	NULL
.	NULL
)	NULL

are	NULL
boxed	NULL
.	NULL

Note	NULL
that	NULL
eight	NULL
of	NULL
the	NULL
nine	NULL
SCMV	NULL
motifs	NULL
have	NULL
the	NULL
sequence	NULL
CCATATATGG	NULL
,	NULL
which	NULL
differs	NULL
from	NULL
the	NULL
classical	NULL
CCTAATATGG	NULL
sequence	NULL
for	NULL
the	NULL
c-Fos	NULL
version	NULL
,	NULL
which	NULL
for	NULL
proper	NULL
alignment	NULL
is	NULL
shown	NULL
inverted	NULL
from	NULL
its	NULL
natural	NULL
polarity	NULL
in	NULL
the	NULL
c-Fos	NULL
promoter	NULL
.	NULL

The	NULL
adjacent	NULL
ETS	NULL
class	NULL
inverted	NULL
core	NULL
GGAA	NULL
motifs	NULL
on	NULL
the	NULL
right	NULL
are	NULL
also	NULL
boxed	NULL
,	NULL
with	NULL
the	NULL
two	NULL
types	NULL
of	NULL
characteristic	NULL
consensus	NULL
motifs	NULL
of	NULL
the	NULL
SNE	NULL
(	NULL
TAGGAA	NULL
)	NULL
and	NULL
SEE	NULL
(	NULL
GCGGAAC	NULL
)	NULL
subtypes	NULL
highlighted	NULL
.	NULL

The	NULL
core	NULL
ETS	NULL
motif	NULL
(	NULL
GGAT	NULL
)	NULL
in	NULL
the	NULL
SRE	NULL
is	NULL
also	NULL
highlighted	NULL
and	NULL
italicized	NULL
.	NULL

Note	NULL
that	NULL
only	NULL
the	NULL
three	NULL
SEE	NULL
sites	NULL
(	NULL
human	NULL
,	NULL
chimpanzee	NULL
,	NULL
and	NULL
baboon	NULL
site	NULL
1	NULL
)	NULL
show	NULL
the	NULL
same	NULL
N2	NULL
spacing	NULL
as	NULL
does	NULL
the	NULL
SRE	NULL
core	NULL
ETS	NULL
motif	NULL
,	NULL
whereas	NULL
the	NULL
others	NULL
are	NULL
all	NULL
N3	NULL
.	NULL

The	NULL
highlighted	NULL
SEE	NULL
motif	NULL
is	NULL
also	NULL
a	NULL
close	NULL
match	NULL
to	NULL
the	NULL
specific	NULL
recognition	NULL
motif	NULL
GCGGAAC	NULL
for	NULL
the	NULL
ETS	NULL
class	NULL
protein	NULL
GABP	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Baboon	NULL
site	NULL
3	NULL
is	NULL
tentatively	NULL
included	NULL
as	NULL
an	NULL
SNE	NULL
because	NULL
it	NULL
contains	NULL
a	NULL
potential	NULL
core	NULL
ETS	NULL
motif	NULL
GGAT	NULL
,	NULL
although	NULL
in	NULL
inverted	NULL
orientation	NULL
relative	NULL
to	NULL
the	NULL
others	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Oligonucleotide	NULL
probes	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

Only	NULL
the	NULL
sequences	NULL
of	NULL
the	NULL
top	NULL
strands	NULL
of	NULL
each	NULL
annealed	NULL
pair	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
core	NULL
SRF	NULL
binding	NULL
sites	NULL
are	NULL
boxed	NULL
,	NULL
and	NULL
the	NULL
core	NULL
inverted	NULL
ETS	NULL
motifs	NULL
including	NULL
the	NULL
consensus	NULL
GABP	NULL
site	NULL
in	NULL
the	NULL
HCMV	NULL
SEE	NULL
are	NULL
highlighted	NULL
.	NULL

Altered	NULL
base	NULL
pairs	NULL
are	NULL
indicated	NULL
by	NULL
solid	NULL
overhead	NULL
circles	NULL
,	NULL
and	NULL
the	NULL
double	NULL
underline	NULL
denotes	NULL
the	NULL
classical	NULL
Ig	NULL
kappa	NULL
NFkB	NULL
motif	NULL
GGGACTTTCC	NULL
or	NULL
the	NULL
16-bp	NULL
palindrome	NULL
series	NULL
I	NULL
CRE	NULL
motif	NULL
CCATTGACGTCAATGG	NULL
.	NULL

The	NULL
spacing	NULL
mutant	NULL
S/InsN	NULL
contains	NULL
two	NULL
added	NULL
guanines	NULL
between	NULL
the	NULL
core	NULL
SRF	NULL
and	NULL
ETS	NULL
motifs	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
annealing	NULL
with	NULL
the	NULL
complementary	NULL
strand	NULL
creates	NULL
4-bp	NULL
BamHI	NULL
and	NULL
Bg/lI	NULL
5	NULL
``	NULL
overhangs	NULL
for	NULL
cloning	NULL
purposes	NULL
that	NULL
are	NULL
filled	NULL
in	NULL
with	NULL
T4	NULL
polymerase	NULL
during	NULL
end	NULL
labeling	NULL
for	NULL
use	NULL
as	NULL
EMSA	NULL
probes	NULL
.	NULL

levels	NULL
of	NULL
infectious	NULL
progeny	NULL
virions	NULL
as	NULL
assayed	NULL
by	NULL
cocultivation	NULL
with	NULL
HF	NULL
cells	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
CMV	NULL
MIE	NULL
gene	NULL
products	NULL
,	NULL
the	NULL
IE1	NULL
and	NULL
IE2	NULL
proteins	NULL
,	NULL
are	NULL
presumed	NULL
to	NULL
be	NULL
involved	NULL
directly	NULL
in	NULL
regulating	NULL
subsequent	NULL
gene	NULL
expression	NULL
during	NULL
the	NULL
viral	NULL
lytic	NULL
cascade	NULL
,	NULL
as	NULL
well	NULL
as	NULL
acting	NULL
as	NULL
potential	NULL
triggers	NULL
of	NULL
the	NULL
switch	NULL
between	NULL
latent	NULL
and	NULL
lytic	NULL
infection	NULL
(	NULL
25	NULL
,	NULL
34	NULL
,	NULL
35	NULL
,	NULL
59	NULL
,	NULL
85	NULL
)	NULL
.	NULL

The	NULL
CMV	NULL
IE1	NULL
acidic	NULL
phosphoprotein	NULL
is	NULL
translated	NULL
from	NULL
a	NULL
1.95-kb	NULL
mRNA	NULL
,	NULL
which	NULL
contains	NULL
exons	NULL
1	NULL
to	NULL
4	NULL
from	NULL
the	NULL
MIE	NULL
gene	NULL
and	NULL
is	NULL
a	NULL
68-	NULL
to	NULL
72-kDa	NULL
(	NULL
HCMV	NULL
)	NULL
or	NULL
94-kDa	NULL
(	NULL
SCMV	NULL
)	NULL
phosphorylated	NULL
nuclear	NULL
protein	NULL
(	NULL
34	NULL
,	NULL
42	NULL
,	NULL
75	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
exact	NULL
function	NULL
of	NULL
the	NULL
IE1	NULL
protein	NULL
is	NULL
not	NULL
clear	NULL
.	NULL

The	NULL
intact	NULL
IEZ	NULL
phosphorylated	NULL
nuclear	NULL
protein	NULL
is	NULL
translated	NULL
from	NULL
a	NULL
2.25-kb	NULL
mRNA	NULL
containing	NULL
exons	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
that	NULL
is	NULL
generated	NULL
from	NULL
the	NULL
MIE	NULL
gene	NULL
by	NULL
alternative	NULL
splicing	NULL
.	NULL

IE2	NULL
functions	NULL
both	NULL
as	NULL
a	NULL
powerful	NULL
nonspecific	NULL
transactivator	NULL
and	NULL
as	NULL
a	NULL
specific	NULL
repressor	NULL
that	NULL
negatively	NULL
autoregulates	NULL
the	NULL
MIE	NULL
promoter	NULL
(	NULL
25	NULL
,	NULL
59	NULL
,	NULL
74	NULL
)	NULL
.	NULL

The	NULL
dimeric	NULL
80-kDa	NULL
form	NULL
of	NULL
the	NULL
IE2	NULL
protein	NULL
in	NULL
particular	NULL
appears	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
both	NULL
up-regulating	NULL
early	NULL
gene	NULL
products	NULL
and	NULL
down-regulating	NULL
its	NULL
own	NULL
gene	NULL
expression	NULL
through	NULL
specific	NULL
binding	NULL
to	NULL
the	NULL
palindromic	NULL
cis	NULL
repression	NULL
sequence	NULL
,	NULL
CGTTTN4AACCG	NULL
,	NULL
located	NULL
at	NULL
the	NULL
cap	NULL
site	NULL
of	NULL
both	NULL
the	NULL
HCMV	NULL
and	NULL
SCMV	NULL
MIE	NULL
regions	NULL
(	NULL
12	NULL
,	NULL
45	NULL
,	NULL
57	NULL
,	NULL
58	NULL
)	NULL
.	NULL

The	NULL
entire	NULL
MIE	NULL
enhancer/promoter	NULL
region	NULL
has	NULL
been	NULL
se	NULL
quenced	NULL
for	NULL
human	NULL
,	NULL
chimpanzee	NULL
,	NULL
African	NULL
green	NULL
monkey	NULL
(	NULL
AGM	NULL
)	NULL
,	NULL
baboon	NULL
,	NULL
and	NULL
rhesus	NULL
CMVs	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
6	NULL
,	NULL
10	NULL
,	NULL
36	NULL
,	NULL
82	NULL
)	NULL
as	NULL
well	NULL
as	NULL
for	NULL
mouse	NULL
and	NULL
rat	NULL
CMVs	NULL
.	NULL

The	NULL
genomic	NULL
structures	NULL
of	NULL
the	NULL
five	NULL
primate	NULL
CMV	NULL
MIE	NULL
enhancer	NULL
regions	NULL
,	NULL
which	NULL
range	NULL
in	NULL
size	NULL
from	NULL
1,500	NULL
to	NULL
3,000	NULL
bp	NULL
,	NULL
show	NULL
two	NULL
distinct	NULL
patterns	NULL
of	NULL
subregion	NULL
organization	NULL
exemplified	NULL
by	NULL
the	NULL
great	NULL
ape	NULL
CMV	NULL
versions	NULL
(	NULL
human	NULL
and	NULL
chimpanzee	NULL
)	NULL
and	NULL
the	NULL
three	NULL
circopithecoid	NULL
versions	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

In	NULL
HCMV	NULL
,	NULL
the	NULL
whole	NULL
MIEy	NULL
,	NULL
regulatory	NULL
region	NULL
(	NULL
previously	NULL
referred	NULL
to	NULL
as	NULL
IE68	NULL
)	NULL
,	NULL
which	NULL
spans	NULL
from	NULL
-1125	NULL
upstream	NULL
to	NULL
+360	NULL
downstream	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
point	NULL
,	NULL
can	NULL
be	NULL
considered	NULL
as	NULL
five	NULL
subregions	NULL
with	NULL
different	NULL
functional	NULL
roles	NULL
.	NULL

These	NULL
are	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
far-upstream	NULL
modulatory	NULL
region	NULL
(	NULL
MOD	NULL
)	NULL
,	NULL
the	NULL
nuclear	NULL
factor	NULL
1	NULL
binding	NULL
site	NULL
region	NULL
(	NULL
NF1	NULL
)	NULL
,	NULL
the	NULL
proximal	NULL
enhancer	NULL
region	NULL
(	NULL
ENH	NULL
)	NULL
,	NULL
the	NULL
minimal	NULL
promoter	NULL
plus	NULL
leader	NULL
region	NULL
(	NULL
MIN	NULL
)	NULL
,	NULL
and	NULL
the	NULL
downstream	NULL
intron	NULL
control	NULL
region	NULL
(	NULL
INT	NULL
)	NULL
.	NULL

The	NULL
HCMV	NULL
proximal	NULL
ENH	NULL
region	NULL
between	NULL
positions	NULL
-613	NULL
and	NULL
-70	NULL
contains	NULL
four	NULL
sets	NULL
of	NULL
interspersed	NULL
multicopy	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
(	NULL
referred	NULL
to	NULL
as	NULL
19-	NULL
,	NULL
16-	NULL
,	NULL
18-	NULL
,	NULL
and	NULL
21-bp	NULL
elements	NULL
)	NULL
and	NULL
represents	NULL
the	NULL
principal	NULL
cis-acting	NULL
basal	NULL
enhancer	NULL
region	NULL
(	NULL
1	NULL
,	NULL
22	NULL
,	NULL
82	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
two	NULL
retinoic	NULL
acid	NULL
(	NULL
RA	NULL
)	NULL
response	NULL
elements	NULL
have	NULL
been	NULL
identified	NULL
within	NULL
the	NULL
ENH	NULL
region	NULL
and	NULL
shown	NULL
to	NULL
mediate	NULL
induction	NULL
in	NULL
human	NULL
teratocarcinoma	NULL
(	NULL
NTera2	NULL
)	NULL
cells	NULL
after	NULL
RA	NULL
stimulation	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
SCMV	NULL
(	NULL
AGM	NULL
)	NULL
enhancer/promoter	NULL
(	NULL
previously	NULL
referred	NULL
to	NULL
as	NULL
8592	NULL
CHAN	NULL
ET	NULL
AL	NULL
.	NULL

1E94	NULL
)	NULL
includes	NULL
a	NULL
proximal	NULL
ENH	NULL
region	NULL
mapping	NULL
between	NULL
-570	NULL
to	NULL
-69	NULL
,	NULL
which	NULL
also	NULL
consists	NULL
of	NULL
several	NULL
sets	NULL
of	NULL
interspersed	NULL
repeated	NULL
sequences	NULL
(	NULL
series	NULL
I	NULL
to	NULL
V	NULL
)	NULL
that	NULL
closely	NULL
resemble	NULL
those	NULL
in	NULL
HCMV	NULL
,	NULL
except	NULL
that	NULL
they	NULL
differ	NULL
greatly	NULL
in	NULL
both	NULL
copy	NULL
number	NULL
and	NULL
organization	NULL
(	NULL
9	NULL
,	NULL
34	NULL
,	NULL
36	NULL
)	NULL
.	NULL

The	NULL
HCMV	NULL
MOD	NULL
region	NULL
contains	NULL
several	NULL
consensus	NULL
NF-1	NULL
and	NULL
YY1	NULL
binding	NULL
sites	NULL
and	NULL
has	NULL
been	NULL
proposed	NULL
to	NULL
play	NULL
a	NULL
negative	NULL
regulatory	NULL
role	NULL
in	NULL
teratocarcinoma	NULL
cell	NULL
lines	NULL
(	NULL
54	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
circopithecoid	NULL
SCMV	NULL
upstream	NULL
regions	NULL
have	NULL
substituted	NULL
additional	NULL
larger	NULL
domains	NULL
in	NULL
place	NULL
of	NULL
the	NULL
HCMV	NULL
MOD	NULL
region	NULL
.	NULL

In	NULL
AGM	NULL
,	NULL
rhesus	NULL
,	NULL
and	NULL
baboon	NULL
SCMVs	NULL
,	NULL
the	NULL
first	NULL
extended	NULL
subregion	NULL
(	NULL
NF1-B	NULL
)	NULL
contains	NULL
approximately	NULL
20	NULL
copies	NULL
of	NULL
30-bp	NULL
tandemly	NULL
repeated	NULL
high-affinity	NULL
palindromic	NULL
NF-1	NULL
binding	NULL
sites	NULL
[	NULL
(	NULL
T	NULL
)	NULL
TGG	NULL
(	NULL
C/A	NULL
)	NULL
N	NULL
,	NULL
GCCAA	NULL
]	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
36	NULL
)	NULL
with	NULL
overlapping	NULL
and	NULL
interspersed	NULL
high-affinity	NULL
YY1	NULL
binding	NULL
sites	NULL
(	NULL
CGCCATT	NULL
TT	NULL
)	NULL
.	NULL

In	NULL
AGM	NULL
and	NULL
baboon	NULL
SCMV	NULL
,	NULL
a	NULL
second	NULL
further	NULL
upstream	NULL
subregion	NULL
(	NULL
BENT	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
ending	NULL
at	NULL
positions	NULL
-2400	NULL
and	NULL
-2160	NULL
,	NULL
respectively	NULL
,	NULL
contains	NULL
a	NULL
1,000-bp	NULL
long	NULL
A+T-rich	NULL
bent	NULL
DNA	NULL
domain	NULL
(	NULL
1	NULL
,	NULL
10	NULL
)	NULL
.	NULL

The	NULL
NF1	NULL
cluster	NULL
and	NULL
bent	NULL
DNA	NULL
region	NULL
in	NULL
the	NULL
far-upstream	NULL
SCMV	NULL
MIE	NULL
,	NULL
control	NULL
region	NULL
do	NULL
not	NULL
have	NULL
basal	NULL
enhancer	NULL
or	NULL
modulatory	NULL
properties	NULL
in	NULL
transient	NULL
assays	NULL
but	NULL
have	NULL
been	NULL
suggested	NULL
to	NULL
play	NULL
an	NULL
indirect	NULL
role	NULL
in	NULL
the	NULL
constitutive	NULL
SCMV	NULL
MIEs	NULL
expression	NULL
in	NULL
human	NULL
NTera2	NULL
teratocarcinoma	NULL
cells	NULL
,	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
RA	NULL
stimulation	NULL
(	NULL
10	NULL
,	NULL
36	NULL
,	NULL
40	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
HCMV	NULL
MOD	NULL
region	NULL
contains	NULL
many	NULL
fewer	NULL
NFI	NULL
sites	NULL
and	NULL
HCMV	NULL
MIE	NULL
;	NULL
gene	NULL
expression	NULL
occurs	NULL
only	NULL
after	NULL
RA	NULL
stimulation	NULL
in	NULL
NTera2	NULL
cells	NULL
(	NULL
23	NULL
,	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Among	NULL
the	NULL
repetitive	NULL
ENH	NULL
motifs	NULL
in	NULL
primate	NULL
CMV	NULL
MIE	NULL
regions	NULL
,	NULL
the	NULL
cyclic	NULL
AMP	NULL
(	NULL
cAMP	NULL
)	NULL
response	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
sites	NULL
(	NULL
series	NULL
I	NULL
or	NULL
19-bp	NULL
elements	NULL
)	NULL
and	NULL
the	NULL
NFKB	NULL
sites	NULL
(	NULL
series	NULL
III	NULL
or	NULL
18-bp	NULL
elements	NULL
)	NULL
have	NULL
received	NULL
the	NULL
most	NULL
attention	NULL
.	NULL

Both	NULL
have	NULL
been	NULL
shown	NULL
convincingly	NULL
to	NULL
be	NULL
functionally	NULL
relevant	NULL
components	NULL
of	NULL
basal	NULL
and	NULL
induced	NULL
enhancer	NULL
activity	NULL
when	NULL
added	NULL
to	NULL
heterologous	NULL
minimal	NULL
promoters	NULL
,	NULL
as	NULL
well	NULL
as	NULL
to	NULL
mediate	NULL
protein	NULL
kinase	NULL
A	NULL
(	NULL
PKA	NULL
)	NULL
or	NULL
PKC	NULL
signal	NULL
transduction	NULL
pathways	NULL
that	NULL
activate	NULL
MIE	NULL
gene	NULL
expression	NULL
.	NULL

Additive	NULL
effects	NULL
of	NULL
between	NULL
5	NULL
and	NULL
11	NULL
of	NULL
the	NULL
16-bp	NULL
palindromic	NULL
series	NULL
I	NULL
repeats	NULL
CCATTGA	NULL
CGTCAATGG	NULL
,	NULL
which	NULL
encompass	NULL
8-bp	NULL
core	NULL
consensus	NULL
CREB	NULL
binding	NULL
sites	NULL
,	NULL
proved	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
both	NULL
basal	NULL
enhancement	NULL
and	NULL
cAMP	NULL
-induced	NULL
activities	NULL
in	NULL
the	NULL
K-562	NULL
erythroleuke-mia	NULL
cell	NULL
line	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
responses	NULL
to	NULL
cAMP	NULL
and	NULL
phytohe-magglutinin-plus-phorbol	NULL
myristate	NULL
acetate	NULL
treatment	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
using	NULL
sets	NULL
of	NULL
deleted	NULL
MIE	NULL
enhancer-driven	NULL
reporter	NULL
genes	NULL
or	NULL
multicopy	NULL
consensus	NULL
CRE	NULL
oligonucleotides	NULL
linked	NULL
to	NULL
heterologous	NULL
minimal	NULL
promoters	NULL
(	NULL
9	NULL
,	NULL
31	NULL
,	NULL
72	NULL
)	NULL
.	NULL

Four	NULL
or	NULL
five	NULL
18-bp	NULL
repeats	NULL
with	NULL
the	NULL
core	NULL
consensus	NULL
GGGGACTTITCC	NULL
,	NULL
which	NULL
closely	NULL
resemble	NULL
the	NULL
classical	NULL
immunoglobulin	NULL
(	NULL
Ig	NULL
)	NULL
kappa	NULL
light-chain	NULL
NFkB	NULL
site	NULL
,	NULL
occur	NULL
in	NULL
both	NULL
the	NULL
human	NULL
and	NULL
chimpanzee	NULL
CMV	NULL
MIE	NULL
enhancers	NULL
and	NULL
were	NULL
postulated	NULL
to	NULL
be	NULL
cis-acting	NULL
phorbol	NULL
myristate	NULL
acetate-responsive	NULL
regulatory	NULL
elements	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
64	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
SCMV	NULL
MIE	NULL
,	NULL
contains	NULL
several	NULL
variant	NULL
nonconsen-sus	NULL
NFkB-related	NULL
elements	NULL
(	NULL
series	NULL
IIIB	NULL
)	NULL
;	NULL
however	NULL
,	NULL
these	NULL
proved	NULL
to	NULL
bind	NULL
preferentially	NULL
to	NULL
KBFI1	NULL
or	NULL
other	NULL
Rel	NULL
proteins	NULL
(	NULL
p50	NULL
:	NULL
p50	NULL
)	NULL
present	NULL
in	NULL
Raji	NULL
B-cell	NULL
extracts	NULL
but	NULL
only	NULL
weakly	NULL
to	NULL
NFkB	NULL
itself	NULL
(	NULL
p65	NULL
:	NULL
p50	NULL
)	NULL
(	NULL
13a	NULL
)	NULL
.	NULL

Several	NULL
consensus	NULL
AP-1	NULL
sites	NULL
in	NULL
the	NULL
HCMV	NULL
MIE	NULL
;	NULL
enhancer	NULL
could	NULL
also	NULL
potentially	NULL
mediate	NULL
TPA	NULL
responses	NULL
,	NULL
but	NULL
the	NULL
SCMV	NULL
MIE	NULL
,	NULL
enhancer	NULL
region	NULL
contains	NULL
no	NULL
compelling	NULL
classical	NULL
consensus	NULL
motifs	NULL
for	NULL
either	NULL
NFkB	NULL
or	NULL
AP-1	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
elsewhere	NULL
that	NULL
the	NULL
SCMV	NULL
MIE	NULL
,	NULL
series	NULL
I	NULL
CREs	NULL
also	NULL
respond	NULL
directly	NULL
to	NULL
TPA	NULL
in	NULL
transient	NULL
assays	NULL
in	NULL
monocyte	NULL
and	NULL
T-cell	NULL
types	NULL
(	NULL
11	NULL
)	NULL
,	NULL
but	NULL
another	NULL
candidate	NULL
transcription	NULL
factor	NULL
for	NULL
mediating	NULL
the	NULL
TPA-induced	NULL
signal	NULL
transduction	NULL
pathway	NULL
in	NULL
SCMV	NULL
has	NULL
turned	NULL
out	NULL
to	NULL
be	NULL
the	NULL
serum	NULL
response	NULL
factor	NULL
(	NULL
SRF	NULL
)	NULL
,	NULL
which	NULL
is	NULL
the	NULL
subject	NULL
of	NULL
this	NULL
study	NULL
.	NULL

Three	NULL
J.	NULL
ViRoL	NULL
.	NULL

copies	NULL
of	NULL
an	NULL
SRF	NULL
core	NULL
consensus	NULL
binding	NULL
site	NULL
motif	NULL
referred	NULL
to	NULL
previously	NULL
as	NULL
the	NULL
series	NULL
V	NULL
repeats	NULL
(	NULL
10	NULL
)	NULL
each	NULL
overlap	NULL
with	NULL
a	NULL
series	NULL
IIIB	NULL
motif	NULL
,	NULL
producing	NULL
novel	NULL
elements	NULL
referred	NULL
to	NULL
as	NULL
SNE	NULL
(	NULL
SRF/NFxB-like	NULL
elements	NULL
)	NULL
with	NULL
the	NULL
consensus	NULL
sequence	NULL
CCA	NULL
TATATGGGTITTCC	NULL
.	NULL

These	NULL
all	NULL
occur	NULL
within	NULL
the	NULL
SCMV	NULL
MIE	NULL
ENH-A2	NULL
subregion	NULL
between	NULL
positions	NULL
-573	NULL
and	NULL
-444	NULL
,	NULL
which	NULL
displays	NULL
basal	NULL
enhancer	NULL
characteristics	NULL
in	NULL
U-937	NULL
cells	NULL
but	NULL
fails	NULL
to	NULL
respond	NULL
to	NULL
serum	NULL
induction	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
(	NULL
10	NULL
)	NULL
.	NULL

In	NULL
other	NULL
studies	NULL
,	NULL
we	NULL
found	NULL
that	NULL
whereas	NULL
the	NULL
ENH-A1l	NULL
and	NULL
ENH-A2	NULL
domains	NULL
each	NULL
respond	NULL
independently	NULL
to	NULL
a	NULL
level	NULL
of	NULL
between	NULL
8-	NULL
and	NULL
15-fold	NULL
to	NULL
TPA	NULL
induction	NULL
in	NULL
immature	NULL
U-937	NULL
cells	NULL
,	NULL
neither	NULL
does	NULL
so	NULL
alone	NULL
in	NULL
the	NULL
more	NULL
mature	NULL
THP-1	NULL
cells	NULL
(	NULL
11	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
ENH-A1	NULL
and	NULL
ENH-A2	NULL
domains	NULL
restores	NULL
the	NULL
ability	NULL
to	NULL
respond	NULL
5.5-fold	NULL
to	NULL
TPA	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
reconstruction	NULL
experiments	NULL
indicated	NULL
that	NULL
two	NULL
tandem	NULL
copies	NULL
of	NULL
a	NULL
30-mer	NULL
SNE	NULL
oligonucleotide	NULL
added	NULL
upstream	NULL
to	NULL
a	NULL
minimal	NULL
SCMV	NULL
MIE	NULL
,	NULL
,	NULL
(	NULL
-69/+30	NULL
)	NULL
promoter	NULL
reporter	NULL
gene	NULL
were	NULL
required	NULL
to	NULL
obtain	NULL
significant	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
15-	NULL
to	NULL
20-fold	NULL
)	NULL
TPA	NULL
responses	NULL
in	NULL
U-937	NULL
cells	NULL
,	NULL
whereas	NULL
four	NULL
copies	NULL
were	NULL
required	NULL
in	NULL
HL-60	NULL
cells	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
present	NULL
studies	NULL
were	NULL
designed	NULL
to	NULL
explore	NULL
the	NULL
mechanism	NULL
of	NULL
TPA	NULL
induction	NULL
associated	NULL
with	NULL
the	NULL
SNE	NULL
motifs	NULL
.	NULL

Serum	NULL
response	NULL
elements	NULL
(	NULL
SREs	NULL
)	NULL
have	NULL
been	NULL
found	NULL
in	NULL
several	NULL
cellular	NULL
IE	NULL
gene	NULL
promoters	NULL
,	NULL
including	NULL
c-fos	NULL
and	NULL
egr-/	NULL
pro-moters	NULL
.	NULL

They	NULL
are	NULL
usually	NULL
regulated	NULL
by	NULL
extracellular	NULL
signals	NULL
including	NULL
serum	NULL
,	NULL
growth	NULL
factors	NULL
,	NULL
mitogens	NULL
,	NULL
and	NULL
phorbol	NULL
esters	NULL
(	NULL
83	NULL
)	NULL
.	NULL

Many	NULL
studies	NULL
on	NULL
the	NULL
mechanism	NULL
of	NULL
c-Fos	NULL
SRE	NULL
responsiveness	NULL
have	NULL
found	NULL
that	NULL
SRF	NULL
and	NULL
a	NULL
ternary	NULL
complex	NULL
factor	NULL
(	NULL
TCF	NULL
)	NULL
,	NULL
which	NULL
can	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
SRE	NULL
motif	NULL
by	NULL
itself	NULL
(	NULL
69	NULL
)	NULL
,	NULL
form	NULL
a	NULL
cooperative	NULL
DNA-bound	NULL
complex	NULL
.	NULL

The	NULL
SRF	NULL
protein	NULL
recognizes	NULL
the	NULL
core	NULL
c-Fos	NULL
SRF	NULL
site	NULL
(	NULL
CCATATTAGG	NULL
)	NULL
and	NULL
the	NULL
TCF	NULL
protein	NULL
contacts	NULL
both	NULL
the	NULL
SRF	NULL
protein	NULL
and	NULL
an	NULL
adjacent	NULL
ETS	NULL
binding	NULL
motif	NULL
(	NULL
CAGGAT	NULL
)	NULL
that	NULL
lies	NULL
2	NULL
bp	NULL
5	NULL
'	NULL
to	NULL
the	NULL
core	NULL
SRF	NULL
motif	NULL
(	NULL
15	NULL
,	NULL
30	NULL
,	NULL
69	NULL
,	NULL
70	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
report	NULL
that	NULL
SRF-related	NULL
SNEs	NULL
are	NULL
consistently	NULL
found	NULL
in	NULL
several	NULL
different	NULL
primate	NULL
MIE	NULL
ENH-A2	NULL
regions	NULL
and	NULL
demonstrate	NULL
that	NULL
the	NULL
HCMV	NULL
MIEy	NULL
;	NULL
region	NULL
also	NULL
contains	NULL
a	NULL
single	NULL
SRF-related	NULL
functional	NULL
element	NULL
at	NULL
-538	NULL
to	NULL
-523	NULL
,	NULL
which	NULL
we	NULL
refer	NULL
to	NULL
as	NULL
an	NULL
SEE	NULL
(	NULL
SRF/ETS	NULL
element	NULL
)	NULL
because	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
both	NULL
SRF	NULL
and	NULL
potential	NULL
consensus	NULL
ETS	NULL
class	NULL
GA-binding	NULL
protein	NULL
(	NULL
GABP	NULL
)	NULL
binding	NULL
sites	NULL
(	NULL
43	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
absence	NULL
of	NULL
NFKB-related	NULL
motifs	NULL
.	NULL

Although	NULL
differing	NULL
in	NULL
the	NULL
spacing	NULL
between	NULL
the	NULL
SRF	NULL
and	NULL
ETS	NULL
motifs	NULL
,	NULL
both	NULL
the	NULL
HCMV	NULL
SEE	NULL
and	NULL
SCMV	NULL
SNE	NULL
motifs	NULL
were	NULL
found	NULL
to	NULL
bind	NULL
in	NULL
vitro	NULL
to	NULL
the	NULL
cellular	NULL
SRF	NULL
and	NULL
to	NULL
form	NULL
a	NULL
ternary	NULL
complex	NULL
with	NULL
an	NULL
ETS	NULL
family	NULL
protein	NULL
.	NULL

They	NULL
both	NULL
also	NULL
responded	NULL
rapidly	NULL
to	NULL
TPA	NULL
induction	NULL
in	NULL
monocyte	NULL
and	NULL
lymphoid	NULL
cell	NULL
lines	NULL
,	NULL
but	NULL
unlike	NULL
NFkB	NULL
sites	NULL
,	NULL
they	NULL
failed	NULL
to	NULL
be	NULL
induced	NULL
by	NULL
okadaic	NULL
acid	NULL
(	NULL
OA	NULL
)	NULL
treatment	NULL
to	NULL
inhibit	NULL
phosphatases	NULL
.	NULL

In	NULL
the	NULL
SCMV	NULL
SNEs	NULL
,	NULL
muta-tional	NULL
analysis	NULL
revealed	NULL
that	NULL
both	NULL
the	NULL
overlapping	NULL
SRF	NULL
and	NULL
ETS	NULL
motifs	NULL
are	NULL
essential	NULL
for	NULL
activity	NULL
and	NULL
that	NULL
they	NULL
have	NULL
synergistic	NULL
effects	NULL
on	NULL
both	NULL
basal	NULL
enhancement	NULL
and	NULL
TPA	NULL
responsiveness	NULL
,	NULL
suggesting	NULL
that	NULL
a	NULL
viral	NULL
version	NULL
of	NULL
this	NULL
cellular	NULL
protein-protein	NULL
interaction	NULL
is	NULL
involved	NULL
in	NULL
regulating	NULL
the	NULL
CMV	NULL
MIE	NULL
transcriptional	NULL
enhancer	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
and	NULL
reagents	NULL
.	NULL

Suspension	NULL
cell	NULL
lines	NULL
(	NULL
human	NULL
K-562	NULL
[	NULL
erythroleukemia	NULL
]	NULL
,	NULL
human	NULL
U-937	NULL
[	NULL
immature	NULL
monocyte-like	NULL
histiocytic	NULL
lymphoma	NULL
]	NULL
,	NULL
human	NULL
HL-60	NULL
[	NULL
promyelocytic	NULL
leukemia	NULL
)	NULL
,	NULL
human	NULL
Jurkat	NULL
[	NULL
T-cell	NULL
leukemia	NULL
)	NULL
,	NULL
and	NULL
human	NULL
THP-1	NULL
[	NULL
mature	NULL
monocytic	NULL
leukemia	NULL
]	NULL
)	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
plus	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
in	NULL
a	NULL
37Â°C	NULL
incubator	NULL
supplied	NULL
with	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
.	NULL

Adherent	NULL
cells	NULL
such	NULL
as	NULL
human	NULL
HF	NULL
,	NULL
mouse	NULL
BALB/c	NULL
3T3	NULL
,	NULL
and	NULL
monkey	NULL
Vero	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
Dulbecco	NULL
modified	NULL
Eagle	NULL
medium	NULL
plus	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

K-562	NULL
,	NULL
U-937	NULL
,	NULL
HL-60	NULL
,	NULL
and	NULL
Jurkat	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Rock-ville	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

.	NULL

THP-1	NULL
cells	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
James	NULL
Hildreth	NULL
(	NULL
Johns	NULL
Hopkins	NULL
School	NULL
of	NULL
Medicine	NULL
)	NULL
.	NULL

TPA	NULL
(	NULL
Sigma	NULL
)	NULL
was	NULL
dissolved	NULL
in	NULL
dimethyl	NULL
sulfoxide	NULL
to	NULL
a	NULL
concentration	NULL
of	NULL
20	NULL
pg/ml	NULL
as	NULL
a	NULL
stock	NULL
solution	NULL
and	NULL
used	NULL
at	NULL
a	NULL
working	NULL
concentration	NULL
of	NULL
50	NULL
ng/ml	NULL
for	NULL
each	NULL
TPA	NULL
stimulation	NULL
experiment	NULL
.	NULL

OA	NULL
was	NULL
purchased	NULL
from	NULL
VoL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
Bochringer	NULL
Mannheim	NULL
Co.	NULL
and	NULL
dissolved	NULL
in	NULL
ethanol	NULL
as	NULL
a	NULL
100	NULL
%	NULL
stock	NULL
solution	NULL
.	NULL

Rabbit	NULL
polyclonal	NULL
antibodies	NULL
recognizing	NULL
ELK-1	NULL
(	NULL
se-355	NULL
)	NULL
,	NULL
ETS-1/2	NULL
(	NULL
sc-112	NULL
)	NULL
,	NULL
ETS-1	NULL
(	NULL
se-111	NULL
)	NULL
,	NULL
and	NULL
PEA3	NULL
(	NULL
sc-113	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotech-nology	NULL
,	NULL
Inc.	NULL
PU1	NULL
antibody	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Richard	NULL
A.	NULL
Maki	NULL
.	NULL

GABPa	NULL
(	NULL
C95	NULL
)	NULL
and	NULL
GABPB	NULL
(	NULL
C96	NULL
)	NULL
rabbit	NULL
anti-mouse	NULL
antibodies	NULL
were	NULL
gifts	NULL
from	NULL
Fabienne	NULL
de	NULL
la	NULL
Brousse	NULL
(	NULL
Tularik	NULL
Inc.	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

and	NULL
U-937	NULL
nuclear	NULL
pellets	NULL
were	NULL
purchased	NULL
from	NULL
the	NULL
Cell	NULL
Culture	NULL
Center	NULL
(	NULL
Cellex	NULL
Biosciences	NULL
Inc.	NULL
,	NULL
Minneapolis	NULL
,	NULL
Minn.	NULL
)	NULL
.	NULL

Construction	NULL
of	NULL
target	NULL
reporter	NULL
genes	NULL
.	NULL

The	NULL
three	NULL
different	NULL
minimal	NULL
reporter	NULL
gene	NULL
backgrounds	NULL
used	NULL
,	NULL
the	NULL
SCMV	NULL
(	NULL
AGM	NULL
)	NULL
MIE	NULL
,	NULL
,	NULL
,	NULL
(	NULL
-69/+30	NULL
)	NULL
-chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
in	NULL
pCJC81	NULL
,	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
A10	NULL
(	NULL
-150/	NULL
+58	NULL
)	NULL
-CAT	NULL
gene	NULL
in	NULL
pA10-CAT	NULL
,	NULL
and	NULL
the	NULL
HCMV	NULL
IES	NULL
,	NULL
,	NULL
(	NULL
-55/+80	NULL
)	NULL
-CAT	NULL
gene	NULL
in	NULL
pYJC90	NULL
,	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
8	NULL
,	NULL
10	NULL
)	NULL
.	NULL

The	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
targets	NULL
containing	NULL
the	NULL
wild-type	NULL
NFxB	NULL
sites	NULL
in	NULL
LTR	NULL
(	NULL
-483/+80	NULL
)	NULL
-CAT	NULL
and	NULL
a	NULL
version	NULL
with	NULL
triple-point	NULL
mutations	NULL
in	NULL
both	NULL
copies	NULL
of	NULL
the	NULL
NFB	NULL
sites	NULL
LTR	NULL
(	NULL
ANFxB	NULL
)	NULL
-CAT	NULL
are	NULL
carried	NULL
in	NULL
plasmids	NULL
pUR-III	NULL
and	NULL
mpUR-III	NULL
(	NULL
53	NULL
)	NULL
.	NULL

A	NULL
single-copy	NULL
23-bp	NULL
oligonucleotide	NULL
form	NULL
of	NULL
the	NULL
c-Fos	NULL
SRE	NULL
placed	NULL
in	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
(	NULL
HSV	NULL
)	NULL
thymidine	NULL
kinase-CAT	NULL
promoter	NULL
background	NULL
was	NULL
obtained	NULL
from	NULL
Barbara	NULL
Christie	NULL
and	NULL
Dan	NULL
Nathans	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Inserted	NULL
30-bp	NULL
oligonucleotides	NULL
representing	NULL
two	NULL
tandem	NULL
30-bp	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
or	NULL
mutant	NULL
SCMV	NULL
consensus	NULL
series	NULL
I	NULL
CRE	NULL
motif	NULL
as	NULL
(	NULL
CRE	NULL
)	NULL
,	NULL
/A10-CAT	NULL
in	NULL
pYNC55	NULL
and	NULL
(	NULL
ACRE	NULL
)	NULL
/A10-CAT	NULL
in	NULL
pYNC70	NULL
,	NULL
or	NULL
as	NULL
two	NULL
or	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
same	NULL
wild-type	NULL
CRE	NULL
motif	NULL
in	NULL
the	NULL
SCMV	NULL
minimal	NULL
MIE	NULL
background	NULL
as	NULL
(	NULL
CRE	NULL
)	NULL
,	NULL
/	NULL
MIE	NULL
,	NULL
,	NULL
-CAT	NULL
in	NULL
pYNC45	NULL
and	NULL
(	NULL
CRE	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
,	NULL
-CAT	NULL
in	NULL
pYNC50	NULL
,	NULL
were	NULL
all	NULL
described	NULL
previously	NULL
by	NULL
Chang	NULL
et	NULL
al	NULL
.	NULL

(	NULL
9	NULL
)	NULL
.	NULL

Similar	NULL
constructions	NULL
containing	NULL
two	NULL
or	NULL
four	NULL
tandem	NULL
30-bp	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
SCMV	NULL
SRE/NFKB-like	NULL
motifs	NULL
(	NULL
LGH218/	NULL
219	NULL
)	NULL
as	NULL
(	NULL
SNE	NULL
)	NULL
y/MIF	NULL
,	NULL
,	NULL
.CAT	NULL
in	NULL
pCJCi12	NULL
,	NULL
(	NULL
SNE	NULL
)	NULL
/MIE	NULL
,	NULL
,	NULL
.CAT	NULL
in	NULL
pCJCii4	NULL
,	NULL
(	NULL
SNE	NULL
)	NULL
/A10-CAT	NULL
in	NULL
pCJC12	NULL
,	NULL
and	NULL
(	NULL
SNE	NULL
)	NULL
,	NULL
/A10-CAT	NULL
in	NULL
pCJC14	NULL
were	NULL
prepared	NULL
.	NULL

Mutant	NULL
versions	NULL
of	NULL
the	NULL
SCMV	NULL
SNEs	NULL
included	NULL
a	NULL
point	NULL
mutant	NULL
in	NULL
the	NULL
SRF	NULL
submotif	NULL
(	NULL
LGH399/400	NULL
)	NULL
as	NULL
(	NULL
S~N*	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
-CAT	NULL
in	NULL
pCJC132	NULL
and	NULL
CAT	NULL
in	NULL
pCJC32	NULL
,	NULL
a	NULL
point	NULL
mutant	NULL
in	NULL
the	NULL
ETS/NFxB-like	NULL
submotif	NULL
(	NULL
LGH324/325	NULL
)	NULL
as	NULL
(	NULL
S*N~	NULL
)	NULL
;	NULL
/MIE	NULL
,	NULL
,	NULL
-CAT	NULL
in	NULL
pCJC152	NULL
and	NULL
(	NULL
S*N~	NULL
)	NULL
/A10-CAT	NULL
in	NULL
pCJC52	NULL
,	NULL
and	NULL
a	NULL
double-point	NULL
mutant	NULL
in	NULL
both	NULL
submotifs	NULL
(	NULL
LGH322/323	NULL
)	NULL
as	NULL
(	NULL
S	NULL
N~	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
_CAT	NULL
in	NULL
pCJC172	NULL
and	NULL
(	NULL
ST~N~	NULL
)	NULL
/A10-CAT	NULL
in	NULL
pCJC72	NULL
.	NULL

The	NULL
(	NULL
SEE	NULL
)	NULL
/MIE	NULL
,	NULL
-CAT	NULL
gene	NULL
(	NULL
pYJC294B	NULL
)	NULL
,	NULL
(	NULL
NFxB	NULL
)	NULL
/MIE	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
(	NULL
pYJC304B	NULL
)	NULL
,	NULL
(	NULL
SkB	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
(	NULL
pYJC224B	NULL
)	NULL
,	NULL
and	NULL
gene	NULL
(	NULL
pYJC244B	NULL
)	NULL
each	NULL
contain	NULL
four	NULL
tandemly	NULL
repeated	NULL
copies	NULL
of	NULL
the	NULL
synthetic	NULL
30-bp	NULL
oligonucleotides	NULL
for	NULL
the	NULL
wild-type	NULL
HCMV	NULL
overlapping	NULL
SRF/ETS	NULL
site	NULL
(	NULL
LGH814/815	NULL
)	NULL
,	NULL
the	NULL
wild-type	NULL
classical	NULL
Ig	NULL
kappa	NULL
NFkB	NULL
site	NULL
(	NULL
LGHS816/817	NULL
)	NULL
,	NULL
an	NULL
SCMV	NULL
SRF	NULL
plus	NULL
modified	NULL
classical	NULL
NFkB	NULL
site	NULL
(	NULL
LGH801/802	NULL
)	NULL
,	NULL
and	NULL
two	NULL
extra	NULL
inserted	NULL
G	NULL
's	NULL
between	NULL
the	NULL
SCMV	NULL
SRF	NULL
and	NULL
NFxB-like	NULL
site	NULL
(	NULL
LGH803/804	NULL
)	NULL
,	NULL
respectively	NULL
,	NULL
placed	NULL
in	NULL
the	NULL
backward	NULL
orientation	NULL
at	NULL
the	NULL
5	NULL
'	NULL
Bg/lI	NULL
site	NULL
in	NULL
the	NULL
SCMV	NULL
minimal	NULL
MIE	NULL
,	NULL
,	NULL
(	NULL
-69/+30	NULL
)	NULL
-CAT	NULL
gene	NULL
background	NULL
of	NULL
pCJC81	NULL
.	NULL

The	NULL
(	NULL
SRE	NULL
)	NULL
Â»	NULL
MIE	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
(	NULL
pYJC262A	NULL
)	NULL
and	NULL
the	NULL
(	NULL
SRE	NULL
,	NULL
.	NULL
)	NULL

/MIE	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
(	NULL
pYJC282A	NULL
)	NULL
each	NULL
contained	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
synthetic	NULL
30-bp	NULL
oligonucleotides	NULL
containing	NULL
either	NULL
the	NULL
wild-type	NULL
c-Fos	NULL
SRE	NULL
site	NULL
(	NULL
SRF	NULL
plus	NULL
ELK	NULL
)	NULL
(	NULL
LGH638/639	NULL
)	NULL
or	NULL
core	NULL
SRE	NULL
site	NULL
only	NULL
(	NULL
LGH642/643	NULL
)	NULL
placed	NULL
in	NULL
the	NULL
forward	NULL
orientation	NULL
at	NULL
the	NULL
5	NULL
'	NULL
Bgill	NULL
site	NULL
in	NULL
the	NULL
minimal	NULL
SCMV	NULL
MIE	NULL
,	NULL
,	NULL
,	NULL
(	NULL
-69/+30	NULL
)	NULL
-CAT	NULL
gene	NULL
background	NULL
of	NULL
pCJC81	NULL
.	NULL

The	NULL
(	NULL
SEE	NULL
)	NULL
/IES	NULL
,	NULL
,	NULL
.CAT	NULL
(	NULL
pYJC384B	NULL
)	NULL
,	NULL
(	NULL
SRE	NULL
)	NULL
,	NULL
/IES	NULL
,	NULL
,	NULL
-CAT	NULL
(	NULL
pYJC414B	NULL
)	NULL
,	NULL
(	NULL
NFkB	NULL
)	NULL
IES-CAT	NULL
(	NULL
pYJC784B	NULL
)	NULL
,	NULL
or	NULL
(	NULL
SNE	NULL
)	NULL
,	NULL
/IES-CAT	NULL
(	NULL
pYJC794B	NULL
)	NULL
gene	NULL
contains	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
synthetic	NULL
30-bp	NULL
oligonucleotides	NULL
encompassing	NULL
wild-type	NULL
HCMV	NULL
SEE	NULL
(	NULL
LGHS814/815	NULL
)	NULL
,	NULL
wild-type	NULL
c-Fos	NULL
SRE	NULL
(	NULL
LGH638/639	NULL
)	NULL
,	NULL
wild-type	NULL
Ig	NULL
kappa	NULL
NFkB	NULL
(	NULL
LGHS816/817	NULL
)	NULL
,	NULL
or	NULL
wild-type	NULL
SCMV	NULL
SNE	NULL
(	NULL
LGH218/219	NULL
)	NULL
,	NULL
respectively	NULL
,	NULL
placed	NULL
in	NULL
the	NULL
backward	NULL
orientation	NULL
at	NULL
the	NULL
5Â°	NULL
BamHI	NULL
site	NULL
in	NULL
the	NULL
minimal	NULL
HCMV	NULL
IES	NULL
,	NULL
,	NULL
,	NULL
(	NULL
-55/+80	NULL
)	NULL
-CAT	NULL
gene	NULL
of	NULL
pYJC90	NULL
.	NULL

Transient	NULL
DNA	NULL
transfection	NULL
and	NULL
CAT	NULL
assays	NULL
.	NULL

For	NULL
U-937	NULL
or	NULL
K-562	NULL
suspension	NULL
cultures	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
grown	NULL
to	NULL
a	NULL
cell	NULL
density	NULL
of	NULL
10	NULL
%	NULL
/ml	NULL
and	NULL
cell	NULL
viability	NULL
was	NULL
checked	NULL
by	NULL
the	NULL
trypan	NULL
blue	NULL
exclusion	NULL
method	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
procedure	NULL
used	NULL
previously	NULL
for	NULL
B	NULL
lymphocytes	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
2	NULL
to	NULL
4	NULL
ug	NULL
of	NULL
CsCl-prepared	NULL
plasmid	NULL
DNA	NULL
was	NULL
added	NULL
to	NULL
5	NULL
X	NULL
10Â°	NULL
cells	NULL
in	NULL
CaTBS	NULL
transfection	NULL
solution	NULL
(	NULL
0.5	NULL
mM	NULL
MgCl	NULL
;	NULL
+	NULL
6H	NULL
;	NULL
0	NULL
,	NULL
1	NULL
mM	NULL
CaCl	NULL
,	NULL
,	NULL
137	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
KCI	NULL
,	NULL
0.3	NULL
mM	NULL
Na	NULL
,	NULL
HPO	NULL
,	NULL
+	NULL
12H,0	NULL
,	NULL
25	NULL
mM	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
)	NULL
containing	NULL
430	NULL
ug	NULL
of	NULL
DEAE-dextran	NULL
per	NULL
ml	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
350	NULL
pl	NULL
at	NULL
37Â°C	NULL
for	NULL
45	NULL
min	NULL
.	NULL

Cells	NULL
were	NULL
pelleted	NULL
at	NULL
1,500	NULL
rpm	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4Â°C	NULL
and	NULL
washed	NULL
with	NULL
500	NULL
l	NULL
of	NULL
serum-free	NULL
RPMI	NULL
medium	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
a	NULL
37Â°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
overnight	NULL
and	NULL
treated	NULL
with	NULL
TPA	NULL
or	NULL
OA	NULL
24	NULL
h	NULL
later	NULL
if	NULL
needed	NULL
.	NULL

TPA	NULL
was	NULL
left	NULL
in	NULL
the	NULL
medium	NULL
at	NULL
the	NULL
final	NULL
concentration	NULL
of	NULL
50	NULL
ng/ml	NULL
,	NULL
or	NULL
OA	NULL
was	NULL
left	NULL
for	NULL
18	NULL
h	NULL
at	NULL
the	NULL
concentrations	NULL
described	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
for	NULL
CAT	NULL
assays	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
59	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
pelleted	NULL
in	NULL
a	NULL
microcentrifuge	NULL
for	NULL
1	NULL
min	NULL
at	NULL
12,000	NULL
rpm	NULL
,	NULL
washed	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
harvest	NULL
buffer	NULL
(	NULL
40	NULL
mM	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
,	NULL
repelleted	NULL
,	NULL
frozen	NULL
and	NULL
thawed	NULL
three	NULL
times	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
250	NULL
mM	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
and	NULL
pelleted	NULL
at	NULL
4Â°C	NULL
for	NULL
10	NULL
min	NULL
at	NULL
12,000	NULL
rpm	NULL
.	NULL

Seventy-five	NULL
microliters	NULL
of	NULL
the	NULL
supernatant	NULL
was	NULL
used	NULL
for	NULL
each	NULL
reaction	NULL
.	NULL

Assays	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
150	NULL
pl	NULL
of	NULL
a	NULL
mixture	NULL
containing	NULL
590	NULL
mM	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
533	NULL
uM	NULL
acetyl	NULL
coenzyme	NULL
A	NULL
,	NULL
and	NULL
0.1	NULL
wCi	NULL
of	NULL
[	NULL
'*CJchloramphenicol	NULL
at	NULL
37Â°C	NULL
for	NULL
1	NULL
h.	NULL
Chloramphenicol	NULL
was	NULL
extracted	NULL
from	NULL
the	NULL
aqueous	NULL
phase	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
ethyl	NULL
acetate	NULL
by	NULL
vigorous	NULL
vortex	NULL
centrifugation	NULL
at	NULL
12,000	NULL
rpm	NULL
for	NULL
3	NULL
min	NULL
at	NULL
20Â°C	NULL
followed	NULL
by	NULL
drying	NULL
in	NULL
a	NULL
vacuum	NULL
centrifuge	NULL
and	NULL
resuspension	NULL
in	NULL
20	NULL
pl	NULL
of	NULL
ethyl	NULL
acetate	NULL
.	NULL

Acetylated	NULL
and	NULL
nonacetylated	NULL
forms	NULL
of	NULL
chloramphenicol	NULL
were	NULL
separated	NULL
by	NULL
thin-layer	NULL
polycthylencimine-cellulose	NULL
chromatography	NULL
on	NULL
glass	NULL
plates	NULL
(	NULL
20	NULL
cm	NULL
by	NULL
20	NULL
cm	NULL
by	NULL
0.5	NULL
mm	NULL
)	NULL
(	NULL
Curtin	NULL
Matheson	NULL
Scientific	NULL
,	NULL
Inc.	NULL
)	NULL
,	NULL
using	NULL
chloroform-methanol	NULL
at	NULL
19:1	NULL
as	NULL
a	NULL
solvent	NULL
for	NULL
1	NULL
h.	NULL
The	NULL
radioactive	NULL
spots	NULL
were	NULL
TPA	NULL
RESPONSES	NULL
OF	NULL
SRF/ETS	NULL
ELEMENTS	NULL
IN	NULL
CMV	NULL
8593	NULL
visualized	NULL
by	NULL
autoradiography	NULL
and	NULL
scraped	NULL
off	NULL
the	NULL
thin-layer	NULL
chromatography	NULL
plates	NULL
for	NULL
measurement	NULL
in	NULL
a	NULL
scintillation	NULL
counter	NULL
.	NULL

Nuclear	NULL
extracts	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
16	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
suspension	NULL
cells	NULL
were	NULL
collected	NULL
at	NULL
a	NULL
density	NULL
of	NULL
10	NULL
%	NULL
/ml	NULL
and	NULL
adherent	NULL
cells	NULL
were	NULL
harvested	NULL
with	NULL
rubber	NULL
scrapers	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
PBS-A	NULL
.	NULL

Two	NULL
packed	NULL
cell	NULL
volumes	NULL
of	NULL
buffer	NULL
A	NULL
containing	NULL
10	NULL
mM	NULL
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic	NULL
acid	NULL
(	NULL
HEPES	NULL
;	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
and	NULL
protease	NULL
inhibitor	NULL
mixture	NULL
(	NULL
0.1	NULL
mM	NULL
TPCK	NULL
,	NULL
1	NULL
mM	NULL
TLCK	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmethylsulfony	NULL
]	NULL
fluoride	NULL
,	NULL
1	NULL
pg	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
,	NULL
1	NULL
wg	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
pepstatin	NULL
A	NULL
per	NULL
ml	NULL
)	NULL
were	NULL
added	NULL
to	NULL
swell	NULL
the	NULL
cells	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
.	NULL

A	NULL
Dounce	NULL
homogenizer	NULL
size	NULL
B	NULL
(	NULL
7	NULL
ml	NULL
)	NULL
was	NULL
used	NULL
to	NULL
rupture	NULL
the	NULL
cell	NULL
membranes	NULL
.	NULL

The	NULL
nuclei	NULL
were	NULL
collected	NULL
at	NULL
3,000	NULL
rpm	NULL
at	NULL
4Â°C	NULL
and	NULL
resuspended	NULL
in	NULL
high-salt	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
25	NULL
%	NULL
[	NULL
vol/vol	NULL
]	NULL
glycerol	NULL
,	NULL
0.42	NULL
M	NULL
NaCl	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
protease	NULL
inhibitor	NULL
mix-ture	NULL
)	NULL
to	NULL
extract	NULL
nuclear	NULL
proteins	NULL
by	NULL
rocking	NULL
at	NULL
4Â°C	NULL
for	NULL
1	NULL
h	NULL
and	NULL
removing	NULL
the	NULL
nuclear	NULL
debris	NULL
.	NULL

The	NULL
supernatant	NULL
which	NULL
contains	NULL
nuclear	NULL
proteins	NULL
was	NULL
aliquoted	NULL
and	NULL
stored	NULL
at	NULL
-70Â°C	NULL
for	NULL
later	NULL
use	NULL
.	NULL

DNA-protein	NULL
binding	NULL
reactions	NULL
were	NULL
set	NULL
up	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
20	NULL
pl	NULL
containing	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
buffer	NULL
,	NULL
0.1	NULL
%	NULL
Triton-X	NULL
100	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
0.1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
and	NULL
0.1	NULL
mM	NULL
phenylmethylsul-fonyl	NULL
fluoride	NULL
,	NULL
5	NULL
to	NULL
10	NULL
jg	NULL
of	NULL
nuclear	NULL
extracts	NULL
,	NULL
1	NULL
mg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
5	NULL
fmol	NULL
of	NULL
the	NULL
*Â°P-end-labeled	NULL
oligonucleotide	NULL
DNA	NULL
probe	NULL
and	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
20Â°C	NULL
(	NULL
48	NULL
,	NULL
62	NULL
)	NULL
.	NULL

The	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
resolved	NULL
by	NULL
EMSA	NULL
through	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
(	NULL
acrylamide/bisacrylamide	NULL
ratio	NULL
of	NULL
29:1	NULL
)	NULL
,	NULL
using	NULL
0.5	NULL
%	NULL
Tris-borate-EDTA	NULL
or	NULL
1	NULL
%	NULL
HEE	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.3	NULL
]	NULL
adjusted	NULL
with	NULL
NaOH	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
EGTA	NULL
)	NULL
as	NULL
the	NULL
running	NULL
buffer	NULL
.	NULL

Electrophoresis	NULL
was	NULL
carried	NULL
out	NULL
at	NULL
150	NULL
to	NULL
200	NULL
V	NULL
for	NULL
60	NULL
to	NULL
120	NULL
min	NULL
at	NULL
20Â°C	NULL
,	NULL
and	NULL
the	NULL
gels	NULL
(	NULL
18	NULL
by	NULL
20	NULL
cm	NULL
)	NULL
were	NULL
dried	NULL
for	NULL
autoradiography	NULL
.	NULL

For	NULL
antibody	NULL
supershift	NULL
experiments	NULL
,	NULL
antibodies	NULL
(	NULL
0.1	NULL
pg/pl	NULL
,	NULL
1	NULL
pl	NULL
)	NULL
were	NULL
added	NULL
into	NULL
the	NULL
solutions	NULL
after	NULL
protein-DNA	NULL
incubation	NULL
for	NULL
30	NULL
min	NULL
at	NULL
20Â°C	NULL
,	NULL
and	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
resolved	NULL
in	NULL
either	NULL
1	NULL
%	NULL
agarose	NULL
or	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
,	NULL
using	NULL
0.5	NULL
%	NULL
Tris-borate-EDTA	NULL
as	NULL
the	NULL
running	NULL
buffer	NULL
.	NULL

Labeling	NULL
of	NULL
synthetic	NULL
oligonucleotides	NULL
.	NULL

Single-stranded	NULL
oligonucleotides	NULL
were	NULL
synthesized	NULL
by	NULL
Scott	NULL
Morrow	NULL
(	NULL
Johns	NULL
Hopkins	NULL
University	NULL
School	NULL
of	NULL
Hygiene	NULL
and	NULL
Public	NULL
Health	NULL
)	NULL
and	NULL
purified	NULL
by	NULL
high-pressure	NULL
liquid	NULL
chromatography	NULL
procedures	NULL
.	NULL

The	NULL
two	NULL
complementary	NULL
strands	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
of	NULL
each	NULL
oligonucleotide	NULL
pair	NULL
were	NULL
heated	NULL
to	NULL
65Â°C	NULL
for	NULL
5	NULL
min	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
STE	NULL
(	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
and	NULL
annealed	NULL
by	NULL
slow	NULL
cooling	NULL
.	NULL

The	NULL
labeling	NULL
reaction	NULL
of	NULL
3'-recessed	NULL
ends	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
20	NULL
pl	NULL
of	NULL
solution	NULL
containing	NULL
1	NULL
pmol	NULL
of	NULL
synthetic	NULL
oligonucleotide	NULL
(	NULL
3	NULL
pl	NULL
)	NULL
per	NULL
pl	NULL
,	NULL
10	NULL
%	NULL
reaction	NULL
buffer	NULL
(	NULL
2	NULL
wl	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
dGTP-dCTP-dTTP	NULL
mixture	NULL
(	NULL
1	NULL
pl	NULL
)	NULL
,	NULL
3.3	NULL
pmol	NULL
of	NULL
[	NULL
Â«	NULL
-P	NULL
]	NULL
JdATP	NULL
(	NULL
1	NULL
pl	NULL
,	NULL
10	NULL
pCi	NULL
)	NULL
per	NULL
pl	NULL
,	NULL
1	NULL
U	NULL
of	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
polynucleotide	NULL
polymerase	NULL
(	NULL
1	NULL
pl	NULL
)	NULL
per	NULL
pl	NULL
,	NULL
and	NULL
12	NULL
pl	NULL
of	NULL
H	NULL
,	NULL
O	NULL
at	NULL
20Â°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
labeled	NULL
double-stranded	NULL
oligonucleotides	NULL
were	NULL
separated	NULL
from	NULL
free	NULL
nucleotides	NULL
by	NULL
centrifugation	NULL
at	NULL
3,000	NULL
rpm	NULL
for	NULL
5	NULL
min	NULL
on	NULL
Sephadex	NULL
G-25	NULL
columns	NULL
(	NULL
Pharmacia	NULL
catalog	NULL
no	NULL
.	NULL

17-0033-01	NULL
)	NULL
.	NULL

RESULTS	NULL
Identification	NULL
of	NULL
novel	NULL
conserved	NULL
SRE-related	NULL
motifs	NULL
in	NULL
all	NULL
primate	NULL
CMV	NULL
MIE	NULL
ENH-A2	NULL
regions	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
previously	NULL
that	NULL
the	NULL
SCMV	NULL
(	NULL
AGM	NULL
)	NULL
MIE	NULL
enhancer	NULL
region	NULL
contains	NULL
two	NULL
distinct	NULL
subdomains	NULL
,	NULL
ENH-A1	NULL
(	NULL
-414	NULL
to	NULL
-69	NULL
)	NULL
and	NULL
ENH-A2	NULL
(	NULL
-604	NULL
to	NULL
-485	NULL
)	NULL
,	NULL
that	NULL
independently	NULL
give	NULL
high	NULL
basal	NULL
expression	NULL
characteristics	NULL
in	NULL
Vero	NULL
cells	NULL
and	NULL
that	NULL
an	NULL
important	NULL
feature	NULL
of	NULL
the	NULL
ENH-AZ2	NULL
domain	NULL
is	NULL
the	NULL
presence	NULL
of	NULL
several	NULL
potential	NULL
consensus	NULL
SRF	NULL
binding	NULL
motifs	NULL
(	NULL
referred	NULL
to	NULL
as	NULL
series	NULL
V	NULL
elements	NULL
)	NULL
that	NULL
indeed	NULL
bind	NULL
efficiently	NULL
to	NULL
SRF	NULL
in	NULL
in	NULL
vitro	NULL
EMSA	NULL
experiments	NULL
(	NULL
10	NULL
)	NULL
.	NULL

To	NULL
search	NULL
for	NULL
additional	NULL
conserved	NULL
elements	NULL
of	NULL
this	NULL
type	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
ENH	NULL
regions	NULL
of	NULL
each	NULL
of	NULL
five	NULL
primate	NULL
MIE	NULL
regions	NULL
,	NULL
from	NULL
human	NULL
(	NULL
6	NULL
,	NULL
82	NULL
)	NULL
,	NULL
AGM	NULL
(	NULL
10	NULL
,	NULL
36	NULL
)	NULL
,	NULL
rhesus	NULL
(	NULL
2	NULL
)	NULL
,	NULL
chimpanzee	NULL
(	NULL
1	NULL
)	NULL
,	NULL
and	NULL
baboon	NULL
(	NULL
1	NULL
)	NULL
CMVs	NULL
,	NULL
and	NULL
identified	NULL
between	NULL
one	NULL
and	NULL
three	NULL
related	NULL
motifs	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
that	NULL
contain	NULL
a	NULL
core	NULL
SRF	NULL
consensus	NULL
binding	NULL
site	NULL
(	NULL
CCATATATGG	NULL
)	NULL
at	NULL
the	NULL
far-upstream	NULL
end	NULL
of	NULL
the	NULL
ENH	NULL
region	NULL
in	NULL
each	NULL
case	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
noticed	NULL
that	NULL
their	NULL
flanking	NULL
regions	NULL
often	NULL
have	NULL
similar	NULL
sequences	NULL
.	NULL

In	NULL
the	NULL
SCMV	NULL
(	NULL
AGM	NULL
)	NULL
MIE	NULL
regions	NULL
,	NULL
some	NULL
of	NULL
these	NULL
resemble	NULL
diverged	NULL
binding	NULL
sites	NULL
(	NULL
ATGGGG	NULL
TITCC	NULL
)	NULL
and	NULL
include	NULL
inverted	NULL
generic	NULL
core	NULL
ETS	NULL
class	NULL
protein	NULL
binding	NULL
sites	NULL
as	NULL
well	NULL
(	NULL
GGAA	NULL
or	NULL
GGAT	NULL
)	NULL
.	NULL

The	NULL
human	NULL
and	NULL
chimpanzee	NULL
CMV	NULL
versions	NULL
in	NULL
particular	NULL
as	NULL
well	NULL
as	NULL
baboon	NULL
site	NULL
1	NULL
also	NULL
not	NULL
only	NULL
match	NULL
well	NULL
to	NULL
the	NULL
specific	NULL
consensus	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
ETS	NULL
class	NULL
GABP	NULL
factor	NULL
GCGGAAC	NULL
(	NULL
44	NULL
)	NULL
but	NULL
also	NULL
have	NULL
different	NULL
spacing	NULL
(	NULL
N2	NULL
)	NULL
compared	NULL
with	NULL
the	NULL
others	NULL
(	NULL
N3	NULL
)	NULL
between	NULL
8594	NULL
CHAN	NULL
ET	NULL
AL	NULL
.	NULL

the	NULL
SRF	NULL
and	NULL
ETS	NULL
core	NULL
motifs	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
refer	NULL
to	NULL
the	NULL
SRF	NULL
consensus	NULL
sites	NULL
and	NULL
adjacent	NULL
conserved	NULL
sequences	NULL
in	NULL
the	NULL
SCMV	NULL
(	NULL
AGM	NULL
)	NULL
MIE	NULL
region	NULL
as	NULL
the	NULL
SNE	NULL
motifs	NULL
(	NULL
because	NULL
of	NULL
the	NULL
overlapping	NULL
SRF	NULL
and	NULL
NFxB-like	NULL
binding	NULL
elements	NULL
)	NULL
and	NULL
to	NULL
that	NULL
of	NULL
the	NULL
equivalent	NULL
sequence	NULL
in	NULL
the	NULL
human	NULL
and	NULL
chimpanzee	NULL
MIE	NULL
region	NULL
as	NULL
well	NULL
as	NULL
to	NULL
baboon	NULL
site	NULL
1	NULL
as	NULL
SEE	NULL
motifs	NULL
.	NULL

Human	NULL
,	NULL
chimpanzee	NULL
,	NULL
and	NULL
rhesus	NULL
CMVs	NULL
each	NULL
contain	NULL
only	NULL
one	NULL
such	NULL
motif	NULL
,	NULL
whereas	NULL
AGM	NULL
and	NULL
baboon	NULL
CMVs	NULL
both	NULL
have	NULL
three	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
three	NULL
SNE	NULL
sites	NULL
in	NULL
the	NULL
SCMV	NULL
(	NULL
AGM	NULL
)	NULL
MIE	NULL
gene	NULL
form	NULL
part	NULL
of	NULL
a	NULL
3	NULL
X	NULL
58-bp	NULL
imperfect	NULL
tandem	NULL
repeat	NULL
region	NULL
that	NULL
overlaps	NULL
the	NULL
ENH-A2	NULL
region	NULL
and	NULL
are	NULL
located	NULL
between	NULL
positions	NULL
-579	NULL
and	NULL
-561	NULL
,	NULL
-521	NULL
and	NULL
-503	NULL
,	NULL
and	NULL
-462	NULL
and	NULL
-444	NULL
upstream	NULL
relative	NULL
to	NULL
the	NULL
mRNA	NULL
transcriptional	NULL
start	NULL
site	NULL
.	NULL

The	NULL
SEE	NULL
site	NULL
in	NULL
the	NULL
HCMV	NULL
MIE	NULL
enhancer	NULL
lies	NULL
between	NULL
positions	NULL
-538	NULL
and	NULL
-522	NULL
.	NULL

The	NULL
close	NULL
resemblance	NULL
between	NULL
these	NULL
CMV	NULL
elements	NULL
and	NULL
the	NULL
classical	NULL
SRE	NULL
motif	NULL
from	NULL
the	NULL
c-fos	NULL
promoter	NULL
(	NULL
present	NULL
in	NULL
inverted	NULL
orientation	NULL
relative	NULL
to	NULL
its	NULL
TATAA	NULL
box	NULL
motif	NULL
)	NULL
is	NULL
also	NULL
illustrated	NULL
in	NULL
the	NULL
alignments	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

Curiously	NULL
,	NULL
as	NULL
we	NULL
have	NULL
shown	NULL
elsewhere	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
,	NULL
neither	NULL
an	NULL
ENH-A2	NULL
fragment	NULL
(	NULL
containing	NULL
two	NULL
tandemly	NULL
repeated	NULL
SNEs	NULL
within	NULL
their	NULL
local	NULL
natural	NULL
promoter	NULL
context	NULL
)	NULL
nor	NULL
multimerized	NULL
copies	NULL
of	NULL
the	NULL
SNE	NULL
motif	NULL
gave	NULL
serum	NULL
responsiveness	NULL
in	NULL
NIH	NULL
3T3	NULL
or	NULL
BALB/c	NULL
3T3	NULL
cells	NULL
,	NULL
although	NULL
the	NULL
latter	NULL
responded	NULL
strongly	NULL
to	NULL
TPA	NULL
induction	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Synergism	NULL
between	NULL
the	NULL
two	NULL
overlapping	NULL
subcomponents	NULL
of	NULL
the	NULL
SNE	NULL
motif	NULL
.	NULL

As	NULL
suggested	NULL
previously	NULL
,	NULL
the	NULL
SNE	NULL
or	NULL
series	NULL
V/IIIB	NULL
motifs	NULL
in	NULL
the	NULL
SCMV	NULL
(	NULL
AGM	NULL
)	NULL
enhancer	NULL
appeared	NULL
to	NULL
be	NULL
composed	NULL
of	NULL
two	NULL
overlapping	NULL
components	NULL
,	NULL
referred	NULL
to	NULL
here	NULL
as	NULL
the	NULL
S	NULL
and	NULL
N	NULL
submotifs	NULL
,	NULL
as	NULL
judged	NULL
from	NULL
known	NULL
binding	NULL
to	NULL
SRF	NULL
and	NULL
predicted	NULL
matches	NULL
to	NULL
NFKB-like	NULL
binding	NULL
sites	NULL
(	NULL
10	NULL
)	NULL
.	NULL

To	NULL
address	NULL
the	NULL
question	NULL
of	NULL
whether	NULL
both	NULL
submotifs	NULL
in	NULL
the	NULL
SNE	NULL
sequences	NULL
are	NULL
required	NULL
for	NULL
full	NULL
function	NULL
,	NULL
we	NULL
synthesized	NULL
new	NULL
30-bp	NULL
oligonucleotide	NULL
versions	NULL
that	NULL
were	NULL
mutated	NULL
in	NULL
either	NULL
the	NULL
S	NULL
or	NULL
N	NULL
submotif	NULL
or	NULL
both	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
,	NULL
inserted	NULL
them	NULL
in	NULL
place	NULL
of	NULL
the	NULL
wild-type	NULL
versions	NULL
in	NULL
the	NULL
(	NULL
S*	NULL
N*	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
-CAT	NULL
reporter	NULL
gene	NULL
to	NULL
generate	NULL
the	NULL
(	NULL
S	NULL
(	NULL
S	NULL
*N~	NULL
)	NULL
,	NULL
/	NULL
,	NULL
and	NULL
(	NULL
SN	NULL
*	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
-CAT	NULL
plasmids	NULL
,	NULL
and	NULL
tested	NULL
their	NULL
activities	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
after	NULL
introduction	NULL
into	NULL
suspension	NULL
culture	NULL
cells	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
procedure	NULL
.	NULL

Two	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
SNE	NULL
sites	NULL
augmented	NULL
basal	NULL
activity	NULL
7.1-fold	NULL
,	NULL
and	NULL
four	NULL
copies	NULL
increased	NULL
the	NULL
activity	NULL
to	NULL
14-fold	NULL
in	NULL
immature	NULL
monocyte-like	NULL
U-937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
SNE	NULL
gave	NULL
a	NULL
more	NULL
than	NULL
13-fold	NULL
increase	NULL
when	NULL
TPA	NULL
was	NULL
added	NULL
at	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
to	NULL
yield	NULL
a	NULL
94-fold	NULL
total	NULL
stimulation	NULL
over	NULL
basal	NULL
levels	NULL
obtained	NULL
with	NULL
the	NULL
parent	NULL
minimal	NULL
MIE	NULL
,	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutations	NULL
in	NULL
either	NULL
the	NULL
S	NULL
component	NULL
alone	NULL
or	NULL
both	NULL
the	NULL
S	NULL
and	NULL
N	NULL
motifs	NULL
totally	NULL
abolished	NULL
the	NULL
basal	NULL
enhancement	NULL
and	NULL
reduced	NULL
the	NULL
TPA	NULL
responses	NULL
to	NULL
the	NULL
levels	NULL
obtained	NULL
with	NULL
the	NULL
parent	NULL
minimal	NULL
promoter	NULL
(	NULL
3.5-fold	NULL
)	NULL
,	NULL
whereas	NULL
mutations	NULL
in	NULL
the	NULL
N	NULL
site	NULL
also	NULL
severely	NULL
diminished	NULL
but	NULL
did	NULL
not	NULL
obliterate	NULL
either	NULL
basal	NULL
enhancement	NULL
or	NULL
TPA	NULL
responses	NULL
(	NULL
3.7-	NULL
and	NULL
3.8-fold	NULL
,	NULL
respectively	NULL
,	NULL
for	NULL
the	NULL
two-copy	NULL
version	NULL
[	NULL
Fig	NULL
.	NULL

2A	NULL
]	NULL
)	NULL
.	NULL

Transfer	NULL
of	NULL
synergistic	NULL
TPA	NULL
responsiveness	NULL
to	NULL
a	NULL
heterologous	NULL
minimal	NULL
promoter	NULL
.	NULL

Because	NULL
the	NULL
TPA	NULL
responses	NULL
were	NULL
so	NULL
potent	NULL
,	NULL
the	NULL
CAT	NULL
enzyme	NULL
levels	NULL
obtained	NULL
were	NULL
often	NULL
beyond	NULL
the	NULL
linear	NULL
range	NULL
with	NULL
two	NULL
or	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
SNE	NULL
,	NULL
especially	NULL
in	NULL
U-937	NULL
and	NULL
K-562	NULL
cells	NULL
when	NULL
we	NULL
used	NULL
the	NULL
SCMV	NULL
MIE	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
background	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
also	NULL
tested	NULL
another	NULL
set	NULL
of	NULL
CAT	NULL
reporter	NULL
genes	NULL
that	NULL
contained	NULL
the	NULL
SV40	NULL
minimal	NULL
promoter	NULL
(	NULL
pA10-CAT	NULL
)	NULL
with	NULL
added	NULL
upstream	NULL
multimerized	NULL
wild-type	NULL
and	NULL
mutant	NULL
SNE	NULL
motifs	NULL
.	NULL

The	NULL
results	NULL
again	NULL
clearly	NULL
demonstrated	NULL
that	NULL
in	NULL
order	NULL
to	NULL
obtain	NULL
both	NULL
basal	NULL
enhancement	NULL
and	NULL
TPA	NULL
responses	NULL
(	NULL
which	NULL
together	NULL
totaled	NULL
30-	NULL
and	NULL
130-fold	NULL
increases	NULL
for	NULL
two	NULL
and	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
SNE	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
both	NULL
the	NULL
S	NULL
and	NULL
N	NULL
submotifs	NULL
were	NULL
required	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

J.	NULL
ViRor	NULL
.	NULL

A	NULL
A	NULL
&	NULL
a	NULL
A	NULL
A	NULL
s	NULL
)	NULL
NAG-1Â°	NULL
F	NULL
â	NULL
$	NULL
50	NULL
*	NULL
wet	NULL
â	NULL
â	NULL
Â£6	NULL
?	NULL

â	NULL
we	NULL
'	NULL
ï¬g	NULL
â	NULL
o	NULL
C	NULL
s	NULL
&	NULL
t	NULL
N	NULL
wo	NULL
y	NULL
we	NULL
?	NULL

ex	NULL
â	NULL
&	NULL
Bos	NULL
eÂ®	NULL
\.Â§-	NULL
â	NULL
w	NULL
I	NULL
[	NULL
1	NULL
if	NULL
P	NULL
TPA	NULL
ie	NULL
a	NULL
s	NULL
R	NULL
7	NULL
.	NULL

3	NULL
Ac	NULL
-	NULL
a	NULL
x	NULL
fs	NULL
oF	NULL
(	NULL
o	NULL
40	NULL
Â«	NULL
0Â°	NULL
K	NULL
of	NULL
R	NULL
&	NULL
y	NULL
v	NULL
Â°	NULL
w-	NULL
p	NULL
F	NULL
a	NULL
ad	NULL
mo	NULL
xD	NULL
Ad	NULL
ad	NULL
mo	NULL
p*	NULL
&	NULL
*	NULL
Â®	NULL
&	NULL
``	NULL
Â®	NULL
an	NULL
eÂ®	NULL
1	NULL
1	NULL
I	NULL
1	NULL
I	NULL
1	NULL
TPA	NULL
-	NULL
=	NULL
+	NULL
#	NULL
00	NULL
-	NULL
o	NULL
#	NULL
0	NULL
0-0	NULL
+	NULL
#	NULL
$	NULL
00	NULL
-	NULL
400-0	NULL
0+	NULL
oe	NULL
e	NULL
e	NULL
e	NULL
0	NULL
Â®	NULL
0	NULL
0	NULL
08	NULL
0	NULL
0	NULL
0	NULL
0	NULL
o	NULL
-	NULL
,	NULL
0.2	NULL
0.3	NULL
0.20	NULL
620	NULL
0.4	NULL
550	NULL
0.3	NULL
02	NULL
0.3	NULL
0.3	NULL
O2	NULL
O2	NULL
020	NULL
02	NULL
%	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
S	NULL
and	NULL
N	NULL
submotifs	NULL
within	NULL
the	NULL
SNE	NULL
consensus	NULL
sequence	NULL
give	NULL
synergistic	NULL
effects	NULL
on	NULL
basal	NULL
enhancement	NULL
and	NULL
TPA	NULL
responses	NULL
within	NULL
their	NULL
natural	NULL
minimal	NULL
promoter	NULL
context	NULL
.	NULL

The	NULL
sample	NULL
autoradiograph	NULL
shows	NULL
the	NULL
results	NULL
of	NULL
a	NULL
transient	NULL
CAT	NULL
expression	NULL
assay	NULL
in	NULL
U-937	NULL
cells	NULL
.	NULL

The	NULL
parent	NULL
minimal	NULL
SCMV	NULL
(	NULL
AGM	NULL
)	NULL
IE94	NULL
(	NULL
-69/+30	NULL
)	NULL
promoter	NULL
region	NULL
driving	NULL
CAT	NULL
reporter	NULL
gene	NULL
expression	NULL
in	NULL
plasmid	NULL
pCJC81	NULL
is	NULL
referred	NULL
to	NULL
as	NULL
MIE	NULL
,	NULL
,	NULL
-CAT	NULL
;	NULL
its	NULL
derivatives	NULL
containing	NULL
a	NULL
series	NULL
of	NULL
insertions	NULL
of	NULL
wild-type	NULL
or	NULL
mutant	NULL
synthetic	NULL
30-bp	NULL
SNE	NULL
oligonucleotides	NULL
were	NULL
transfected	NULL
into	NULL
parallel	NULL
cultures	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
TPA	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

The	NULL
(	NULL
S	NULL
*N*	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
(	NULL
pCJC112B	NULL
)	NULL
and	NULL
(	NULL
S	NULL
*N	NULL
*	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
(	NULL
pCJC114B	NULL
)	NULL
contain	NULL
two	NULL
and	NULL
four	NULL
tandem	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
SNE	NULL
motifs	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
(	NULL
S	NULL
N~	NULL
)	NULL
/MIE	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
(	NULL
pCJC132B	NULL
)	NULL
,	NULL
(	NULL
S	NULL
*N~	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
(	NULL
pCIC152B	NULL
)	NULL
,	NULL
and	NULL
(	NULL
S~N*	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
(	NULL
pCJC172B	NULL
)	NULL
contain	NULL
two	NULL
tandem	NULL
copies	NULL
of	NULL
mutant	NULL
SNE	NULL
motifs	NULL
with	NULL
altered	NULL
base	NULL
pairs	NULL
in	NULL
the	NULL
N	NULL
submotif	NULL
only	NULL
(	NULL
S*N~	NULL
)	NULL
,	NULL
in	NULL
the	NULL
S	NULL
submotif	NULL
only	NULL
(	NULL
S~N*	NULL
)	NULL
,	NULL
and	NULL
in	NULL
both	NULL
the	NULL
S	NULL
and	NULL
N	NULL
submotifs	NULL
(	NULL
S	NULL
N~	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Percent	NULL
conversion	NULL
of	NULL
[	NULL
**CJchloramphenicol	NULL
(	NULL
CM	NULL
)	NULL
to	NULL
acetylated	NULL
forms	NULL
(	NULL
Ac	NULL
)	NULL
is	NULL
indicated	NULL
below	NULL
each	NULL
lane	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Transfer	NULL
of	NULL
synergistic	NULL
TPA	NULL
responsiveness	NULL
properties	NULL
to	NULL
a	NULL
heterologous	NULL
minimal	NULL
promoter	NULL
background	NULL
.	NULL

The	NULL
sample	NULL
autoradiograph	NULL
shows	NULL
the	NULL
results	NULL
of	NULL
similar	NULL
transient	NULL
CAT	NULL
expression	NULL
assays	NULL
in	NULL
extracts	NULL
from	NULL
U-937	NULL
cells	NULL
transfected	NULL
with	NULL
parent	NULL
plasmids	NULL
containing	NULL
the	NULL
SV40	NULL
minimal	NULL
early	NULL
T-antigen	NULL
promoter	NULL
(	NULL
pA10-CAT	NULL
)	NULL
and	NULL
its	NULL
derivatives	NULL
(	NULL
S*N*	NULL
)	NULL
/A10-CAT	NULL
(	NULL
pCJC12B	NULL
)	NULL
,	NULL
(	NULL
S*N*	NULL
)	NULL
/A10-CAT	NULL
(	NULL
pCJIC14B	NULL
)	NULL
,	NULL
(	NULL
S	NULL
~N~	NULL
)	NULL
/A10-CAT	NULL
(	NULL
pCJC32B	NULL
)	NULL
,	NULL
(	NULL
S	NULL
*N~	NULL
)	NULL
/A10-CAT	NULL
(	NULL
pCJC52B	NULL
)	NULL
,	NULL
and	NULL
(	NULL
STN	NULL
*	NULL
)	NULL
/A10-CAT	NULL
(	NULL
pCJC72B	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
S	NULL
and	NULL
N	NULL
mutations	NULL
on	NULL
basal	NULL
enhancement	NULL
and	NULL
TPA	NULL
responsiveness	NULL
in	NULL
several	NULL
monocyte	NULL
and	NULL
lymphocyte	NULL
cell	NULL
types	NULL
.	NULL

The	NULL
results	NULL
with	NULL
the	NULL
mutant	NULL
SNE	NULL
oligonucleotides	NULL
in	NULL
the	NULL
minimal	NULL
SCMV	NULL
MIE	NULL
promoter	NULL
background	NULL
in	NULL
U-937	NULL
cells	NULL
and	NULL
four	NULL
other	NULL
cell	NULL
types	NULL
,	NULL
mature	NULL
monocytes	NULL
(	NULL
THP-1	NULL
)	NULL
,	NULL
T	NULL
cells	NULL
(	NULL
Jur-kat	NULL
)	NULL
,	NULL
and	NULL
both	NULL
HL-60	NULL
and	NULL
K-562	NULL
cells	NULL
,	NULL
are	NULL
compared	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
.	NULL

In	NULL
some	NULL
cell	NULL
types	NULL
,	NULL
we	NULL
also	NULL
compared	NULL
the	NULL
SNE	NULL
results	NULL
with	NULL
those	NULL
for	NULL
parallel	NULL
samples	NULL
receiving	NULL
similar	NULL
target	NULL
constructions	NULL
containing	NULL
two	NULL
tandem	NULL
repeats	NULL
of	NULL
wild-type	NULL
and	NULL
mutant	NULL
forms	NULL
of	NULL
the	NULL
SCMV	NULL
series	NULL
I	NULL
16-bp	NULL
CRE	NULL
placed	NULL
in	NULL
the	NULL
SCMV	NULL
minimal	NULL
MIE	NULL
promoter	NULL
background	NULL
,	NULL
as	NULL
well	NULL
as	NULL
with	NULL
those	NULL
for	NULL
a	NULL
classical	NULL
c-Fos	NULL
SRE	NULL
placed	NULL
in	NULL
an	NULL
HSV	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
background	NULL
.	NULL

In	NULL
general	NULL
,	NULL
basal	NULL
activity	NULL
for	NULL
the	NULL
SNE	NULL
was	NULL
highest	NULL
in	NULL
K-562	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
the	NULL
S*N~	NULL
version	NULL
still	NULL
showed	NULL
considerable	NULL
activity	NULL
also	NULL
and	NULL
the	NULL
single-copy	NULL
c-Fos	NULL
SRE	NULL
positive	NULL
control	NULL
gave	NULL
a	NULL
22-fold	NULL
TPA	NULL
response	NULL
.	NULL

U-937	NULL
cells	NULL
showed	NULL
the	NULL
next-highest	NULL
basal	NULL
levels	NULL
,	NULL
followed	NULL
by	NULL
Jurkat	NULL
,	NULL
HL-60	NULL
,	NULL
and	NULL
VoL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
A	NULL
<	NULL
4	NULL
--	NULL
--	NULL
--	NULL
-	NULL
MiEm	NULL
--	NULL
--	NULL
-	NULL
Â»	NULL
(	NULL
i-*	NULL
uP	NULL
y	NULL
gto	NULL
yt	NULL
&	NULL
$	NULL
``	NULL
&	NULL
men	NULL
g*	NULL
6	NULL
&	NULL
&	NULL
&	NULL
&	NULL
F	NULL
F	NULL
#	NULL
12.6x	NULL
>	NULL
13x	NULL
U-937	NULL
K562	NULL
Jurkat	NULL
3.5x	NULL
18x	NULL
-	NULL
10x	NULL
33.5x	NULL
15.7	NULL
%	NULL
HL-60	NULL
2.1	NULL
%	NULL
THP-1	NULL
=+	NULL
-+	NULL
-+	NULL
-	NULL
TPA	NULL
TPA	NULL
RESPONSES	NULL
OF	NULL
SRF/ETS	NULL
ELEMENTS	NULL
IN	NULL
CMV	NULL
8595	NULL
NF	NULL
oNt	NULL
oan	NULL
o	NULL
(	NULL
an	NULL
AQ	NULL
``	NULL
oo	NULL
-S	NULL
``	NULL
pF	NULL
a	NULL
a	NULL
sN	NULL
as	NULL
Y	NULL
.	NULL

$	NULL
``	NULL
g*	NULL
o	NULL
``	NULL
.	NULL

@	NULL
CEC	NULL
8	NULL
&	NULL
Â¢	NULL
&	NULL
&	NULL
A10	NULL
&	NULL
@	NULL
60	NULL
50	NULL
7	NULL
138x	NULL
40	NULL
-I	NULL
so	NULL
{	NULL
u-937	NULL
20	NULL
7|	NULL
10	NULL
13x	NULL
4x	NULL
0.9x	NULL
K562	NULL
Jurkat	NULL
%	NULL
os	NULL
HL-60	NULL
-	NULL
2x	NULL
Lax	NULL
-	NULL
0.9	NULL
%	NULL
tx	NULL
-	NULL
1.5	NULL
%	NULL
**7	NULL
day	NULL
14	NULL
%	NULL
1.2x	NULL
0.0	NULL
sod	NULL
n	NULL
d	NULL
n	NULL
t	NULL
n	NULL
dn	NULL
d	NULL
nop	NULL
n	NULL
48	NULL
dn	NULL
4	NULL
09	NULL
4	NULL
0	NULL
TPA	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Comparison	NULL
of	NULL
the	NULL
TPA	NULL
responses	NULL
of	NULL
wild-type	NULL
and	NULL
mutant	NULL
SNE	NULL
motifs	NULL
in	NULL
the	NULL
minimal	NULL
SCMV	NULL
(	NULL
AGM	NULL
)	NULL
MIE	NULL
,	NULL
promoter	NULL
background	NULL
in	NULL
five	NULL
different	NULL
monocyte	NULL
and	NULL
T-cell	NULL
lines	NULL
.	NULL

The	NULL
histogram	NULL
plots	NULL
the	NULL
results	NULL
of	NULL
CAT	NULL
assay	NULL
measurements	NULL
as	NULL
direct	NULL
percent	NULL
conversion	NULL
values	NULL
.	NULL

Fold	NULL
induction	NULL
levels	NULL
for	NULL
the	NULL
sample	NULL
pairs	NULL
are	NULL
shown	NULL
.	NULL

Open	NULL
bars	NULL
indicate	NULL
no	NULL
treatment	NULL
,	NULL
and	NULL
solid	NULL
bars	NULL
denote	NULL
measurements	NULL
obtained	NULL
after	NULL
addition	NULL
of	NULL
TPA	NULL
in	NULL
parallel	NULL
cultures	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Comparison	NULL
of	NULL
the	NULL
TPA	NULL
responses	NULL
of	NULL
wild-type	NULL
and	NULL
mutant	NULL
SNE	NULL
motifs	NULL
in	NULL
the	NULL
heterologous	NULL
minimal	NULL
SV40	NULL
promoter	NULL
background	NULL
in	NULL
four	NULL
different	NULL
monocyte	NULL
or	NULL
T-cell	NULL
lines	NULL
.	NULL

The	NULL
histogram	NULL
plots	NULL
the	NULL
results	NULL
of	NULL
CAT	NULL
assay	NULL
measurements	NULL
as	NULL
direct	NULL
percent	NULL
conversion	NULL
values	NULL
.	NULL

Fold	NULL
induction	NULL
values	NULL
for	NULL
the	NULL
sample	NULL
pairs	NULL
are	NULL
shown	NULL
.	NULL

Open	NULL
bars	NULL
represent	NULL
no	NULL
treatment	NULL
samples	NULL
,	NULL
and	NULL
solid	NULL
bars	NULL
represent	NULL
plus-TPA	NULL
samples	NULL
.	NULL

THP-1	NULL
cells	NULL
.	NULL

In	NULL
U-937	NULL
and	NULL
HL-60	NULL
cells	NULL
,	NULL
the	NULL
positive	NULL
control	NULL
4	NULL
%	NULL
CREs	NULL
gave	NULL
12-	NULL
to	NULL
15-fold	NULL
TPA	NULL
responses	NULL
,	NULL
although	NULL
the	NULL
1	NULL
%	NULL
c-Fos	NULL
SRE	NULL
now	NULL
gave	NULL
only	NULL
a	NULL
2.5-	NULL
to	NULL
4-fold	NULL
stimulation	NULL
;	NULL
however	NULL
,	NULL
neither	NULL
produced	NULL
a	NULL
detectable	NULL
TPA	NULL
response	NULL
in	NULL
THP-1	NULL
cells	NULL
,	NULL
whereas	NULL
the	NULL
4X	NULL
SNEs	NULL
still	NULL
gave	NULL
33-	NULL
and	NULL
8-fold	NULL
TPA	NULL
responses	NULL
in	NULL
HL-60	NULL
and	NULL
THP-1	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
minimal	NULL
SCMV	NULL
MIE	NULL
,	NULL
,	NULL
,	NULL
promoter	NULL
(	NULL
which	NULL
still	NULL
has	NULL
one	NULL
diverged	NULL
series	NULL
I	NULL
CRE/ATF-like	NULL
motif	NULL
present	NULL
)	NULL
contributed	NULL
basal	NULL
plus	NULL
TPA-induced	NULL
background	NULL
levels	NULL
of	NULL
approximately	NULL
3.5-fold	NULL
in	NULL
both	NULL
U-937	NULL
and	NULL
K-562	NULL
cells	NULL
.	NULL

Except	NULL
for	NULL
this	NULL
background	NULL
activity	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
S	NULL
motif	NULL
abolished	NULL
essentially	NULL
all	NULL
SNE-mediated	NULL
activity	NULL
in	NULL
all	NULL
cell	NULL
types	NULL
,	NULL
and	NULL
mutation	NULL
of	NULL
the	NULL
N	NULL
motif	NULL
considerably	NULL
reduced	NULL
both	NULL
basal	NULL
enhancement	NULL
and	NULL
TPA	NULL
responses	NULL
in	NULL
U-937	NULL
and	NULL
K-562	NULL
cells	NULL
and	NULL
abolished	NULL
the	NULL
responses	NULL
in	NULL
Jurkat	NULL
,	NULL
HL-60	NULL
,	NULL
and	NULL
THP-1	NULL
cells	NULL
.	NULL

The	NULL
basal	NULL
activities	NULL
and	NULL
TPA	NULL
responses	NULL
of	NULL
the	NULL
mutant	NULL
SNE	NULL
sites	NULL
in	NULL
the	NULL
minimal	NULL
A10-CAT	NULL
reporter	NULL
gene	NULL
background	NULL
obtained	NULL
in	NULL
four	NULL
different	NULL
cell	NULL
lines	NULL
are	NULL
compared	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
.	NULL

Control	NULL
or	NULL
reference	NULL
target	NULL
genes	NULL
containing	NULL
either	NULL
two	NULL
tandemly	NULL
repeated	NULL
wild-type	NULL
or	NULL
mutant	NULL
NFxB	NULL
sites	NULL
or	NULL
four	NULL
tandemly	NULL
repeated	NULL
wild-type	NULL
or	NULL
mutant	NULL
series	NULL
I	NULL
CREs	NULL
were	NULL
also	NULL
all	NULL
placed	NULL
into	NULL
the	NULL
same	NULL
A10	NULL
minimal	NULL
SV40	NULL
promoter	NULL
background	NULL
and	NULL
were	NULL
included	NULL
in	NULL
some	NULL
experiments	NULL
.	NULL

Basal	NULL
activities	NULL
in	NULL
the	NULL
SV40	NULL
minimal	NULL
promoter	NULL
background	NULL
were	NULL
much	NULL
lower	NULL
than	NULL
those	NULL
in	NULL
the	NULL
MIE	NULL
minimal	NULL
promoter	NULL
and	NULL
could	NULL
usually	NULL
be	NULL
detected	NULL
only	NULL
in	NULL
K-562	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
background	NULL
,	NULL
the	NULL
2X	NULL
SNE	NULL
motifs	NULL
gave	NULL
31-	NULL
and	NULL
15-fold	NULL
TPA	NULL
responses	NULL
in	NULL
U-937	NULL
and	NULL
K-562	NULL
cells	NULL
,	NULL
which	NULL
increased	NULL
synergistically	NULL
to	NULL
138-	NULL
and	NULL
43-fold	NULL
with	NULL
the	NULL
4X	NULL
SNE	NULL
versions	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
comparable	NULL
to	NULL
10-fold	NULL
TPA	NULL
effects	NULL
for	NULL
the	NULL
2X	NULL
NFxB	NULL
sites	NULL
and	NULL
11-fold	NULL
for	NULL
the	NULL
4	NULL
%	NULL
CREs	NULL
in	NULL
K-562	NULL
cells	NULL
,	NULL
both	NULL
of	NULL
which	NULL
were	NULL
eliminated	NULL
by	NULL
specific	NULL
point	NULL
mutations	NULL
within	NULL
the	NULL
core	NULL
binding	NULL
site	NULL
motifs	NULL
.	NULL

Similarly	NULL
,	NULL
mutation	NULL
of	NULL
either	NULL
the	NULL
S	NULL
or	NULL
N	NULL
components	NULL
of	NULL
the	NULL
SNE	NULL
motifs	NULL
essentially	NULL
abolished	NULL
both	NULL
basal	NULL
(	NULL
30-fold	NULL
reduction	NULL
in	NULL
U-937	NULL
cells	NULL
)	NULL
and	NULL
all	NULL
TPA-induced	NULL
activity	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
.	NULL

In	NULL
Jurkat	NULL
cells	NULL
,	NULL
only	NULL
the	NULL
4X	NULL
SNE	NULL
and	NULL
4X	NULL
CRE	NULL
targets	NULL
gave	NULL
any	NULL
specific	NULL
increase	NULL
in	NULL
signal	NULL
after	NULL
TPA	NULL
treatment	NULL
(	NULL
six-	NULL
to	NULL
sevenfold	NULL
each	NULL
)	NULL
,	NULL
and	NULL
in	NULL
both	NULL
HL-60	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
and	NULL
THP-1	NULL
cells	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
there	NULL
was	NULL
no	NULL
detectable	NULL
activity	NULL
even	NULL
with	NULL
TPA	NULL
for	NULL
any	NULL
of	NULL
these	NULL
low	NULL
basal-level	NULL
target	NULL
reporter	NULL
genes	NULL
.	NULL

The	NULL
TPA	NULL
response	NULL
in	NULL
DNA-transfected	NULL
U-937	NULL
cells	NULL
can	NULL
be	NULL
detected	NULL
within	NULL
2	NULL
h	NULL
and	NULL
reaches	NULL
at	NULL
least	NULL
250-fold	NULL
stimulation	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
time	NULL
course	NULL
of	NULL
TPA	NULL
induction	NULL
mediated	NULL
by	NULL
the	NULL
SCMV	NULL
SNE	NULL
sequences	NULL
,	NULL
we	NULL
also	NULL
introduced	NULL
the	NULL
wild-type	NULL
(	NULL
S*N+*	NULL
)	NULL
,	NULL
/A10-CAT	NULL
and	NULL
double-mutant	NULL
(	NULL
S	NULL
Â°N~	NULL
)	NULL
/A10-CAT	NULL
target	NULL
reporter	NULL
genes	NULL
into	NULL
U-937	NULL
cells	NULL
for	NULL
24	NULL
h	NULL
and	NULL
then	NULL
measured	NULL
the	NULL
induced	NULL
CAT	NULL
activity	NULL
in	NULL
extracts	NULL
prepared	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
12	NULL
,	NULL
and	NULL
24	NULL
h	NULL
after	NULL
TPA	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

The	NULL
control	NULL
mutant	NULL
target	NULL
gene	NULL
gave	NULL
no	NULL
more	NULL
than	NULL
2-	NULL
to	NULL
3-fold	NULL
stimulation	NULL
even	NULL
as	NULL
late	NULL
as	NULL
24	NULL
h	NULL
after	NULL
TPA	NULL
treatment	NULL
,	NULL
whereas	NULL
the	NULL
wild-type	NULL
version	NULL
produced	NULL
greater	NULL
than	NULL
20-fold	NULL
induction	NULL
effects	NULL
at	NULL
2	NULL
h	NULL
and	NULL
80-fold	NULL
at	NULL
4	NULL
h	NULL
,	NULL
with	NULL
a	NULL
nearly	NULL
linear	NULL
response	NULL
(	NULL
as	NULL
judged	NULL
by	NULL
5-	NULL
and	NULL
25-fold	NULL
dilutions	NULL
of	NULL
the	NULL
extract	NULL
)	NULL
for	NULL
up	NULL
to	NULL
24	NULL
h	NULL
,	NULL
reaching	NULL
an	NULL
overall	NULL
increase	NULL
of	NULL
more	NULL
than	NULL
1,000-fold	NULL
,	NULL
with	NULL
a	NULL
peak	NULL
TPA	NULL
stimulation	NULL
of	NULL
250-fold	NULL
at	NULL
both	NULL
8	NULL
and	NULL
12	NULL
h.	NULL
From	NULL
the	NULL
results	NULL
of	NULL
all	NULL
of	NULL
these	NULL
experiments	NULL
,	NULL
we	NULL
can	NULL
con-clude	NULL
,	NULL
first	NULL
,	NULL
that	NULL
the	NULL
overlapping	NULL
S	NULL
and	NULL
N	NULL
submotifs	NULL
are	NULL
both	NULL
essential	NULL
for	NULL
these	NULL
activities	NULL
and	NULL
that	NULL
they	NULL
work	NULL
synergistically	NULL
in	NULL
mediating	NULL
transcriptional	NULL
activation	NULL
;	NULL
second	NULL
,	NULL
that	NULL
multimerized	NULL
copies	NULL
also	NULL
act	NULL
synergistically	NULL
;	NULL
third	NULL
,	NULL
that	NULL
the	NULL
response	NULL
can	NULL
be	NULL
transferred	NULL
to	NULL
a	NULL
heterologous	NULL
promoter	NULL
;	NULL
and	NULL
fourth	NULL
,	NULL
that	NULL
8596	NULL
CHAN	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
U-937	NULL
100	NULL
B	NULL
a	NULL
ge	NULL
CN	NULL
est	NULL
``	NULL
-	NULL
gee	NULL
!	NULL
``	NULL

m-80	NULL
TPA	NULL
-	NULL
+	NULL
-	NULL
+	NULL
=g=	NULL
Â§	NULL
-	NULL
so	NULL
SN+	NULL
f	NULL
--	NULL
StN+	NULL
(	NULL
1:5	NULL
)	NULL
Â«	NULL
@	NULL
|	NULL
,	NULL
c	NULL
g	NULL
-	NULL
#	NULL
-	NULL
g+N+	NULL
(	NULL
1:25	NULL
)	NULL
8	NULL
Â®	NULL
-	NULL
&	NULL
-	NULL
gx	NULL
@	NULL
Â»	NULL
#	NULL
20	NULL
e	NULL
0	NULL
0	NULL
*	NULL
~	NULL
0	NULL
0	NULL
10	NULL
20	NULL
30	NULL
Hours	NULL
after	NULL
TPA	NULL
Added	NULL
<	NULL
0.3	NULL
<	NULL
0.4	NULL
10	NULL
-	NULL
88	NULL
%	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Time	NULL
course	NULL
and	NULL
quantitation	NULL
of	NULL
TPA	NULL
responsiveness	NULL
of	NULL
multimerized	NULL
SNE	NULL
motifs	NULL
after	NULL
transfection	NULL
into	NULL
U-937	NULL
cells	NULL
.	NULL

The	NULL
(	NULL
S*N*	NULL
)	NULL
Z/A10-CAT	NULL
and	NULL
(	NULL
S	NULL
target	NULL
genes	NULL
(	NULL
in	NULL
plasmids	NULL
pCJCI14B	NULL
and	NULL
pCJC34B	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
multiwell	NULL
dish	NULL
cultures	NULL
,	NULL
and	NULL
TPA	NULL
was	NULL
added	NULL
after	NULL
24	NULL
h.	NULL
Samples	NULL
were	NULL
then	NULL
taken	NULL
for	NULL
CAT	NULL
assays	NULL
at	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
12	NULL
,	NULL
and	NULL
22	NULL
h.	NULL
Measurements	NULL
were	NULL
made	NULL
with	NULL
both	NULL
the	NULL
and	NULL
STN~	NULL
extracts	NULL
as	NULL
undiluted	NULL
samples	NULL
(	NULL
open	NULL
symbols	NULL
)	NULL
,	NULL
and	NULL
the	NULL
STN~*	NULL
extracts	NULL
were	NULL
also	NULL
assayed	NULL
at	NULL
5-	NULL
and	NULL
25-fold	NULL
dilution	NULL
(	NULL
solid	NULL
symbols	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
analogous	NULL
isolated	NULL
SEE	NULL
motif	NULL
from	NULL
the	NULL
HCMV	NULL
MIEy	NULL
enhancer	NULL
also	NULL
responds	NULL
strongly	NULL
to	NULL
TPA	NULL
induction	NULL
.	NULL

The	NULL
sample	NULL
autoradiograph	NULL
shows	NULL
the	NULL
results	NULL
of	NULL
transient	NULL
CAT	NULL
expression	NULL
assays	NULL
in	NULL
U-937	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
TPA	NULL
,	NULL
using	NULL
the	NULL
(	NULL
SEE	NULL
)	NULL
,	NULL
/IES	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
(	NULL
pYJC384B	NULL
)	NULL
containing	NULL
an	NULL
upstream	NULL
insertion	NULL
of	NULL
four	NULL
tandem	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
HCMV	NULL
SEE	NULL
motif	NULL
as	NULL
a	NULL
synthetic	NULL
30-bp	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
added	NULL
to	NULL
the	NULL
parent	NULL
minimal	NULL
IES	NULL
,	NULL
,	NULL
-CAT	NULL
target	NULL
gene	NULL
(	NULL
pYJC90	NULL
)	NULL
.	NULL

significant	NULL
effects	NULL
can	NULL
be	NULL
detected	NULL
as	NULL
soon	NULL
as	NULL
1	NULL
to	NULL
2	NULL
h	NULL
after	NULL
TPA	NULL
treatment	NULL
,	NULL
making	NULL
it	NULL
likely	NULL
that	NULL
this	NULL
is	NULL
a	NULL
direct	NULL
signal	NULL
transduction	NULL
event	NULL
rather	NULL
than	NULL
a	NULL
process	NULL
that	NULL
requires	NULL
prior	NULL
cell	NULL
differentiation	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
basal	NULL
enhancement	NULL
and	NULL
TPA	NULL
responses	NULL
of	NULL
the	NULL
HCMV	NULL
SEE	NULL
and	NULL
SCMV	NULL
SNE	NULL
motifs	NULL
in	NULL
U-937	NULL
and	NULL
HL-60	NULL
cells	NULL
.	NULL

Having	NULL
obtained	NULL
considerable	NULL
evidence	NULL
in	NULL
support	NULL
of	NULL
a	NULL
role	NULL
for	NULL
SRF	NULL
and	NULL
against	NULL
the	NULL
idea	NULL
that	NULL
NFB/Rel	NULL
factors	NULL
were	NULL
responsible	NULL
for	NULL
the	NULL
TPA	NULL
induction	NULL
mediated	NULL
by	NULL
the	NULL
SCMV	NULL
ENH-A2	NULL
region	NULL
,	NULL
despite	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
series	NULL
IIIB	NULL
NFKB-like	NULL
motifs	NULL
,	NULL
we	NULL
reevaluated	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
HCMV	NULL
MIE	NULL
enhancer	NULL
has	NULL
a	NULL
functionally	NULL
similar	NULL
element	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
consensus	NULL
core	NULL
SRF	NULL
site	NULL
and	NULL
surrounding	NULL
sequences	NULL
from	NULL
positions	NULL
-538	NULL
to	NULL
-522	NULL
in	NULL
HCMV	NULL
(	NULL
Towne	NULL
)	NULL
were	NULL
synthesized	NULL
as	NULL
a	NULL
30-mer	NULL
oligonucleotide	NULL
pair	NULL
,	NULL
which	NULL
we	NULL
refer	NULL
to	NULL
as	NULL
the	NULL
SEE	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
because	NULL
of	NULL
the	NULL
adjacent	NULL
potential	NULL
GABP/ETS	NULL
class	NULL
binding	NULL
site	NULL
and	NULL
the	NULL
absence	NULL
of	NULL
potential	NULL
Rel/NFkB	NULL
class	NULL
motifs	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
the	NULL
human	NULL
SEE	NULL
motif	NULL
behaves	NULL
as	NULL
a	NULL
functional	NULL
equivalent	NULL
of	NULL
the	NULL
SCMV	NULL
(	NULL
AGM	NULL
)	NULL
SNE	NULL
motif	NULL
,	NULL
we	NULL
initially	NULL
compared	NULL
their	NULL
basal	NULL
enhancer	NULL
activities	NULL
and	NULL
abilities	NULL
to	NULL
mediate	NULL
TPA	NULL
responses	NULL
,	NULL
using	NULL
an	NULL
(	NULL
SEE	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
-CAT	NULL
target	NULL
reporter	NULL
gene	NULL
containing	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
tandemly	NULL
repeated	NULL
30-bp	NULL
SEE	NULL
inserted	NULL
into	NULL
the	NULL
minimal	NULL
SCMV	NULL
MIE	NULL
,	NULL
,	NULL
,	NULL
promoter	NULL
.	NULL

The	NULL
parent	NULL
MIE	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
and	NULL
its	NULL
derivatives	NULL
(	NULL
SNE	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
-CAT	NULL
,	NULL
(	NULL
SEE	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
-CAT	NULL
,	NULL
and	NULL
(	NULL
SRE	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
-CAT	NULL
were	NULL
introduced	NULL
into	NULL
U-937	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
TPA	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
18	NULL
h	NULL
later	NULL
.	NULL

The	NULL
results	NULL
showed	NULL
that	NULL
both	NULL
the	NULL
SNE	NULL
and	NULL
SEE	NULL
motifs	NULL
gave	NULL
approximately	NULL
equal	NULL
TPA	NULL
responsiveness	NULL
but	NULL
displayed	NULL
different	NULL
levels	NULL
of	NULL
basal	NULL
enhancement	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

The	NULL
(	NULL
SNE	NULL
)	NULL
,	NULL
and	NULL
(	NULL
SRE	NULL
)	NULL
,	NULL
inserts	NULL
both	NULL
boosted	NULL
the	NULL
basal	NULL
activity	NULL
five-	NULL
to	NULL
sixfold	NULL
in	NULL
comparison	NULL
with	NULL
the	NULL
parent	NULL
MIE	NULL
,	NULL
,	NULL
,	NULL
-CAT	NULL
,	NULL
whereas	NULL
the	NULL
(	NULL
SEE	NULL
)	NULL
,	NULL
insert	NULL
failed	NULL
to	NULL
do	NULL
so	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TPA	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
(	NULL
SEE	NULL
)	NULL
,	NULL
MIE	NULL
,	NULL
,	NULL
-CAT	NULL
was	NULL
increased	NULL
41-fold	NULL
over	NULL
the	NULL
basal	NULL
activity	NULL
,	NULL
whereas	NULL
the	NULL
minimal	NULL
MIE	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
responded	NULL
5.7-fold	NULL
.	NULL

In	NULL
comparison	NULL
,	NULL
responses	NULL
of	NULL
the	NULL
(	NULL
SNE	NULL
)	NULL
,	NULL
and	NULL
(	NULL
SRE	NULL
)	NULL
;	NULL
inserts	NULL
as	NULL
well	NULL
as	NULL
a	NULL
modified	NULL
(	NULL
SRE	NULL
)	NULL
,	NULL
insert	NULL
containing	NULL
a	NULL
core	NULL
RSRF	NULL
binding	NULL
site	NULL
(	NULL
CTATATATAG	NULL
[	NULL
68	NULL
]	NULL
)	NULL
in	NULL
place	NULL
of	NULL
the	NULL
classical	NULL
core	NULL
SRF	NULL
binding	NULL
site	NULL
(	NULL
CCATATTAGG	NULL
)	NULL
were	NULL
all	NULL
beyond	NULL
the	NULL
linear	NULL
range	NULL
of	NULL
the	NULL
assay	NULL
.	NULL

However	NULL
,	NULL
neither	NULL
the	NULL
core	NULL
or	NULL
flanking	NULL
J.	NULL
ViRoL	NULL
.	NULL

sequence	NULL
mutants	NULL
of	NULL
SRE	NULL
gave	NULL
any	NULL
increased	NULL
basal	NULL
level	NULL
or	NULL
TPA	NULL
responses	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
tested	NULL
for	NULL
SNE	NULL
and	NULL
SEE	NULL
function	NULL
in	NULL
the	NULL
promyelocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
HL-60	NULL
,	NULL
which	NULL
gave	NULL
very	NULL
low	NULL
basal	NULL
activity	NULL
and	NULL
no	NULL
TPA	NULL
induction	NULL
with	NULL
the	NULL
parent	NULL
minimal	NULL
SCMV	NULL
MIE	NULL
,	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
but	NULL
did	NULL
demonstrate	NULL
TPA	NULL
responsiveness	NULL
through	NULL
the	NULL
added	NULL
elements	NULL
in	NULL
the	NULL
(	NULL
SNE	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
,	NULL
-CAT	NULL
,	NULL
(	NULL
SEE	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
-CAT	NULL
,	NULL
and	NULL
(	NULL
SRE	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
-CAT	NULL
genes	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

In	NULL
this	NULL
experiment	NULL
,	NULL
the	NULL
minimal	NULL
1E94	NULL
MIE	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
responded	NULL
to	NULL
TPA	NULL
stimulation	NULL
only	NULL
1.2-fold	NULL
and	NULL
none	NULL
of	NULL
the	NULL
target	NULL
constructions	NULL
displayed	NULL
measurable	NULL
increases	NULL
in	NULL
basal	NULL
expression	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
addition	NULL
of	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
SNE	NULL
and	NULL
SEE	NULL
motifs	NULL
gave	NULL
8-	NULL
and	NULL
9-fold	NULL
TPA	NULL
responses	NULL
,	NULL
respectively	NULL
,	NULL
which	NULL
were	NULL
somewhat	NULL
lower	NULL
than	NULL
the	NULL
13-fold	NULL
obtained	NULL
with	NULL
the	NULL
wild-type	NULL
(	NULL
SRE	NULL
)	NULL
,	NULL
motifs	NULL
.	NULL

Once	NULL
again	NULL
TPA	NULL
induction	NULL
through	NULL
the	NULL
HCMV	NULL
(	NULL
NFB	NULL
)	NULL
,	NULL
site	NULL
or	NULL
with	NULL
multimerized	NULL
mutant	NULL
ASNE	NULL
and	NULL
ASRE	NULL
motifs	NULL
was	NULL
undetectable	NULL
in	NULL
HL-60	NULL
cells	NULL
under	NULL
these	NULL
conditions	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
both	NULL
the	NULL
SEE	NULL
and	NULL
SNE	NULL
motifs	NULL
enhance	NULL
basal	NULL
activity	NULL
and	NULL
behave	NULL
similarly	NULL
to	NULL
each	NULL
other	NULL
as	NULL
well	NULL
as	NULL
to	NULL
the	NULL
intact	NULL
c-Fos	NULL
SRE	NULL
in	NULL
response	NULL
to	NULL
TPA	NULL
stimulation	NULL
in	NULL
both	NULL
U-937	NULL
and	NULL
HL-60	NULL
cell	NULL
types	NULL
.	NULL

Effects	NULL
of	NULL
spacing	NULL
and	NULL
substitution	NULL
mutations	NULL
on	NULL
functions	NULL
of	NULL
the	NULL
SNE	NULL
motifs	NULL
.	NULL

To	NULL
further	NULL
dissect	NULL
the	NULL
molecular	NULL
mechanism	NULL
for	NULL
synergism	NULL
between	NULL
the	NULL
S	NULL
and	NULL
N	NULL
submotifs	NULL
in	NULL
the	NULL
SNE	NULL
,	NULL
we	NULL
both	NULL
altered	NULL
the	NULL
spacing	NULL
between	NULL
the	NULL
two	NULL
submotifs	NULL
(	NULL
S/InsN	NULL
)	NULL
and	NULL
changed	NULL
the	NULL
series	NULL
IIIB	NULL
NFKB-like	NULL
N	NULL
submotif	NULL
to	NULL
a	NULL
perfect	NULL
classical	NULL
consensus	NULL
Ig	NULL
kappa	NULL
NFB	NULL
binding	NULL
site	NULL
(	NULL
SNFkB	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
these	NULL
changes	NULL
preserved	NULL
the	NULL
wild-type	NULL
SNE	NULL
function	NULL
and	NULL
whether	NULL
NFB	NULL
was	NULL
indeed	NULL
involved	NULL
in	NULL
synergism	NULL
with	NULL
SRF	NULL
,	NULL
we	NULL
tested	NULL
their	NULL
effects	NULL
on	NULL
basal	NULL
enhancement	NULL
and	NULL
TPA	NULL
responses	NULL
in	NULL
transient	NULL
transfection	NULL
CAT	NULL
assays	NULL
in	NULL
both	NULL
U-937	NULL
and	NULL
HL-60	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
both	NULL
the	NULL
basal	NULL
enhancement	NULL
and	NULL
TPA	NULL
responses	NULL
of	NULL
the	NULL
(	NULL
S/NFkB	NULL
)	NULL
,	NULL
/	NULL
MIE	NULL
,	NULL
,	NULL
,	NULL
-CAT	NULL
and	NULL
(	NULL
S/InsN	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
,	NULL
-CAT	NULL
plasmids	NULL
were	NULL
highly	NULL
impaired	NULL
compared	NULL
with	NULL
those	NULL
of	NULL
(	NULL
SNE	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
,	NULL
-CAT	NULL
in	NULL
U-937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
,	NULL
and	NULL
the	NULL
TPA	NULL
responses	NULL
of	NULL
both	NULL
altered	NULL
SNEs	NULL
were	NULL
also	NULL
virtually	NULL
eliminated	NULL
in	NULL
HL-60	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Even	NULL
the	NULL
classical	NULL
HCMV	NULL
,	NULL
HIV	NULL
,	NULL
or	NULL
Ig	NULL
kappa	NULL
(	NULL
NFxB	NULL
)	NULL
,	NULL
insert	NULL
gave	NULL
no	NULL
increase	NULL
in	NULL
basal	NULL
activity	NULL
and	NULL
only	NULL
a	NULL
2-fold	NULL
boost	NULL
in	NULL
TPA	NULL
response	NULL
(	NULL
from	NULL
5.7-	NULL
to	NULL
13-fold	NULL
)	NULL
in	NULL
the	NULL
MIE	NULL
,	NULL
,	NULL
,	NULL
-CAT	NULL
background	NULL
in	NULL
U-937	NULL
cells	NULL
and	NULL
was	NULL
inactive	NULL
in	NULL
HL-60	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
it	NULL
is	NULL
not	NULL
NFB	NULL
that	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
synergism	NULL
with	NULL
SRF	NULL
to	NULL
activate	NULL
the	NULL
SNE	NULL
site	NULL
.	NULL

Clearly	NULL
the	NULL
spacing	NULL
between	NULL
the	NULL
S	NULL
and	NULL
N	NULL
submotifs	NULL
is	NULL
also	NULL
important	NULL
for	NULL
efficient	NULL
SNE	NULL
function	NULL
.	NULL

Lack	NULL
of	NULL
response	NULL
of	NULL
the	NULL
SNE	NULL
,	NULL
SEE	NULL
,	NULL
and	NULL
c-Fos	NULL
SRE	NULL
motifs	NULL
to	NULL
OA	NULL
.	NULL

To	NULL
avoid	NULL
the	NULL
complications	NULL
of	NULL
the	NULL
high	NULL
basal	NULL
levels	NULL
,	NULL
over-scale	NULL
responses	NULL
,	NULL
and	NULL
three-	NULL
to	NULL
fivefold	NULL
background	NULL
TPA	NULL
effects	NULL
obtained	NULL
with	NULL
the	NULL
minimal	NULL
SCMV	NULL
MIE	NULL
,	NULL
,	NULL
,	NULL
promoter	NULL
alone	NULL
in	NULL
U-937	NULL
cells	NULL
,	NULL
we	NULL
also	NULL
generated	NULL
another	NULL
set	NULL
of	NULL
heterologous	NULL
reporter	NULL
plasmids	NULL
in	NULL
the	NULL
minimal	NULL
HCMV	NULL
IES	NULL
(	NULL
-57/+77	NULL
)	NULL
-CAT	NULL
promoter	NULL
background	NULL
,	NULL
which	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
IES	NULL
enhancer	NULL
control	NULL
region	NULL
regulating	NULL
the	NULL
HCMV	NULL
US3	NULL
gene	NULL
(	NULL
8	NULL
)	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
SEE	NULL
oligonucleotide	NULL
increased	NULL
the	NULL
basal	NULL
activity	NULL
33-fold	NULL
and	NULL
gave	NULL
an	NULL
additional	NULL
9-fold	NULL
stimulation	NULL
after	NULL
TPA	NULL
treatment	NULL
in	NULL
U-937	NULL
cells	NULL
,	NULL
whereas	NULL
the	NULL
parent	NULL
minimal	NULL
HCMV	NULL
IES	NULL
,	NULL
,	NULL
,	NULL
-CAT	NULL
plasmid	NULL
gave	NULL
neither	NULL
significant	NULL
enhancement	NULL
of	NULL
basal	NULL
levels	NULL
nor	NULL
any	NULL
TPA	NULL
responsiveness	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
previously	NULL
that	NULL
,	NULL
unlike	NULL
the	NULL
intact	NULL
enhancer/promoter	NULL
region	NULL
in	NULL
the	NULL
HIV	NULL
LTR	NULL
,	NULL
HCMV	NULL
MIE	NULL
,	NULL
and	NULL
HCMV	NULL
IES	NULL
(	NULL
US3	NULL
)	NULL
genes	NULL
,	NULL
the	NULL
intact	NULL
SCMV	NULL
enhancer/	NULL
promoter	NULL
region	NULL
from	NULL
positions	NULL
-633	NULL
to	NULL
+30	NULL
fails	NULL
to	NULL
respond	NULL
either	NULL
to	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
TNF-	NULL
Â«	NULL
)	NULL
or	NULL
to	NULL
OA	NULL
in	NULL
U-937	NULL
cells	NULL
(	NULL
8	NULL
,	NULL
11	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
this	NULL
finding	NULL
represented	NULL
a	NULL
difference	NULL
between	NULL
the	NULL
isolated	NULL
multimerized	NULL
SNE	NULL
,	NULL
VoL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
TPA	NULL
RESPONSES	NULL
OF	NULL
SRF/ETS	NULL
ELEMENTS	NULL
IN	NULL
CMV	NULL
_	NULL
8597	NULL
n	NULL
MlEm	NULL
Â»	NULL
>	NULL
w	NULL
C	NULL
t	NULL
i	NULL
p	NULL
tou	NULL
&	NULL
'	NULL
_	NULL
S	NULL
&	NULL
5	NULL
5	NULL
A	NULL
T	NULL
a	NULL
c	NULL
G	NULL
C	NULL
C	NULL
E	NULL
&	NULL
&	NULL
2	NULL
%	NULL
U-937	NULL
B	NULL
%	NULL
HL-60	NULL
HIV	NULL
-	NULL
1ESm	NULL
-	NULL
--	NULL
-	NULL
#	NULL
Â»	NULL
HIV	NULL
C	NULL
LTR	NULL
IESm	NULL
LTR	NULL
__	NULL
(	NULL
SNE	NULL
)	NULL
,	NULL
|	NULL
(	NULL
SEE	NULL
)	NULL
q	NULL
-	NULL
(	NULL
SRE	NULL
)	NULL
4	NULL
(	NULL
SREc	NULL
)	NULL
4	NULL
40	NULL
42x	NULL
30	NULL
%	NULL
20	NULL
-	NULL
]	NULL
7.2	NULL
%	NULL
U-937	NULL
{	NULL
5.8x	NULL
7.1x	NULL
10	NULL
7.2	NULL
%	NULL
1.3x	NULL
1.4x	NULL
7	NULL
1.3x	NULL
1.4x	NULL
1.6x	NULL
1.5	NULL
%	NULL
1.0x	NULL
1.4x	NULL
O.8xÂ¢	NULL
0	NULL
-	NULL
2	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
Evidence	NULL
that	NULL
NFB	NULL
is	NULL
not	NULL
involved	NULL
in	NULL
synergism	NULL
with	NULL
SRF	NULL
and	NULL
that	NULL
the	NULL
spacing	NULL
between	NULL
the	NULL
S	NULL
and	NULL
N	NULL
motifs	NULL
is	NULL
critical	NULL
for	NULL
synergism	NULL
.	NULL

The	NULL
histograms	NULL
show	NULL
the	NULL
results	NULL
of	NULL
transient	NULL
CAT	NULL
expression	NULL
assays	NULL
in	NULL
U-937	NULL
cells	NULL
(	NULL
A	NULL
)	NULL
or	NULL
HL-60	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
with	NULL
the	NULL
parent	NULL
SCMV	NULL
{	NULL
(	NULL
AGM	NULL
)	NULL
minimal	NULL
MIE	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
(	NULL
pCJC81	NULL
)	NULL
,	NULL
or	NULL
versions	NULL
containing	NULL
upstream	NULL
insertions	NULL
of	NULL
four	NULL
tandem	NULL
copies	NULL
of	NULL
the	NULL
SNE	NULL
oligonucleotide	NULL
motif	NULL
from	NULL
the	NULL
SCMV	NULL
(	NULL
AGM	NULL
)	NULL
MIE	NULL
,	NULL
enhancer	NULL
,	NULL
to	NULL
generate	NULL
the	NULL
(	NULL
SNE	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
(	NULL
pCJC114B	NULL
)	NULL
,	NULL
a	NULL
version	NULL
with	NULL
the	NULL
classical	NULL
Ig	NULL
kappa	NULL
NFxB	NULL
motif	NULL
substituted	NULL
for	NULL
the	NULL
N	NULL
submotif	NULL
in	NULL
(	NULL
S/NFxB	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
-CAT	NULL
(	NULL
pYJC224B	NULL
)	NULL
,	NULL
a	NULL
2-bp	NULL
insertion	NULL
mutant	NULL
between	NULL
the	NULL
two	NULL
submotifs	NULL
in	NULL
(	NULL
S/InsN	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
-CAT	NULL
(	NULL
pYJC244B	NULL
)	NULL
,	NULL
and	NULL
the	NULL
HCMV	NULL
SEE	NULL
motifs	NULL
in	NULL
the	NULL
(	NULL
SEE	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
(	NULL
pYJC294B	NULL
)	NULL
.	NULL

Other	NULL
control	NULL
and	NULL
mutant	NULL
target	NULL
constructions	NULL
include	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
HCMV	NULL
MIE	NULL
;	NULL
;	NULL
consensus	NULL
NFkB	NULL
site	NULL
in	NULL
(	NULL
NFxB	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
,	NULL
.CAT	NULL
(	NULL
pYJC304	NULL
)	NULL
,	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
c-Fos	NULL
wild-type	NULL
SRE	NULL
in	NULL
(	NULL
SRE	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
,	NULL
.CAT	NULL
(	NULL
pYJC262	NULL
)	NULL
,	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
c-Fos	NULL
SRE	NULL
flanking	NULL
ETS	NULL
sequence	NULL
mutant	NULL
(	NULL
SRE	NULL
,	NULL
.	NULL
)	NULL

,	NULL
/MIE	NULL
,	NULL
,	NULL
-CAT	NULL
(	NULL
pYNC282	NULL
)	NULL
,	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
c-Fos	NULL
SRE	NULL
core	NULL
SRF	NULL
point	NULL
mutant	NULL
in	NULL
(	NULL
SREp	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
-CAT	NULL
(	NULL
pYJC324	NULL
)	NULL
,	NULL
and	NULL
four	NULL
copies	NULL
of	NULL
a	NULL
c-Fos	NULL
SRE	NULL
variant	NULL
containing	NULL
an	NULL
RSRF	NULL
core	NULL
binding	NULL
site	NULL
in	NULL
(	NULL
RSRF	NULL
)	NULL
,	NULL
/MIE	NULL
,	NULL
,	NULL
.-CAT	NULL
(	NULL
pYJC314	NULL
)	NULL
.	NULL

ND	NULL
,	NULL
not	NULL
determined	NULL
.	NULL

Samples	NULL
were	NULL
either	NULL
untreated	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
TPA	NULL
(	NULL
solid	NULL
bars	NULL
)	NULL
.	NULL

Results	NULL
are	NULL
plotted	NULL
as	NULL
percent	NULL
conversion	NULL
of	NULL
[	NULL
'*CJchloramphenicol	NULL
to	NULL
acetylated	NULL
forms	NULL
,	NULL
and	NULL
fold	NULL
induction	NULL
values	NULL
are	NULL
indicated	NULL
for	NULL
the	NULL
sample	NULL
pairs	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Unlike	NULL
the	NULL
HIV	NULL
NFxB	NULL
motifs	NULL
,	NULL
the	NULL
SNE	NULL
,	NULL
SEE	NULL
,	NULL
and	NULL
SRE	NULL
motifs	NULL
do	NULL
not	NULL
respond	NULL
to	NULL
OA	NULL
stimulation	NULL
U-937	NULL
cells	NULL
.	NULL

The	NULL
histogram	NULL
shows	NULL
the	NULL
TPA	NULL
and	NULL
OA	NULL
responsiveness	NULL
in	NULL
U-937	NULL
cells	NULL
of	NULL
the	NULL
parent	NULL
minimal	NULL
nonresponsive	NULL
IES	NULL
(	NULL
-54/+80	NULL
)	NULL
-CAT	NULL
gene	NULL
(	NULL
=IES	NULL
,	NULL
,	NULL
,	NULL
-CAT	NULL
in	NULL
pÂ¥YJC90	NULL
)	NULL
or	NULL
versions	NULL
containing	NULL
four	NULL
added	NULL
tandem	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
SCMV	NULL
SNE	NULL
motif	NULL
in	NULL
the	NULL
(	NULL
SNE	NULL
)	NULL
,	NULL
/IES	NULL
,	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
(	NULL
pYJC794B	NULL
)	NULL
,	NULL
the	NULL
wild-type	NULL
HCMV	NULL
SEE	NULL
motif	NULL
in	NULL
the	NULL
(	NULL
SEE	NULL
)	NULL
,	NULL
/IES	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
(	NULL
pYJC384B	NULL
)	NULL
,	NULL
the	NULL
wild-type	NULL
c-Fos	NULL
SRE	NULL
motif	NULL
in	NULL
the	NULL
(	NULL
SRE	NULL
)	NULL
,	NULL
/IES	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
(	NULL
pYJC414B	NULL
)	NULL
,	NULL
and	NULL
a	NULL
c-Fos	NULL
core	NULL
SRE	NULL
motif	NULL
only	NULL
containing	NULL
point	NULL
mutations	NULL
in	NULL
the	NULL
flanking	NULL
ETS	NULL
binding	NULL
site	NULL
(	NULL
SRE	NULL
,	NULL
.	NULL
)	NULL

y/IES	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
(	NULL
pYJC282A	NULL
)	NULL
.	NULL

The	NULL
wild-type	NULL
HIV	NULL
LTR-CAT	NULL
gene	NULL
(	NULL
in	NULL
plasmid	NULL
pU3RIII	NULL
)	NULL
and	NULL
a	NULL
derivative	NULL
with	NULL
the	NULL
NFB	NULL
sites	NULL
mutated	NULL
as	NULL
the	NULL
LTR	NULL
(	NULL
ANFxB	NULL
)	NULL
-CAT	NULL
gene	NULL
(	NULL
mpU3RIIIT	NULL
)	NULL
were	NULL
used	NULL
as	NULL
controls	NULL
.	NULL

Parallel	NULL
cultures	NULL
were	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
50	NULL
ng	NULL
of	NULL
TPA	NULL
per	NULL
ml	NULL
or	NULL
25	NULL
nM	NULL
OA	NULL
or	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
both	NULL
and	NULL
harvested	NULL
for	NULL
CAT	NULL
assays	NULL
.	NULL

Measurements	NULL
are	NULL
plotted	NULL
as	NULL
percent	NULL
conversion	NULL
,	NULL
and	NULL
fold	NULL
induction	NULL
values	NULL
are	NULL
shown	NULL
.	NULL

Open	NULL
bars	NULL
,	NULL
no	NULL
treatment	NULL
;	NULL
solid	NULL
bars	NULL
,	NULL
plus	NULL
TPA	NULL
;	NULL
hatched	NULL
bars	NULL
,	NULL
plus	NULL
OA	NULL
.	NULL

SEE	NULL
,	NULL
or	NULL
SRE	NULL
motifs	NULL
and	NULL
the	NULL
classical	NULL
Ig	NULL
kappa-like	NULL
NFkB	NULL
binding	NULL
sites	NULL
that	NULL
are	NULL
present	NULL
in	NULL
all	NULL
three	NULL
of	NULL
the	NULL
other	NULL
enhance-ers	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
TPA	NULL
and	NULL
OA	NULL
responses	NULL
among	NULL
CAT	NULL
reporter	NULL
genes	NULL
containing	NULL
the	NULL
parent	NULL
minimal	NULL
HCMV	NULL
IES	NULL
promoter	NULL
(	NULL
IES	NULL
,	NULL
,	NULL
-CAT	NULL
)	NULL
with	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
SCMV	NULL
SNE	NULL
,	NULL
HCMV	NULL
SEE	NULL
,	NULL
c-Fos	NULL
SRE	NULL
,	NULL
or	NULL
c-Fos	NULL
core	NULL
SRF	NULL
motif	NULL
added	NULL
in	NULL
a	NULL
transient	NULL
DNA	NULL
transfection	NULL
assay	NULL
in	NULL
U-937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
minimal	NULL
promoter	NULL
in	NULL
IES-CAT	NULL
failed	NULL
to	NULL
respond	NULL
to	NULL
either	NULL
TPA	NULL
or	NULL
OA	NULL
,	NULL
whereas	NULL
the	NULL
basal	NULL
CAT	NULL
enzyme	NULL
levels	NULL
increased	NULL
19-fold	NULL
with	NULL
the	NULL
(	NULL
SNE	NULL
)	NULL
,	NULL
/IES	NULL
,	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
,	NULL
and	NULL
TPA	NULL
stimulation	NULL
gave	NULL
an	NULL
additional	NULL
6-fold	NULL
boost	NULL
in	NULL
activity	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
OA	NULL
stimulation	NULL
gave	NULL
only	NULL
a	NULL
1.3-fold	NULL
increase	NULL
over	NULL
basal	NULL
levels	NULL
.	NULL

Similarly	NULL
,	NULL
(	NULL
SEE	NULL
)	NULL
//IES	NULL
,	NULL
,	NULL
-CAT	NULL
displayed	NULL
a	NULL
9-fold	NULL
increased	NULL
basal	NULL
level	NULL
and	NULL
responded	NULL
7-fold	NULL
to	NULL
TPA	NULL
but	NULL
not	NULL
to	NULL
OA	NULL
(	NULL
1.3-fold	NULL
increase	NULL
)	NULL
.	NULL

The	NULL
(	NULL
SRE	NULL
)	NULL
,	NULL
/IES	NULL
,	NULL
,	NULL
-CAT	NULL
gene	NULL
behaved	NULL
essentially	NULL
the	NULL
same	NULL
as	NULL
our	NULL
SEE	NULL
and	NULL
SNE	NULL
targets	NULL
by	NULL
giving	NULL
20-fold	NULL
increased	NULL
basal	NULL
CAT	NULL
enzyme	NULL
levels	NULL
and	NULL
a	NULL
7-fold	NULL
TPA	NULL
response	NULL
but	NULL
only	NULL
a	NULL
1.4-fold	NULL
OA	NULL
response	NULL
.	NULL

Both	NULL
effects	NULL
were	NULL
8598	NULL
CHAN	NULL
ET	NULL
AL	NULL
.	NULL

lost	NULL
by	NULL
mutation	NULL
of	NULL
the	NULL
flanking	NULL
ETS	NULL
motif	NULL
in	NULL
the	NULL
SRE	NULL
.	NULL

In	NULL
comparison	NULL
,	NULL
although	NULL
no	NULL
significant	NULL
OA	NULL
responses	NULL
were	NULL
observed	NULL
with	NULL
any	NULL
of	NULL
the	NULL
three	NULL
SRF-containing	NULL
elements	NULL
,	NULL
the	NULL
same	NULL
concentration	NULL
of	NULL
OA	NULL
stimulated	NULL
the	NULL
wild-type	NULL
HIV	NULL
LTR-CAT	NULL
control	NULL
target	NULL
containing	NULL
two	NULL
intact	NULL
classical	NULL
NFkB	NULL
sites	NULL
sevenfold	NULL
in	NULL
parallel	NULL
assays	NULL
but	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
HIV	NULL
LTR	NULL
(	NULL
ANFKB	NULL
)	NULL
-CAT	NULL
mutant	NULL
version	NULL
in	NULL
which	NULL
both	NULL
NFKB	NULL
sites	NULL
were	NULL
mutated	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
have	NULL
also	NULL
been	NULL
obtained	NULL
with	NULL
2	NULL
%	NULL
tandemly	NULL
repeated	NULL
wild-type	NULL
and	NULL
mutant	NULL
NFB	NULL
sites	NULL
placed	NULL
upstream	NULL
of	NULL
the	NULL
SV40	NULL
minimal	NULL
promoter	NULL
in	NULL
the	NULL
A10-CAT	NULL
gene	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
all	NULL
three	NULL
SRF-containing	NULL
elements	NULL
respond	NULL
to	NULL
signal	NULL
transduction	NULL
pathways	NULL
generated	NULL
by	NULL
TPA	NULL
stimulation	NULL
(	NULL
presumably	NULL
predominantly	NULL
by	NULL
PKC	NULL
pathways	NULL
)	NULL
but	NULL
that	NULL
unlike	NULL
NFB	NULL
motifs	NULL
,	NULL
they	NULL
do	NULL
not	NULL
respond	NULL
to	NULL
OA	NULL
at	NULL
concentrations	NULL
that	NULL
are	NULL
known	NULL
to	NULL
inhibit	NULL
phosphatase	NULL
2A	NULL
(	NULL
PP2A	NULL
)	NULL
activity	NULL
and	NULL
subsequent	NULL
IxB	NULL
degrada-tion	NULL
.	NULL

Identification	NULL
of	NULL
specific	NULL
cellular	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
SNE	NULL
motifs	NULL
in	NULL
U-937	NULL
and	NULL
Raji	NULL
nuclear	NULL
extracts	NULL
.	NULL

The	NULL
67-kDa	NULL
SRF	NULL
protein	NULL
(	NULL
p67Â°~	NULL
``	NULL
)	NULL
was	NULL
identified	NULL
as	NULL
a	NULL
constitutively	NULL
expressed	NULL
cellular	NULL
DNA-binding	NULL
protein	NULL
that	NULL
specifically	NULL
recognizes	NULL
the	NULL
core	NULL
motif	NULL
,	NULL
CCATATTAGG	NULL
,	NULL
within	NULL
the	NULL
c-Fos	NULL
SRE	NULL
sequence	NULL
(	NULL
56	NULL
,	NULL
83	NULL
)	NULL
.	NULL

SRF	NULL
also	NULL
forms	NULL
a	NULL
ternary	NULL
complex	NULL
with	NULL
an	NULL
ETS	NULL
family	NULL
protein	NULL
,	NULL
p62	NULL
``	NULL
(	NULL
now	NULL
known	NULL
as	NULL
ELK-1	NULL
or	NULL
SAP-1	NULL
)	NULL
,	NULL
which	NULL
recognizes	NULL
the	NULL
flanking	NULL
sequence	NULL
(	NULL
C/A	NULL
)	NULL
(	NULL
C/A	NULL
)	NULL
GGA	NULL
(	NULL
T/A	NULL
)	NULL
located	NULL
2	NULL
bp	NULL
3	NULL
'	NULL
to	NULL
the	NULL
c-Fos	NULL
core	NULL
SRF	NULL
binding	NULL
site	NULL
and	NULL
has	NULL
been	NULL
thought	NULL
to	NULL
be	NULL
required	NULL
for	NULL
full	NULL
serum	NULL
response	NULL
activity	NULL
(	NULL
24	NULL
,	NULL
52	NULL
,	NULL
63	NULL
,	NULL
66	NULL
,	NULL
69	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
ELK-1	NULL
and	NULL
SAP-1	NULL
do	NULL
not	NULL
bind	NULL
stably	NULL
to	NULL
this	NULL
sequence	NULL
on	NULL
their	NULL
own	NULL
.	NULL

Since	NULL
both	NULL
the	NULL
SNE	NULL
and	NULL
SEE	NULL
motifs	NULL
also	NULL
contain	NULL
consensus	NULL
core	NULL
ETS	NULL
binding	NULL
motifs	NULL
(	NULL
GGAA	NULL
)	NULL
,	NULL
although	NULL
their	NULL
flanking	NULL
sequences	NULL
differ	NULL
significantly	NULL
from	NULL
those	NULL
of	NULL
the	NULL
c-Fos	NULL
SRE	NULL
site	NULL
,	NULL
we	NULL
needed	NULL
to	NULL
know	NULL
what	NULL
cellular	NULL
factors	NULL
might	NULL
be	NULL
involved	NULL
in	NULL
binding	NULL
to	NULL
the	NULL
N	NULL
or	NULL
E	NULL
submotif	NULL
to	NULL
generate	NULL
the	NULL
synergistic	NULL
TPA	NULL
response	NULL
effects	NULL
with	NULL
the	NULL
S	NULL
submotif	NULL
.	NULL

We	NULL
showed	NULL
previously	NULL
that	NULL
a	NULL
30-bp	NULL
SNE	NULL
oligonucleotide	NULL
probe	NULL
from	NULL
the	NULL
SCMV	NULL
MIE	NULL
ENH-A2	NULL
region	NULL
bound	NULL
to	NULL
cellular	NULL
SRF	NULL
by	NULL
EMSA	NULL
using	NULL
a	NULL
partially	NULL
purified	NULL
heparin-agarose	NULL
fraction	NULL
from	NULL
a	NULL
Raji	NULL
cell	NULL
nuclear	NULL
extract	NULL
that	NULL
contains	NULL
SRF	NULL
binding	NULL
activity	NULL
(	NULL
10	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
retrospect	NULL
it	NULL
was	NULL
not	NULL
clear	NULL
whether	NULL
this	NULL
represented	NULL
just	NULL
SRF	NULL
or	NULL
a	NULL
potential	NULL
SRF-ETS	NULL
ternary	NULL
complex	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
an	NULL
initial	NULL
experiment	NULL
with	NULL
the	NULL
same	NULL
Raji	NULL
cell	NULL
fraction	NULL
,	NULL
a	NULL
control	NULL
Â°Â°P-labeled	NULL
classical	NULL
c-Fos	NULL
SRE	NULL
oligonucleotide	NULL
probe	NULL
was	NULL
compared	NULL
with	NULL
both	NULL
wild-type	NULL
and	NULL
mutant	NULL
forms	NULL
of	NULL
the	NULL
SNE	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

The	NULL
wild-type	NULL
SNE	NULL
probe	NULL
as	NULL
well	NULL
as	NULL
the	NULL
N	NULL
submotif	NULL
mutated	NULL
SNE	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
SAN	NULL
)	NULL
both	NULL
formed	NULL
single	NULL
complexes	NULL
migrating	NULL
at	NULL
the	NULL
same	NULL
position	NULL
as	NULL
the	NULL
wild-type	NULL
SRE	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
a	NULL
probe	NULL
with	NULL
mutations	NULL
in	NULL
both	NULL
the	NULL
S	NULL
and	NULL
N	NULL
submotifs	NULL
(	NULL
ASAN	NULL
;	NULL
lane	NULL
4	NULL
)	NULL
failed	NULL
to	NULL
generate	NULL
a	NULL
shifted	NULL
band	NULL
at	NULL
the	NULL
same	NULL
position	NULL
.	NULL

Evidently	NULL
,	NULL
partially	NULL
purified	NULL
Raji	NULL
SRF	NULL
can	NULL
form	NULL
a	NULL
direct	NULL
protein-DNA	NULL
complex	NULL
with	NULL
the	NULL
wild-type	NULL
SNE	NULL
that	NULL
lacks	NULL
any	NULL
ETS	NULL
protein	NULL
component	NULL
and	NULL
is	NULL
indistinguishable	NULL
from	NULL
that	NULL
of	NULL
the	NULL
SRF	NULL
binary	NULL
complex	NULL
formed	NULL
on	NULL
the	NULL
SRE	NULL
.	NULL

Formation	NULL
of	NULL
this	NULL
binary	NULL
complex	NULL
is	NULL
also	NULL
independent	NULL
of	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
flanking	NULL
series	NULL
IIIB	NULL
N	NULL
motif	NULL
or	NULL
core	NULL
ETS	NULL
motifs	NULL
in	NULL
the	NULL
SNE	NULL
probe	NULL
.	NULL

To	NULL
look	NULL
for	NULL
potential	NULL
additional	NULL
specific	NULL
SNE-binding	NULL
proteins	NULL
in	NULL
U-937	NULL
cells	NULL
,	NULL
we	NULL
also	NULL
performed	NULL
EMSAs	NULL
using	NULL
a	NULL
more	NULL
extensive	NULL
series	NULL
of	NULL
synthetic	NULL
30-bp	NULL
oligonucleotides	NULL
derived	NULL
from	NULL
the	NULL
wild-type	NULL
SCMV	NULL
SNE	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

The	NULL
wild-type	NULL
SNE	NULL
probe	NULL
formed	NULL
the	NULL
classical	NULL
SRF	NULL
complex	NULL
with	NULL
unfractionated	NULL
U-937	NULL
nuclear	NULL
extracts	NULL
,	NULL
together	NULL
with	NULL
both	NULL
a	NULL
slow-er-mobility	NULL
band	NULL
(	NULL
C	NULL
complex	NULL
)	NULL
and	NULL
a	NULL
faster-mobility	NULL
band	NULL
(	NULL
YY1	NULL
[	NULL
not	NULL
shown	NULL
]	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

The	NULL
YY1	NULL
complex	NULL
will	NULL
be	NULL
described	NULL
elsewhere	NULL
,	NULL
but	NULL
its	NULL
binding	NULL
pattern	NULL
does	NULL
not	NULL
correlate	NULL
J.	NULL
ViRoL	NULL
.	NULL

directly	NULL
with	NULL
TPA	NULL
responsiveness	NULL
(	NULL
1	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
SRF	NULL
submotif	NULL
mutant	NULL
AS/N	NULL
probe	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
was	NULL
not	NULL
able	NULL
to	NULL
form	NULL
either	NULL
the	NULL
SRF	NULL
,	NULL
YY1	NULL
,	NULL
or	NULL
C	NULL
complex	NULL
,	NULL
but	NULL
the	NULL
series	NULL
IIIB/ETS	NULL
submotif	NULL
mutation	NULL
in	NULL
the	NULL
S/AN	NULL
probe	NULL
prevented	NULL
formation	NULL
of	NULL
only	NULL
the	NULL
ternary	NULL
C	NULL
complex	NULL
,	NULL
with	NULL
a	NULL
concomitant	NULL
large	NULL
increase	NULL
in	NULL
the	NULL
abundance	NULL
of	NULL
the	NULL
binary	NULL
SRF	NULL
complex	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
double-mutant	NULL
probe	NULL
,	NULL
AS/AN	NULL
,	NULL
failed	NULL
to	NULL
form	NULL
any	NULL
of	NULL
these	NULL
three	NULL
DNA-protein	NULL
complexes	NULL
but	NULL
did	NULL
produce	NULL
a	NULL
new	NULL
,	NULL
presumably	NULL
nonrelevant	NULL
bound	NULL
species	NULL
(	NULL
X	NULL
)	NULL
that	NULL
was	NULL
not	NULL
seen	NULL
with	NULL
any	NULL
other	NULL
probe	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

The	NULL
mutant	NULL
probe	NULL
,	NULL
which	NULL
was	NULL
modified	NULL
in	NULL
its	NULL
flanking	NULL
sequences	NULL
to	NULL
mimic	NULL
the	NULL
Ig	NULL
kappa	NULL
classical	NULL
NFB	NULL
binding	NULL
sequence	NULL
,	NULL
again	NULL
gave	NULL
a	NULL
high	NULL
level	NULL
of	NULL
binary	NULL
SRF	NULL
complexes	NULL
but	NULL
failed	NULL
to	NULL
form	NULL
any	NULL
C	NULL
complex	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
mutant	NULL
S/InsN	NULL
probe	NULL
,	NULL
which	NULL
contained	NULL
intact	NULL
SRF	NULL
and	NULL
ETS	NULL
submotifs	NULL
but	NULL
with	NULL
two	NULL
extra	NULL
base	NULL
pairs	NULL
inserted	NULL
to	NULL
change	NULL
the	NULL
spacing	NULL
between	NULL
them	NULL
,	NULL
still	NULL
formed	NULL
the	NULL
C	NULL
complex	NULL
although	NULL
at	NULL
reduced	NULL
efficiency	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
concluded	NULL
that	NULL
the	NULL
C	NULL
complex	NULL
must	NULL
consist	NULL
of	NULL
both	NULL
SRF	NULL
and	NULL
a	NULL
second	NULL
,	NULL
unknown	NULL
factor	NULL
that	NULL
is	NULL
not	NULL
and	NULL
that	NULL
both	NULL
proteins	NULL
might	NULL
be	NULL
involved	NULL
in	NULL
mediating	NULL
the	NULL
synergism	NULL
between	NULL
the	NULL
S	NULL
and	NULL
N	NULL
submotifs	NULL
in	NULL
enhancing	NULL
the	NULL
basal	NULL
transcriptional	NULL
activity	NULL
and	NULL
conferring	NULL
TPA	NULL
responsiveness	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
SEE	NULL
and	NULL
SRE	NULL
motif-binding	NULL
factors	NULL
by	NULL
competition	NULL
EMSAs	NULL
.	NULL

Although	NULL
SRF	NULL
DNA-protein	NULL
complexes	NULL
formed	NULL
efficiently	NULL
on	NULL
the	NULL
SNE	NULL
motif	NULL
,	NULL
formation	NULL
of	NULL
the	NULL
direct	NULL
binary	NULL
complex	NULL
could	NULL
not	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
inducible	NULL
enhancer	NULL
properties	NULL
of	NULL
the	NULL
SNE	NULL
or	NULL
SEE	NULL
because	NULL
the	NULL
S/AN	NULL
probe	NULL
,	NULL
which	NULL
failed	NULL
to	NULL
give	NULL
normal	NULL
levels	NULL
of	NULL
basal	NULL
enhancement	NULL
and	NULL
TPA	NULL
responses	NULL
,	NULL
still	NULL
formed	NULL
the	NULL
binary	NULL
SRF	NULL
complex	NULL
with	NULL
high	NULL
efficiency	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
and	NULL
B	NULL
,	NULL
lanes	NULL
3	NULL
)	NULL
.	NULL

Similar	NULL
conclusions	NULL
were	NULL
derived	NULL
by	NULL
others	NULL
from	NULL
c-Fos	NULL
SRE	NULL
studies	NULL
,	NULL
indicating	NULL
that	NULL
SRF	NULL
is	NULL
necessary	NULL
,	NULL
but	NULL
not	NULL
sufficient	NULL
,	NULL
both	NULL
for	NULL
ternary	NULL
complex	NULL
formation	NULL
and	NULL
for	NULL
mediating	NULL
serum	NULL
and	NULL
TPA	NULL
responses	NULL
(	NULL
26	NULL
,	NULL
69	NULL
,	NULL
83	NULL
)	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
flanking	NULL
sequences	NULL
in	NULL
the	NULL
SRE	NULL
,	NULL
SEE	NULL
,	NULL
and	NULL
SNE	NULL
reveals	NULL
little	NULL
homology	NULL
except	NULL
for	NULL
a	NULL
GGA	NULL
(	NULL
A/T	NULL
)	NULL
motif	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
,	NULL
which	NULL
represents	NULL
a	NULL
common	NULL
core	NULL
element	NULL
recognized	NULL
by	NULL
many	NULL
ETS	NULL
family	NULL
proteins	NULL
such	NULL
as	NULL
GABP	NULL
,	NULL
ETS-1	NULL
,	NULL
ETS-2	NULL
,	NULL
PEA3	NULL
,	NULL
SAP-1	NULL
,	NULL
ELK-1	NULL
,	NULL
and	NULL
PU1	NULL
(	NULL
38	NULL
,	NULL
51	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
flanking	NULL
sequence	NULL
of	NULL
the	NULL
SEE	NULL
motif	NULL
resembles	NULL
a	NULL
perfect	NULL
GABP	NULL
binding	NULL
site	NULL
,	NULL
GCGGAAC	NULL
(	NULL
43	NULL
)	NULL
,	NULL
and	NULL
it	NULL
is	NULL
known	NULL
that	NULL
both	NULL
the	NULL
ELK-1	NULL
and	NULL
SAP-1	NULL
ETS	NULL
class	NULL
proteins	NULL
can	NULL
form	NULL
ternary	NULL
complexes	NULL
with	NULL
SRF	NULL
on	NULL
the	NULL
c-Fos	NULL
SRE	NULL
site	NULL
(	NULL
15	NULL
,	NULL
30	NULL
,	NULL
66	NULL
)	NULL
,	NULL
we	NULL
were	NULL
interested	NULL
in	NULL
knowing	NULL
whether	NULL
these	NULL
or	NULL
any	NULL
other	NULL
ETS	NULL
family	NULL
proteins	NULL
could	NULL
form	NULL
complexes	NULL
with	NULL
SRF	NULL
on	NULL
our	NULL
SEE	NULL
or	NULL
SNE	NULL
motif	NULL
.	NULL

Therefore	NULL
,	NULL
to	NULL
test	NULL
whether	NULL
the	NULL
C	NULL
complex	NULL
contains	NULL
both	NULL
ETS	NULL
family	NULL
proteins	NULL
and	NULL
SRF	NULL
,	NULL
competition	NULL
EMSAs	NULL
were	NULL
performed	NULL
with	NULL
either	NULL
the	NULL
SNE	NULL
,	NULL
SEE	NULL
,	NULL
or	NULL
SRE	NULL
oligonucleotide	NULL
pairs	NULL
as	NULL
probes	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
U-937	NULL
or	NULL
HeLa	NULL
cells	NULL
.	NULL

Both	NULL
the	NULL
SNE	NULL
and	NULL
SEE	NULL
probes	NULL
formed	NULL
the	NULL
typical	NULL
SRF	NULL
and	NULL
ternary	NULL
C	NULL
complexes	NULL
with	NULL
HeLa	NULL
cell	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
core	NULL
SRF	NULL
binding	NULL
site	NULL
only	NULL
,	NULL
both	NULL
the	NULL
binary	NULL
SRF	NULL
and	NULL
C	NULL
complexes	NULL
were	NULL
abolished	NULL
,	NULL
whereas	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
oligonucleotides	NULL
containing	NULL
three	NULL
adjacent	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
core	NULL
GABP	NULL
binding	NULL
sites	NULL
as	NULL
a	NULL
competitor	NULL
,	NULL
formation	NULL
of	NULL
only	NULL
the	NULL
C	NULL
complex	NULL
was	NULL
abolished	NULL
from	NULL
the	NULL
HeLa	NULL
cell	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
and	NULL
(	NULL
particularly	NULL
for	NULL
SEE	NULL
)	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
binary	NULL
SRF	NULL
band	NULL
increased	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
same	NULL
change	NULL
in	NULL
pattern	NULL
with	NULL
the	NULL
3X	NULL
GABP	NULL
competitor	NULL
was	NULL
observed	NULL
for	NULL
both	NULL
the	NULL
SEE	NULL
and	NULL
SRE	NULL
probes	NULL
with	NULL
U-937	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
,	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
10	NULL
and	NULL
11	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
mutant	NULL
GABP	NULL
oligonucleotide	NULL
probe	NULL
3X	NULL
AGABP	NULL
was	NULL
not	NULL
able	NULL
to	NULL
compete	NULL
with	NULL
C-complex	NULL
formation	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
12	NULL
)	NULL
.	NULL

An	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
containing	NULL
just	NULL
a	NULL
single	NULL
GABP	NULL
core	NULL
motif	NULL
1X	NULL
GABP	NULL
also	NULL
consistently	NULL
reduced	NULL
SNE	NULL
C-complex	NULL
formation	NULL
,	NULL
although	NULL
to	NULL
a	NULL
lesser	NULL
degree	NULL
than	NULL
with	NULL
3X	NULL
GABP	NULL
VoL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
TPA	NULL
RESPONSES	NULL
OF	NULL
SRE/ETS	NULL
ELEMENTS	NULL
IN	NULL
CMV	NULL
_	NULL
8599	NULL
A	NULL
B	NULL
C	NULL
HeLa	NULL
Raji	NULL
lâUM	NULL
?	NULL

Probe	NULL
-	NULL
SNE	NULL
_	NULL
SEE	NULL
Probe	NULL
(	NULL
git/	NULL
(	NULL
QÃ©bgie	NULL
5	NULL
``	NULL
bnt	NULL
-	NULL
SRF-ETS	NULL
bas	NULL
tut	NULL
tut	NULL
U	NULL
fl	NULL
tw	NULL
C	NULL
snr	NULL
-C	NULL
v4	NULL
-*	NULL
-	NULL
``	NULL
u	NULL
UH	NULL
=S	NULL
u	NULL
_X	NULL
1	NULL
2	NULL
3	NULL
4	NULL
102	NULL
3	NULL
4	NULL
50	NULL
6	NULL
10	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
P	NULL
4957	NULL
0	NULL
g	NULL
ul	NULL
SEE	NULL
sRe	NULL
(	NULL
LGH	NULL
814/815	NULL
)	NULL
(	NULL
LGH	NULL
638	NULL
/	NULL
639	NULL
)	NULL
I	NULL
Nam	NULL
h	NULL
1	NULL
Â«	NULL
get	NULL
.	NULL

gm	NULL
?	NULL

f	NULL
Comp	NULL
.	NULL

l	NULL
.	NULL

6	NULL
G	NULL
,	NULL
\	NULL
â¬	NULL
6D	NULL
)	NULL
-	NULL
&	NULL
0C	NULL
?	NULL

&	NULL
``	NULL
Extract	NULL
-	NULL
+	NULL
4	NULL
+	NULL
+	NULL
+	NULL
+	NULL
#	NULL
+	NULL
+	NULL
t	NULL
+	NULL
+	NULL
+	NULL
+	NULL
&	NULL
#	NULL
._tuz	NULL
t	NULL
-Sff	NULL
``	NULL
``	NULL
10	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Demonstration	NULL
of	NULL
SRF	NULL
and	NULL
ETS	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
SNE	NULL
and	NULL
SEE	NULL
probes	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSA	NULL
results	NULL
showing	NULL
binding	NULL
of	NULL
Raji	NULL
cell	NULL
SRF	NULL
protein	NULL
to	NULL
both	NULL
the	NULL
c-Fos	NULL
SRE	NULL
and	NULL
the	NULL
SCMV	NULL
SNE	NULL
core	NULL
sequences	NULL
.	NULL

A	NULL
pool	NULL
of	NULL
fractions	NULL
from	NULL
heparin-agarose	NULL
chromatography	NULL
of	NULL
a	NULL
Raji	NULL
cell	NULL
nuclear	NULL
extract	NULL
previously	NULL
shown	NULL
to	NULL
contain	NULL
SRF	NULL
activity	NULL
was	NULL
incubated	NULL
with	NULL
*Â°P-labeled	NULL
30-bp	NULL
oligonucleotide	NULL
probes	NULL
representing	NULL
the	NULL
wild-type	NULL
c-Fos	NULL
SRE	NULL
motif	NULL
(	NULL
LGH638/639	NULL
;	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
the	NULL
wild-type	NULL
SCMV	NULL
SNE	NULL
motif	NULL
(	NULL
LGH218/219	NULL
;	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
the	NULL
N	NULL
submotif	NULL
mutated	NULL
SNE	NULL
site	NULL
(	NULL
LGH324/325	NULL
;	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
the	NULL
S	NULL
and	NULL
N	NULL
submotif	NULL
double-mutated	NULL
SNE	NULL
site	NULL
(	NULL
LGH322/323	NULL
;	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

SRF	NULL
refers	NULL
to	NULL
the	NULL
core	NULL
SRF-bound	NULL
complex	NULL
.	NULL

Only	NULL
the	NULL
relevant	NULL
upper	NULL
portion	NULL
of	NULL
the	NULL
gel	NULL
is	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Detection	NULL
of	NULL
novel	NULL
SNE-specific	NULL
DNA-protein	NULL
complexes	NULL
in	NULL
unfractionated	NULL
U-937	NULL
nuclear	NULL
extracts	NULL
.	NULL

Total	NULL
U-937	NULL
nuclear	NULL
extracts	NULL
were	NULL
used	NULL
in	NULL
an	NULL
EMSA	NULL
with	NULL
a	NULL
series	NULL
of	NULL
*Â°P-labeled	NULL
oligonucleotide	NULL
probes	NULL
representing	NULL
the	NULL
wild-type	NULL
SNE	NULL
motif	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
the	NULL
S	NULL
submotif	NULL
mutated	NULL
SNE	NULL
site	NULL
(	NULL
AS/N	NULL
,	NULL
LGH399/400	NULL
;	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
the	NULL
N	NULL
submotif	NULL
mutated	NULL
SNE	NULL
site	NULL
(	NULL
S/AN	NULL
,	NULL
LGH324/325	NULL
;	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
the	NULL
S	NULL
and	NULL
N	NULL
double-mutated	NULL
SNE	NULL
site	NULL
(	NULL
AS/AN	NULL
,	NULL
LGH322/323	NULL
;	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
the	NULL
classical	NULL
NFxB	NULL
modified	NULL
SNE	NULL
site	NULL
(	NULL
S/NFxB	NULL
,	NULL
LGH801	NULL
,	NULL
/802	NULL
;	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
and	NULL
the	NULL
SNE	NULL
site	NULL
with	NULL
a	NULL
2-bp	NULL
insertion	NULL
(	NULL
S/InsN	NULL
,	NULL
LGH803/804	NULL
;	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

A	NULL
partially	NULL
purified	NULL
Raji	NULL
cell	NULL
extract	NULL
fraction	NULL
was	NULL
used	NULL
to	NULL
show	NULL
the	NULL
position	NULL
of	NULL
a	NULL
core	NULL
SRF	NULL
complex	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

C	NULL
refers	NULL
to	NULL
a	NULL
tripartite	NULL
SRF-ETS	NULL
complex	NULL
found	NULL
in	NULL
the	NULL
U-937	NULL
cell	NULL
extract	NULL
but	NULL
not	NULL
in	NULL
the	NULL
Raji	NULL
extract	NULL
fractions	NULL
.	NULL

X	NULL
indicates	NULL
a	NULL
nonrelevant	NULL
artifactual	NULL
binding	NULL
factor	NULL
associated	NULL
with	NULL
the	NULL
SNE	NULL
(	NULL
AS/AN	NULL
)	NULL
double	NULL
mutation	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Demonstration	NULL
that	NULL
the	NULL
slowly	NULL
migrating	NULL
C	NULL
band	NULL
represents	NULL
a	NULL
tripartite	NULL
SRF-ETS	NULL
class	NULL
protein	NULL
complex	NULL
.	NULL

EMSA	NULL
results	NULL
using	NULL
an	NULL
unfractionated	NULL
HeLa	NULL
cell	NULL
extract	NULL
with	NULL
``	NULL
P-labeled	NULL
wild-type	NULL
SCMV	NULL
SNE	NULL
(	NULL
LGH218/219	NULL
)	NULL
and	NULL
HCMV	NULL
SEE	NULL
(	NULL
LGHS814/815	NULL
)	NULL
oligonucleotide	NULL
probes	NULL
.	NULL

Control	NULL
lanes	NULL
received	NULL
added	NULL
protein	NULL
extract	NULL
and	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
but	NULL
without	NULL
specific	NULL
competitor	NULL
(	NULL
Comp	NULL
.	NULL

;	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Unlabeled	NULL
30-bp	NULL
annealed	NULL
oligonucleotides	NULL
were	NULL
added	NULL
as	NULL
competitor	NULL
DNA	NULL
in	NULL
300-fold	NULL
molar	NULL
excess	NULL
over	NULL
the	NULL
probe	NULL
DNA	NULL
.	NULL

These	NULL
included	NULL
either	NULL
the	NULL
c-Fos	NULL
core	NULL
SRE	NULL
motif	NULL
with	NULL
the	NULL
core	NULL
c-Fos	NULL
SRF	NULL
binding	NULL
site	NULL
intact	NULL
,	NULL
but	NULL
the	NULL
adjacent	NULL
ETS	NULL
motif	NULL
mutated	NULL
(	NULL
SRE	NULL
,	NULL
LGH642/643	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
,	NULL
or	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
GABP	NULL
motif	NULL
from	NULL
the	NULL
HSV	NULL
IE175	NULL
promoter	NULL
[	NULL
(	NULL
GABP	NULL
)	NULL
;	NULL
,	NULL
LGH663/807	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
]	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Similarity	NULL
of	NULL
the	NULL
HCMV	NULL
SEE	NULL
binding	NULL
pattern	NULL
to	NULL
that	NULL
of	NULL
the	NULL
c-Fos	NULL
SRE	NULL
.	NULL

Competition	NULL
EMSA	NULL
results	NULL
using	NULL
U-937	NULL
nuclear	NULL
extracts	NULL
and	NULL
*Â°P-labeled	NULL
oligonucleotide	NULL
probes	NULL
representing	NULL
the	NULL
wild-type	NULL
HCMV	NULL
SEE	NULL
motif	NULL
(	NULL
LGH814/815	NULL
)	NULL
or	NULL
the	NULL
wild-type	NULL
c-Fos	NULL
SRE	NULL
motif	NULL
(	NULL
LGH638/639	NULL
)	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
unlabeled	NULL
annealed	NULL
oligonucleotides	NULL
were	NULL
added	NULL
as	NULL
competitor	NULL
DNA	NULL
(	NULL
300-fold	NULL
excess	NULL
)	NULL
;	NULL
these	NULL
contained	NULL
the	NULL
wild-type	NULL
(	NULL
GABP	NULL
)	NULL
;	NULL
sites	NULL
(	NULL
LGH663/807	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
11	NULL
)	NULL
,	NULL
mutant	NULL
(	NULL
AGABP	NULL
)	NULL
;	NULL
sites	NULL
(	NULL
LGH665/666	NULL
;	NULL
lanes	NULL
4	NULL
and	NULL
12	NULL
)	NULL
,	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
the	NULL
wild-type	NULL
(	NULL
GABP	NULL
)	NULL
;	NULL
site	NULL
(	NULL
LGH808/809	NULL
;	NULL
lanes	NULL
5	NULL
and	NULL
13	NULL
)	NULL
,	NULL
the	NULL
wild-type	NULL
Ig	NULL
kappa	NULL
NFxB	NULL
site	NULL
(	NULL
LGH816/817	NULL
;	NULL
lanes	NULL
6	NULL
and	NULL
14	NULL
)	NULL
,	NULL
the	NULL
c-Fos	NULL
core	NULL
SRF	NULL
binding	NULL
sites	NULL
(	NULL
SRE	NULL
,	NULL
,	NULL
LGH642/643	NULL
;	NULL
lanes	NULL
7	NULL
and	NULL
15	NULL
)	NULL
,	NULL
or	NULL
a	NULL
nonspecific	NULL
(	NULL
NS	NULL
)	NULL
30-bp	NULL
sequence	NULL
(	NULL
LGHS31/532	NULL
;	NULL
lanes	NULL
8	NULL
and	NULL
16	NULL
)	NULL
.	NULL

Control	NULL
lanes	NULL
received	NULL
either	NULL
no	NULL
protein	NULL
and	NULL
no	NULL
competitor	NULL
DNA	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
9	NULL
)	NULL
or	NULL
added	NULL
protein	NULL
and	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
without	NULL
specific	NULL
competitor	NULL
DNA	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
10	NULL
)	NULL
.	NULL

F	NULL
,	NULL
free	NULL
probe	NULL
;	NULL
SRF	NULL
,	NULL
bound	NULL
core	NULL
SRF-bound	NULL
DNA	NULL
complex	NULL
;	NULL
SRF-ETS	NULL
,	NULL
bound	NULL
tripartite	NULL
complex	NULL
containing	NULL
SRF	NULL
and	NULL
an	NULL
ETS-like	NULL
protein	NULL
.	NULL

(	NULL
lanes	NULL
5	NULL
and	NULL
13	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
oligonucleotides	NULL
representing	NULL
the	NULL
wild-type	NULL
classical	NULL
Ig	NULL
kappa	NULL
NFB	NULL
binding	NULL
sites	NULL
(	NULL
Ig	NULL
NFkB	NULL
)	NULL
,	NULL
which	NULL
incidentally	NULL
also	NULL
contains	NULL
GGAA	NULL
in	NULL
the	NULL
sequence	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
C-complex	NULL
formation	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
14	NULL
)	NULL
.	NULL

However	NULL
,	NULL
competitor	NULL
oligonucleotides	NULL
containing	NULL
only	NULL
the	NULL
core	NULL
SRF	NULL
binding	NULL
site	NULL
(	NULL
CCATATTAGG	NULL
)	NULL
(	NULL
SRE	NULL
,	NULL
;	NULL
lanes	NULL
7	NULL
and	NULL
15	NULL
)	NULL
once	NULL
again	NULL
completely	NULL
abolished	NULL
the	NULL
formation	NULL
of	NULL
both	NULL
the	NULL
binary	NULL
SRF	NULL
and	NULL
C	NULL
complexes	NULL
with	NULL
the	NULL
U-937	NULL
extract	NULL
.	NULL

A	NULL
control	NULL
irrelevant	NULL
oligonucleotide	NULL
competitor	NULL
at	NULL
the	NULL
same	NULL
concentration	NULL
also	NULL
failed	NULL
to	NULL
affect	NULL
complex	NULL
formation	NULL
(	NULL
lanes	NULL
8	NULL
and	NULL
16	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
almost	NULL
exactly	NULL
the	NULL
same	NULL
overall	NULL
patterns	NULL
of	NULL
complex	NULL
formation	NULL
and	NULL
competition	NULL
were	NULL
observed	NULL
when	NULL
the	NULL
c-Fos	NULL
SRE	NULL
oligonucleotide	NULL
pair	NULL
was	NULL
used	NULL
as	NULL
an	NULL
EMSA	NULL
probe	NULL
compared	NULL
with	NULL
the	NULL
SEE	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
)	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
common	NULL
core	NULL
GGAA-like	NULL
recognition	NULL
sequences	NULL
for	NULL
all	NULL
ETS	NULL
class	NULL
proteins	NULL
,	NULL
it	NULL
was	NULL
not	NULL
possible	NULL
to	NULL
determine	NULL
from	NULL
these	NULL
experiments	NULL
whether	NULL
GABP	NULL
itself	NULL
forms	NULL
the	NULL
ternary	NULL
C	NULL
complex	NULL
with	NULL
SRF	NULL
on	NULL
the	NULL
overlapping	NULL
SRF-ETS	NULL
site	NULL
in	NULL
the	NULL
SEE	NULL
probe	NULL
.	NULL

Perhaps	NULL
any	NULL
ETS	NULL
family	NULL
protein	NULL
,	NULL
including	NULL
SAP-1	NULL
or	NULL
ELK-1	NULL
,	NULL
can	NULL
be	NULL
competed	NULL
by	NULL
the	NULL
GABP	NULL
binding	NULL
sites	NULL
in	NULL
a	NULL
semispecific	NULL
manner	NULL
.	NULL

GABP	NULL
itself	NULL
usually	NULL
binds	NULL
stably	NULL
only	NULL
as	NULL
an	NULL
Â«	NULL
-B	NULL
heterodimer	NULL
to	NULL
two	NULL
adjacent	NULL
core	NULL
GCGGAAC-like	NULL
motifs	NULL
.	NULL

However	NULL
,	NULL
it	NULL
appeared	NULL
very	NULL
likely	NULL
that	NULL
some	NULL
ETS	NULL
class	NULL
family	NULL
protein	NULL
formed	NULL
the	NULL
tripartite	NULL
C	NULL
complex	NULL
together	NULL
with	NULL
SRF	NULL
,	NULL
whereas	NULL
SRF	NULL
alone	NULL
produced	NULL
the	NULL
faster-migrating	NULL
binary	NULL
SRF	NULL
complex	NULL
.	NULL

Evidently	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
excess	NULL
competing	NULL
core	NULL
ETS	NULL
binding	NULL
sites	NULL
,	NULL
C-complex	NULL
formation	NULL
was	NULL
disrupted	NULL
and	NULL
SRF	NULL
was	NULL
released	NULL
from	NULL
the	NULL
ternary	NULL
complex	NULL
to	NULL
form	NULL
more	NULL
of	NULL
the	NULL
direct	NULL
binary	NULL
SRF	NULL
complex	NULL
.	NULL

Relative	NULL
abundance	NULL
of	NULL
SRF	NULL
and	NULL
SRF-ETS	NULL
complexes	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
SRF	NULL
and	NULL
associated	NULL
ETS	NULL
class	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
SEE	NULL
and	NULL
SNE	NULL
probes	NULL
show	NULL
a	NULL
cell-type-specific	NULL
distribution	NULL
pattern	NULL
,	NULL
we	NULL
performed	NULL
EMSAs	NULL
using	NULL
Â°Â°P-labeled	NULL
probes	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

The	NULL
results	NULL
showed	NULL
that	NULL
SRF	NULL
was	NULL
present	NULL
in	NULL
every	NULL
cell	NULL
type	NULL
tested	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
9	NULL
)	NULL
,	NULL
but	NULL
its	NULL
amount	NULL
varied	NULL
(	NULL
low	NULL
in	NULL
Raji	NULL
and	NULL
Vero	NULL
cells	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
SRF-ETS	NULL
C	NULL
complex	NULL
was	NULL
not	NULL
found	NULL
in	NULL
HF	NULL
,	NULL
Raji	NULL
,	NULL
BALB/c	NULL
313	NULL
,	NULL
or	NULL
Vero	NULL
cells	NULL
by	NULL
EMSA	NULL
,	NULL
although	NULL
both	NULL
the	NULL
SRF	NULL
and	NULL
SRF-ETS	NULL
C	NULL
complexes	NULL
were	NULL
present	NULL
at	NULL
approximately	NULL
equal	NULL
levels	NULL
in	NULL
U-937	NULL
,	NULL
K-562	NULL
,	NULL
HeLa	NULL
,	NULL
and	NULL
HL-60	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
there	NULL
appeared	NULL
to	NULL
be	NULL
a	NULL
significant	NULL
increase	NULL
(	NULL
approaching	NULL
twofold	NULL
)	NULL
in	NULL
the	NULL
ratio	NULL
of	NULL
ternary	NULL
SRF-ELK-1	NULL
complexes	NULL
compared	NULL
with	NULL
binary	NULL
SRF	NULL
8600	NULL
CHAN	NULL
ET	NULL
AL	NULL
.	NULL

J.	NULL
ViRoL	NULL
.	NULL

A	NULL
Prob	NULL
HCMV	NULL
SEE	NULL
B	NULL
robe	NULL
(	NULL
LGH	NULL
814/815	NULL
)	NULL
Probe	NULL
OCT	NULL
(	NULL
GABP	NULL
)	NULL
;	NULL
SNE	NULL
CBF	NULL
a	NULL
mmr	NULL
5944065	NULL
Â»	NULL
L	NULL
x	NULL
Â»	NULL
Extract	NULL
-	NULL
H	NULL
R	NULL
-	NULL
H	NULL
Ro	NULL
-	NULL
HR	NULL
-	NULL
HR	NULL
Extract	NULL
Q3	NULL
@	NULL
x59	NULL
05	NULL
F6~be	NULL
Ã©rb	NULL
?	NULL

Â°\-\Â°	NULL
â	NULL
>	NULL
c	NULL
bd	NULL
-	NULL
sRF-ETS	NULL
SRF-ETS	NULL
-	NULL
Aa	NULL
~	NULL
-	NULL
SAF	NULL
sRF	NULL
-	NULL
m	NULL
cert	NULL
a	NULL
â	NULL
ocrr-	NULL
-	NULL
W	NULL
MBps	NULL
]	NULL
10	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
#	NULL
0	NULL
=	NULL
-cs=	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
60	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Differences	NULL
in	NULL
cell-type-specific	NULL
distribution	NULL
of	NULL
the	NULL
SRF	NULL
and	NULL
ETS	NULL
factors	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Preferential	NULL
distribution	NULL
of	NULL
SRF-ETS	NULL
complexes	NULL
in	NULL
myeloid	NULL
cell	NULL
types	NULL
compared	NULL
with	NULL
HF	NULL
and	NULL
BALB/c	NULL
3T3	NULL
cells	NULL
.	NULL

The	NULL
autoradiograph	NULL
shows	NULL
results	NULL
of	NULL
EMSA	NULL
using	NULL
the	NULL
*Â°P-labeled	NULL
wild-type	NULL
SEE	NULL
probe	NULL
(	NULL
LGH814/815	NULL
)	NULL
and	NULL
different	NULL
nuclear	NULL
extracts	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
HF	NULL
cells	NULL
;	NULL
2	NULL
,	NULL
HL-60	NULL
cells	NULL
;	NULL
3	NULL
,	NULL
U-937	NULL
cells	NULL
;	NULL
4	NULL
,	NULL
U-937	NULL
cells	NULL
stimulated	NULL
with	NULL
TPA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
for	NULL
18	NULL
h	NULL
;	NULL
5	NULL
,	NULL
K-562	NULL
cells	NULL
;	NULL
6	NULL
,	NULL
HeLa	NULL
cells	NULL
;	NULL
7	NULL
,	NULL
BALB/c	NULL
3T3	NULL
cells	NULL
;	NULL
8	NULL
,	NULL
Raji	NULL
cells	NULL
;	NULL
9	NULL
,	NULL
Vero	NULL
cells	NULL
.	NULL

Control	NULL
lane	NULL
10	NULL
received	NULL
*Â°P-labeled	NULL
probe	NULL
DNA	NULL
without	NULL
any	NULL
added	NULL
sample	NULL
protein	NULL
.	NULL

F	NULL
,	NULL
free	NULL
probe	NULL
;	NULL
SRF	NULL
,	NULL
core	NULL
SRF-bound	NULL
DNA	NULL
complexes	NULL
;	NULL
SRF-ETS	NULL
,	NULL
tripartite	NULL
DNA	NULL
complexes	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Selective	NULL
absence	NULL
of	NULL
GABP	NULL
and	NULL
SRF	NULL
from	NULL
Raji	NULL
cell	NULL
extracts	NULL
compared	NULL
with	NULL
HeLa	NULL
extracts	NULL
.	NULL

The	NULL
autoradiograph	NULL
compares	NULL
the	NULL
patterns	NULL
of	NULL
binding	NULL
to	NULL
four	NULL
transcription	NULL
factor	NULL
site	NULL
probes	NULL
in	NULL
unfractionated	NULL
HeLa	NULL
(	NULL
H	NULL
)	NULL
and	NULL
Raji	NULL
(	NULL
R	NULL
)	NULL
cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

The	NULL
probes	NULL
used	NULL
(	NULL
all	NULL
30-mer	NULL
oligonucleotide	NULL
pairs	NULL
)	NULL
represented	NULL
classical	NULL
OCT	NULL
sites	NULL
(	NULL
LGH49/50	NULL
;	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
,	NULL
the	NULL
HSV	NULL
triple	NULL
GABP	NULL
sites	NULL
(	NULL
LGH663/807	NULL
;	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
,	NULL
the	NULL
SCMV	NULL
wild-type	NULL
SNE	NULL
sites	NULL
(	NULL
LGH218/219	NULL
;	NULL
lanes	NULL
7	NULL
to	NULL
9	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
EBNAZ	NULL
promoter	NULL
site	NULL
CBF1	NULL
(	NULL
LGH941/942	NULL
;	NULL
lanes	NULL
10	NULL
to	NULL
12	NULL
)	NULL
.	NULL

The	NULL
third	NULL
lane	NULL
in	NULL
each	NULL
set	NULL
represents	NULL
a	NULL
no	NULL
extract	NULL
control	NULL
.	NULL

complexes	NULL
bound	NULL
to	NULL
the	NULL
SEE	NULL
probe	NULL
in	NULL
18-h	NULL
TPA-treated	NULL
extracts	NULL
relative	NULL
to	NULL
that	NULL
in	NULL
untreated	NULL
U-937	NULL
nuclear	NULL
extracts	NULL
(	NULL
compare	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

For	NULL
further	NULL
evaluation	NULL
of	NULL
the	NULL
apparent	NULL
large	NULL
differences	NULL
between	NULL
HeLa	NULL
and	NULL
Raji	NULL
cells	NULL
,	NULL
we	NULL
also	NULL
compared	NULL
the	NULL
patterns	NULL
of	NULL
protein	NULL
binding	NULL
to	NULL
four	NULL
different	NULL
oligonucleotide	NULL
probes	NULL
(	NULL
OCT	NULL
,	NULL
GABP	NULL
,	NULL
SNE	NULL
,	NULL
and	NULL
CBF1	NULL
)	NULL
,	NULL
using	NULL
total	NULL
unfractionated	NULL
HeLa	NULL
and	NULL
Raji	NULL
cell	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

The	NULL
results	NULL
revealed	NULL
that	NULL
although	NULL
the	NULL
unfractionated	NULL
Raji	NULL
B-lymphocyte	NULL
sample	NULL
contained	NULL
just	NULL
as	NULL
much	NULL
or	NULL
more	NULL
OCT	NULL
-1	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
and	NULL
CBF-1	NULL
(	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
as	NULL
were	NULL
present	NULL
in	NULL
the	NULL
HeLa	NULL
cell	NULL
extract	NULL
(	NULL
as	NULL
well	NULL
as	NULL
a	NULL
B-cell-specific	NULL
OCT	NULL
-2	NULL
band	NULL
;	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
it	NULL
was	NULL
totally	NULL
devoid	NULL
of	NULL
GABP	NULL
binding	NULL
activity	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
and	NULL
formed	NULL
only	NULL
very	NULL
limited	NULL
amounts	NULL
of	NULL
an	NULL
SNE-bound	NULL
SRF	NULL
band	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
which	NULL
did	NULL
not	NULL
include	NULL
any	NULL
detectable	NULL
SRF-ETS	NULL
C-complex	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
conclude	NULL
both	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
SRF	NULL
varies	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
and	NULL
that	NULL
the	NULL
particular	NULL
ETS	NULL
protein	NULL
involved	NULL
shows	NULL
a	NULL
highly	NULL
cell-type-specific	NULL
distribution	NULL
that	NULL
does	NULL
not	NULL
include	NULL
Raji	NULL
,	NULL
HF	NULL
,	NULL
BALB/c	NULL
3T3	NULL
,	NULL
or	NULL
Vero	NULL
cells	NULL
.	NULL

Antibodies	NULL
specific	NULL
to	NULL
several	NULL
ETS	NULL
family	NULL
proteins	NULL
fail	NULL
to	NULL
recognize	NULL
the	NULL
SNE	NULL
protein	NULL
complex	NULL
.	NULL

ETS	NULL
family	NULL
proteins	NULL
consist	NULL
of	NULL
at	NULL
least	NULL
seven	NULL
distinct	NULL
members	NULL
that	NULL
have	NULL
similar	NULL
DNA	NULL
binding	NULL
domains	NULL
(	NULL
with	NULL
the	NULL
common	NULL
core	NULL
target	NULL
recognition	NULL
motif	NULL
GGAA	NULL
or	NULL
GGAT	NULL
)	NULL
,	NULL
but	NULL
they	NULL
differ	NULL
greatly	NULL
in	NULL
structure	NULL
over	NULL
the	NULL
remaining	NULL
domains	NULL
of	NULL
each	NULL
protein	NULL
(	NULL
67	NULL
)	NULL
.	NULL

To	NULL
attempt	NULL
to	NULL
determine	NULL
definitively	NULL
which	NULL
member	NULL
of	NULL
the	NULL
ETS	NULL
family	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
synergism	NULL
with	NULL
SRF	NULL
,	NULL
we	NULL
performed	NULL
supershift	NULL
EMSAs	NULL
with	NULL
specific	NULL
antibodies	NULL
added	NULL
to	NULL
the	NULL
complexes	NULL
formed	NULL
by	NULL
U-937	NULL
and	NULL
HeLa	NULL
nuclear	NULL
extracts	NULL
with	NULL
the	NULL
SEE	NULL
,	NULL
SNE	NULL
,	NULL
and	NULL
SRE	NULL
probes	NULL
.	NULL

Since	NULL
the	NULL
SEE	NULL
flanking	NULL
sequences	NULL
closely	NULL
resemble	NULL
the	NULL
GABP	NULL
binding	NULL
site	NULL
,	NULL
we	NULL
also	NULL
wanted	NULL
to	NULL
determine	NULL
whether	NULL
GABP	NULL
might	NULL
itself	NULL
be	NULL
involved	NULL
in	NULL
forming	NULL
C	NULL
complexes	NULL
with	NULL
SRF	NULL
.	NULL

First	NULL
,	NULL
we	NULL
used	NULL
our	NULL
control	NULL
triple-motif	NULL
GABP	NULL
binding	NULL
site	NULL
probe	NULL
from	NULL
the	NULL
HSV	NULL
IE175	NULL
promoter	NULL
to	NULL
determine	NULL
whether	NULL
U-937	NULL
cells	NULL
express	NULL
GABP	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
antibody	NULL
,	NULL
U-937	NULL
nuclear	NULL
extracts	NULL
formed	NULL
a	NULL
predominant	NULL
relatively	NULL
fast-migrating	NULL
band	NULL
with	NULL
the	NULL
3X	NULL
GABP	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

This	NULL
band	NULL
was	NULL
totally	NULL
supershifted	NULL
by	NULL
either	NULL
anti-mouse	NULL
GABPa	NULL
or	NULL
anti-mouse	NULL
rabbit	NULL
polyclonal	NULL
anti-serum	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
other	NULL
antisera	NULL
recognizing	NULL
different	NULL
members	NULL
of	NULL
the	NULL
ETS	NULL
family	NULL
such	NULL
as	NULL
the	NULL
ETS-1	NULL
,	NULL
ETS-2	NULL
,	NULL
PEA3	NULL
,	NULL
and	NULL
PU1	NULL
proteins	NULL
all	NULL
failed	NULL
to	NULL
supershift	NULL
the	NULL
GABP	NULL
complex	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
7	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
U-937	NULL
cells	NULL
do	NULL
contain	NULL
both	NULL
GABPa	NULL
and	NULL
GABPB	NULL
.	NULL

However	NULL
,	NULL
with	NULL
U-937	NULL
extracts	NULL
,	NULL
neither	NULL
the	NULL
SRF-ETS	NULL
C	NULL
complex	NULL
that	NULL
formed	NULL
on	NULL
the	NULL
SEE	NULL
site	NULL
probe	NULL
nor	NULL
that	NULL
formed	NULL
on	NULL
the	NULL
c-Fos	NULL
SRE	NULL
site	NULL
probe	NULL
was	NULL
supershifted	NULL
by	NULL
any	NULL
of	NULL
the	NULL
antisera	NULL
tested	NULL
,	NULL
including	NULL
GABPa	NULL
and	NULL
-B	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

\	NULL
)	NULL
7Ve	NULL
also	NULL
tested	NULL
HeLa	NULL
cell	NULL
nuclear	NULL
extracts	NULL
with	NULL
both	NULL
the	NULL
SEE	NULL
and	NULL
GABP	NULL
probes	NULL
to	NULL
determine	NULL
whether	NULL
HeLa	NULL
cells	NULL
also	NULL
contain	NULL
GABP	NULL
and	NULL
whether	NULL
GABP	NULL
or	NULL
other	NULL
known	NULL
ETS	NULL
class	NULL
proteins	NULL
form	NULL
complexes	NULL
with	NULL
SRF	NULL
.	NULL

Again	NULL
,	NULL
the	NULL
3X	NULL
GABP	NULL
probe	NULL
bound	NULL
to	NULL
factors	NULL
present	NULL
in	NULL
the	NULL
extract	NULL
and	NULL
was	NULL
supershifted	NULL
by	NULL
anti-GABPa	NULL
Â«	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

8C	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
but	NULL
not	NULL
by	NULL
the	NULL
anti-ETS-1	NULL
,	NULL
anti-ETS-1/2	NULL
,	NULL
or	NULL
anti-PEA3	NULL
antibodies	NULL
,	NULL
whereas	NULL
the	NULL
C	NULL
complexes	NULL
formed	NULL
with	NULL
the	NULL
SEE	NULL
probe	NULL
failed	NULL
to	NULL
be	NULL
affected	NULL
by	NULL
any	NULL
of	NULL
the	NULL
antibodies	NULL
tested	NULL
.	NULL

ELK-1	NULL
but	NULL
not	NULL
GABPa	NULL
forms	NULL
ternary	NULL
complexes	NULL
with	NULL
SRF	NULL
on	NULL
both	NULL
the	NULL
SEE	NULL
and	NULL
SNE	NULL
motifs	NULL
.	NULL

Although	NULL
the	NULL
flanking	NULL
sequences	NULL
of	NULL
the	NULL
SEE	NULL
and	NULL
SNE	NULL
motifs	NULL
do	NULL
not	NULL
closely	NULL
resemble	NULL
those	NULL
of	NULL
the	NULL
c-Fos	NULL
SRE	NULL
,	NULL
and	NULL
the	NULL
SNE	NULL
sites	NULL
do	NULL
not	NULL
mediate	NULL
serum	NULL
responsiveness	NULL
,	NULL
it	NULL
still	NULL
seemed	NULL
plausible	NULL
that	NULL
ELK-1	NULL
or	NULL
SAP-1	NULL
might	NULL
recognize	NULL
these	NULL
atypical	NULL
sequences	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
ELK-1	NULL
protein	NULL
formed	NULL
a	NULL
ternary	NULL
complex	NULL
with	NULL
SRF	NULL
on	NULL
the	NULL
SEE	NULL
or	NULL
SNE	NULL
site	NULL
,	NULL
we	NULL
performed	NULL
an	NULL
additional	NULL
set	NULL
of	NULL
supershift	NULL
EMSAs	NULL
in	NULL
agarose	NULL
gels	NULL
with	NULL
the	NULL
anti-mouse	NULL
GABPa	NULL
and	NULL
anti-human	NULL
ELK-1	NULL
rabbit	NULL
polyclonal	NULL
antisera	NULL
,	NULL
using	NULL
U-937	NULL
nuclear	NULL
extracts	NULL
and	NULL
the	NULL
Â°Â°P-labeled	NULL
(	NULL
GABP	NULL
)	NULL
;	NULL
,	NULL
SEE	NULL
,	NULL
and	NULL
SRE	NULL
oligonucleotide	NULL
probes	NULL
.	NULL

Control	NULL
experiments	NULL
showed	NULL
that	NULL
the	NULL
appropriate	NULL
anti-GABPa	NULL
and	NULL
anti	NULL
VoL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
A	NULL
``	NULL
dite	NULL
(	NULL
GABP	NULL
)	NULL
(	NULL
LGH	NULL
663	NULL
/	NULL
807	NULL
)	NULL
R	NULL
Q	NULL
Antibody	NULL
__	NULL
peeve	NULL
Ã©Â¢s\	NULL
.	NULL

â	NULL
%	NULL
\	NULL
@	NULL
QO	NULL
``	NULL
102	NULL
3	NULL
4	NULL
5	NULL
60	NULL
7	NULL
U-937	NULL
PSB	NULL
HCMV	NULL
SEE	NULL
cfos	NULL
SRE	NULL
rone	NULL
(	NULL
LGH	NULL
814/815	NULL
)	NULL
(	NULL
LGH	NULL
638	NULL
/	NULL
639	NULL
)	NULL
I	NULL
I	NULL
;	NULL
Â£	NULL
8eA	NULL
en	NULL
,	NULL
&	NULL
\	NULL
x	NULL
Antibody	NULL
__	NULL
(	NULL
by	NULL
?	NULL

v9	NULL
Â«	NULL
566-9	NULL
Q	NULL
0	NULL
v9	NULL
age	NULL
QQ	NULL
â	NULL
P	NULL
Co	NULL
sRF-ETS	NULL
-	NULL
My	NULL
toe	NULL
til	NULL
taa	NULL
by6	NULL
b	NULL
//	NULL
tuh	NULL
10	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
Hela	NULL
Pich	NULL
GABP	NULL
SEE	NULL
``	NULL
Â°Â°Â°	NULL
_	NULL
(	NULL
LGH	NULL
663/807	NULL
)	NULL
_	NULL
(	NULL
LGH	NULL
814/815	NULL
)	NULL
|	NULL
(	NULL
LI	NULL
|	NULL
ml	NULL
AN	NULL
``	NULL
>	NULL
8	NULL
cA	NULL
eN	NULL
P	NULL
Antibody	NULL
_	NULL
.	NULL

Q	NULL
}	NULL
'	NULL
E	NULL
L	NULL
Â¢	NULL
,	NULL
case	NULL
-	NULL
Â§	NULL
#	NULL
102	NULL
3	NULL
4	NULL
5	NULL
tut	NULL
bud	NULL
bud	NULL
but	NULL
bud	NULL
-	NULL
SRE-ETS	NULL
-	NULL
SRF	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Antibody	NULL
supershift	NULL
assays	NULL
fail	NULL
to	NULL
detect	NULL
GABP	NULL
or	NULL
several	NULL
other	NULL
ETS	NULL
family	NULL
proteins	NULL
in	NULL
the	NULL
SRF-ETS	NULL
complexes	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Only	NULL
anti-GABP	NULL
antibodies	NULL
supershift	NULL
the	NULL
standard	NULL
GABP	NULL
complex	NULL
from	NULL
U-937	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
``	NULL
P-labeled	NULL
wild-type	NULL
triple	NULL
(	NULL
GABP	NULL
)	NULL
;	NULL
site	NULL
probe	NULL
(	NULL
LGH663/	NULL
807	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
antibodies	NULL
against	NULL
different	NULL
ETS	NULL
family	NULL
members	NULL
(	NULL
GABPa	NULL
,	NULL
GABPB	NULL
,	NULL
ETS-1	NULL
,	NULL
ETS-1/2	NULL
,	NULL
PEA3	NULL
,	NULL
and	NULL
PU1	NULL
}	NULL
.	NULL

The	NULL
control	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
received	NULL
added	NULL
protein	NULL
sample	NULL
without	NULL
any	NULL
antibody	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Similar	NULL
antibody	NULL
supershift	NULL
experiments	NULL
using	NULL
U-937	NULL
nuclear	NULL
extracts	NULL
and	NULL
the	NULL
*Â°P-labeled	NULL
single-copy	NULL
wild-type	NULL
HCMV	NULL
SEE	NULL
motif	NULL
(	NULL
LGH814/815	NULL
)	NULL
and	NULL
wild-type	NULL
c-Fos	NULL
SRE	NULL
motif	NULL
(	NULL
LGH638/639	NULL
)	NULL
probes	NULL
.	NULL

Control	NULL
lanes	NULL
1	NULL
and	NULL
8	NULL
received	NULL
added	NULL
protein	NULL
sample	NULL
without	NULL
any	NULL
antibody	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Similar	NULL
antibody	NULL
supershift	NULL
using	NULL
HeLa	NULL
cell	NULL
nuclear	NULL
extracts	NULL
and	NULL
the	NULL
P-labeled	NULL
wild-type	NULL
(	NULL
GABP	NULL
)	NULL
;	NULL
and	NULL
HCMV	NULL
SEE	NULL
probes	NULL
.	NULL

Note	NULL
that	NULL
only	NULL
the	NULL
relevant	NULL
upper	NULL
parts	NULL
of	NULL
the	NULL
polyacrylamide	NULL
gels	NULL
are	NULL
shown	NULL
.	NULL

ELK-1	NULL
antibodies	NULL
specifically	NULL
supershifted	NULL
either	NULL
the	NULL
GABP	NULL
or	NULL
the	NULL
SRF-ELK-1	NULL
complexes	NULL
on	NULL
the	NULL
IE175	NULL
3X	NULL
GABP	NULL
and	NULL
c-Fos	NULL
SRE	NULL
site	NULL
probes	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

9A	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
18	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
SRF-ETS	NULL
C-complex	NULL
formed	NULL
on	NULL
the	NULL
HCMV	NULL
SEE	NULL
probe	NULL
was	NULL
also	NULL
totally	NULL
supershifted	NULL
by	NULL
the	NULL
ELK-1	NULL
antibody	NULL
but	NULL
not	NULL
by	NULL
the	NULL
GABPa	NULL
antibody	NULL
(	NULL
lanes	NULL
10	NULL
and	NULL
12	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
in	NULL
the	NULL
U-937	NULL
cell	NULL
extracts	NULL
,	NULL
ELK-1	NULL
does	NULL
associate	NULL
with	NULL
bound	NULL
SRF	NULL
efficiently	NULL
to	NULL
form	NULL
the	NULL
ternary	NULL
C	NULL
complex	NULL
on	NULL
the	NULL
HCMV	NULL
SEE	NULL
probe	NULL
,	NULL
as	NULL
well	NULL
as	NULL
on	NULL
the	NULL
c-Fos	NULL
SRE	NULL
probe	NULL
.	NULL

Importantly	NULL
,	NULL
control	NULL
samples	NULL
containing	NULL
free	NULL
probes	NULL
plus	NULL
antibodies	NULL
only	NULL
did	NULL
not	NULL
show	NULL
any	NULL
nonspecific	NULL
bands	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
5	NULL
,	NULL
9	NULL
,	NULL
11	NULL
,	NULL
15	NULL
,	NULL
and	NULL
17	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
SRF-ETS	NULL
complex	NULL
that	NULL
recognized	NULL
the	NULL
SCMV	NULL
SNE	NULL
site	NULL
also	NULL
contained	NULL
the	NULL
ELK-1	NULL
protein	NULL
,	NULL
we	NULL
performed	NULL
similar	NULL
supershift	NULL
EMSAs	NULL
using	NULL
both	NULL
the	NULL
SEE	NULL
and	NULL
SNE	NULL
probes	NULL
and	NULL
the	NULL
U-937	NULL
cell	NULL
nuclear	NULL
extract	NULL
.	NULL

Indeed	NULL
the	NULL
anti-ELK-1	NULL
antibody	NULL
proved	NULL
to	NULL
supershift	NULL
the	NULL
SRF-ETS	NULL
C	NULL
TPA	NULL
RESPONSES	NULL
OF	NULL
SRF/ETS	NULL
ELEMENTS	NULL
IN	NULL
CMV	NULL
8601	NULL
complexes	NULL
on	NULL
both	NULL
the	NULL
SEE	NULL
and	NULL
SNE	NULL
probes	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Again	NULL
,	NULL
the	NULL
control	NULL
lanes	NULL
with	NULL
free	NULL
probes	NULL
plus	NULL
antibodies	NULL
did	NULL
not	NULL
show	NULL
any	NULL
nonspecific	NULL
DNA-binding	NULL
activity	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
totally	NULL
supershifted	NULL
SRFETS	NULL
complex	NULL
obtained	NULL
with	NULL
the	NULL
SEE	NULL
probe	NULL
,	NULL
only	NULL
part	NULL
of	NULL
the	NULL
tripartite	NULL
SRF-ETS	NULL
C	NULL
complex	NULL
obtained	NULL
with	NULL
the	NULL
SNE	NULL
site	NULL
probe	NULL
was	NULL
supershifted	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
ELK-1	NULL
antibody	NULL
.	NULL

Instead	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
unassociated	NULL
SRF	NULL
protein	NULL
that	NULL
bound	NULL
to	NULL
the	NULL
core	NULL
SRE	NULL
site	NULL
as	NULL
the	NULL
binary	NULL
SRF	NULL
complex	NULL
was	NULL
increased	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
;	NULL
compare	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
ELK-1	NULL
antibody	NULL
interferes	NULL
with	NULL
the	NULL
ternary	NULL
SRF-ELK-1	NULL
complex	NULL
on	NULL
the	NULL
SNE	NULL
motif	NULL
,	NULL
whereas	NULL
it	NULL
produced	NULL
a	NULL
stable	NULL
bound	NULL
antibody-SRF-ELK-1-DNA	NULL
complex	NULL
on	NULL
the	NULL
SEE	NULL
motif	NULL
.	NULL

Since	NULL
there	NULL
are	NULL
differences	NULL
between	NULL
them	NULL
in	NULL
the	NULL
relative	NULL
spacing	NULL
of	NULL
the	NULL
core	NULL
SRF	NULL
and	NULL
ETS	NULL
motifs	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
2	NULL
bp	NULL
in	NULL
SEE	NULL
sites	NULL
but	NULL
3	NULL
bp	NULL
in	NULL
the	NULL
SNE	NULL
sites	NULL
[	NULL
Fig	NULL
.	NULL

1BJ	NULL
)	NULL
as	NULL
well	NULL
as	NULL
differences	NULL
in	NULL
the	NULL
sequences	NULL
of	NULL
the	NULL
core	NULL
SRF	NULL
binding	NULL
motifs	NULL
compared	NULL
with	NULL
the	NULL
c-Fos	NULL
SRE	NULL
,	NULL
we	NULL
suggest	NULL
that	NULL
the	NULL
conformations	NULL
of	NULL
the	NULL
SRF-ELK-1	NULL
complexes	NULL
on	NULL
the	NULL
SEE	NULL
and	NULL
SNE	NULL
sites	NULL
may	NULL
be	NULL
somewhat	NULL
different	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

DISCUSSION	NULL
Role	NULL
of	NULL
the	NULL
PKC	NULL
pathway	NULL
in	NULL
activating	NULL
CMV	NULL
MIE	NULL
genes	NULL
.	NULL

Since	NULL
regulation	NULL
of	NULL
the	NULL
HCMV	NULL
MIE	NULL
enhancer/promoter	NULL
directly	NULL
influences	NULL
both	NULL
expression	NULL
of	NULL
the	NULL
IE1	NULL
and	NULL
IE2	NULL
mRNAs	NULL
and	NULL
the	NULL
subsequent	NULL
effects	NULL
of	NULL
the	NULL
IE1	NULL
and	NULL
IE2	NULL
proteins	NULL
on	NULL
progression	NULL
of	NULL
the	NULL
viral	NULL
lytic	NULL
cycle	NULL
,	NULL
it	NULL
is	NULL
presumed	NULL
to	NULL
provide	NULL
the	NULL
major	NULL
switch	NULL
point	NULL
leading	NULL
into	NULL
and	NULL
out	NULL
of	NULL
latency	NULL
and	NULL
the	NULL
lytic	NULL
cycle	NULL
.	NULL

Therefore	NULL
,	NULL
a	NULL
full	NULL
understanding	NULL
of	NULL
HCMV	NULL
MIE	NULL
gene	NULL
regulation	NULL
is	NULL
expected	NULL
to	NULL
both	NULL
offer	NULL
major	NULL
insights	NULL
into	NULL
CMV	NULL
biology	NULL
and	NULL
allow	NULL
for	NULL
its	NULL
more	NULL
effective	NULL
use	NULL
in	NULL
gene	NULL
therapy	NULL
procedures	NULL
in	NULL
the	NULL
future	NULL
.	NULL

An	NULL
early	NULL
model	NULL
involving	NULL
mouse	NULL
CMV	NULL
latency	NULL
demonstrated	NULL
that	NULL
the	NULL
virus	NULL
lytic	NULL
cycle	NULL
could	NULL
be	NULL
reactivated	NULL
from	NULL
quiescently	NULL
infected	NULL
mouse	NULL
monocytes	NULL
after	NULL
differentiation	NULL
into	NULL
macrophages	NULL
(	NULL
17	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
cell	NULL
types	NULL
involved	NULL
in	NULL
reactivation	NULL
and	NULL
latency	NULL
for	NULL
primate	NULL
CMVs	NULL
have	NULL
not	NULL
yet	NULL
been	NULL
unambiguously	NULL
identified	NULL
.	NULL

Certainly	NULL
,	NULL
differentiated	NULL
macrophages	NULL
can	NULL
be	NULL
permissive	NULL
for	NULL
HCMV	NULL
infection	NULL
(	NULL
19	NULL
,	NULL
32	NULL
,	NULL
46	NULL
,	NULL
79	NULL
)	NULL
,	NULL
and	NULL
since	NULL
monocytes	NULL
from	NULL
healthy	NULL
HCMV	NULL
carriers	NULL
harbor	NULL
PCR-detectable	NULL
CMV	NULL
genomes	NULL
without	NULL
expressing	NULL
IE	NULL
gene	NULL
products	NULL
,	NULL
they	NULL
are	NULL
suspected	NULL
of	NULL
being	NULL
a	NULL
primary	NULL
site	NULL
of	NULL
HCMV	NULL
latency	NULL
also	NULL
(	NULL
39	NULL
,	NULL
71	NULL
,	NULL
78	NULL
)	NULL
.	NULL

Several	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
TPA	NULL
stimulation	NULL
can	NULL
differentiate	NULL
HL-60	NULL
promyelocytic	NULL
cells	NULL
or	NULL
U-937	NULL
histiocytic	NULL
leukemia	NULL
cells	NULL
into	NULL
macro-phage-like	NULL
cells	NULL
(	NULL
27	NULL
,	NULL
77	NULL
,	NULL
86	NULL
)	NULL
as	NULL
well	NULL
as	NULL
induce	NULL
both	NULL
the	NULL
HIV	NULL
LTR	NULL
and	NULL
HCMV	NULL
MIE	NULL
promoter/enhancer	NULL
regions	NULL
(	NULL
11	NULL
,	NULL
53	NULL
,	NULL
64	NULL
)	NULL
.	NULL

These	NULL
processes	NULL
are	NULL
generally	NULL
anticipated	NULL
to	NULL
involve	NULL
induction	NULL
of	NULL
NFB	NULL
by	NULL
release	NULL
from	NULL
IxB	NULL
inhibition	NULL
and	NULL
can	NULL
be	NULL
mimicked	NULL
with	NULL
TNF-a	NULL
(	NULL
18	NULL
,	NULL
73	NULL
)	NULL
or	NULL
abolished	NULL
by	NULL
mutation	NULL
of	NULL
target	NULL
NFkB	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
LTR	NULL
(	NULL
3	NULL
,	NULL
53	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
TPA	NULL
stimulation	NULL
also	NULL
strongly	NULL
activates	NULL
the	NULL
SCMV	NULL
MIE	NULL
enhancer	NULL
through	NULL
other	NULL
motifs	NULL
that	NULL
include	NULL
both	NULL
the	NULL
multiple	NULL
CREs	NULL
in	NULL
the	NULL
ENH-A1	NULL
region	NULL
and	NULL
the	NULL
SNE	NULL
motifs	NULL
in	NULL
the	NULL
ENH-A2	NULL
region	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
lymphocyte	NULL
and	NULL
monocyte	NULL
cell	NULL
lineages	NULL
(	NULL
11	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
here	NULL
,	NULL
the	NULL
SNE-mediated	NULL
effect	NULL
occurs	NULL
within	NULL
2	NULL
h	NULL
of	NULL
addition	NULL
of	NULL
TPA	NULL
to	NULL
U-937	NULL
cells	NULL
,	NULL
which	NULL
suggests	NULL
that	NULL
it	NULL
can	NULL
involve	NULL
a	NULL
direct	NULL
signal	NULL
transduction	NULL
event	NULL
without	NULL
requiring	NULL
prior	NULL
differentiation	NULL
events	NULL
.	NULL

Another	NULL
cell	NULL
culture	NULL
induction	NULL
model	NULL
has	NULL
shown	NULL
that	NULL
nonpermissive	NULL
human	NULL
teratocarcinoma	NULL
stem	NULL
cells	NULL
can	NULL
become	NULL
permissive	NULL
to	NULL
HCMV	NULL
infection	NULL
after	NULL
differentiation	NULL
by	NULL
RA	NULL
(	NULL
23	NULL
,	NULL
40	NULL
)	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
,	NULL
the	NULL
differentiation	NULL
signal	NULL
not	NULL
only	NULL
changes	NULL
the	NULL
cellular	NULL
status	NULL
but	NULL
also	NULL
appears	NULL
to	NULL
directly	NULL
potentiate	NULL
viral	NULL
gene	NULL
expression	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Overall	NULL
,	NULL
the	NULL
results	NULL
of	NULL
our	NULL
studies	NULL
as	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

11	NULL
have	NULL
now	NULL
clearly	NULL
defined	NULL
the	NULL
mechanism	NULL
of	NULL
a	NULL
third	NULL
distinct	NULL
PKC-targeted	NULL
TPA	NULL
response	NULL
pathway	NULL
,	NULL
which	NULL
involves	NULL
the	NULL
SRF	NULL
8602	NULL
CHAN	NULL
ET	NULL
AL	NULL
.	NULL

J.	NULL
ViRoL	NULL
.	NULL

A	NULL
B	NULL
SEE	NULL
SNE	NULL
(	NULL
Gasp	NULL
see	NULL
3	NULL
Probe	NULL
Probe	NULL
(	NULL
Lox	NULL
s14/815	NULL
)	NULL
(	NULL
Lak	NULL
218/219	NULL
)	NULL
(	NULL
LGH	NULL
sea	NULL
/	NULL
807	NULL
)	NULL
(	NULL
LGH	NULL
814/815	NULL
)	NULL
(	NULL
LGH	NULL
s38	NULL
/	NULL
639	NULL
)	NULL
(	NULL
|	NULL
1	NULL
eELKC-1	NULL
'â+	NULL
THT	NULL
â	NULL
a	NULL
.	NULL

M	NULL
Â£	NULL
M	NULL
A	NULL
.	NULL

Pe	NULL
P	NULL
m	NULL
M	NULL
z	NULL
y	NULL
a	NULL
``	NULL
Â®	NULL
=	NULL
=	NULL
f	NULL
wELKA	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
*	NULL
Extract	NULL
=	NULL
-	NULL
%	NULL
+	NULL
=	NULL
=	NULL
#	NULL
+	NULL
wGABPe	NULL
-=	NULL
~	NULL
+	NULL
+	NULL
Â«	NULL
wok	NULL
gogo	NULL
k	NULL
%	NULL
wok	NULL
omg	NULL
%	NULL
ie	NULL
Extract	NULL
|	NULL
-	NULL
+	NULL
40	NULL
>	NULL
0+	NULL
-o	NULL
-	NULL
+	NULL
+	NULL
-o	NULL
40	NULL
>	NULL
+	NULL
+	NULL
.	NULL

--	NULL
SRFETS	NULL
-	NULL
Â»	NULL
land	NULL
.	NULL

.	NULL

tib	NULL
#	NULL
#	NULL
bond	NULL
Â«	NULL
#	NULL
nd	NULL
#	NULL
=	NULL
shrets	NULL
S9r	NULL
~	NULL
saF	NULL
casp-	NULL
Â«	NULL
t	NULL
t	NULL
2	NULL
&	NULL
&	NULL
-	NULL
#	NULL
B	NULL
28	NULL
_	NULL
10r	NULL
s	NULL
40	NULL
sos	NULL
roa	NULL
og	NULL
ao	NULL
gr	NULL
2	NULL
11	NULL
44	NULL
4s	NULL
as	NULL
as	NULL
~E	NULL
10	NULL
r	NULL
3	NULL
4	NULL
s	NULL
6	NULL
T	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

Antibody	NULL
supershift	NULL
assays	NULL
demonstrate	NULL
that	NULL
ELK-1	NULL
protein	NULL
is	NULL
present	NULL
in	NULL
both	NULL
the	NULL
HCMV	NULL
and	NULL
SCMV	NULL
SRF-ETS	NULL
complexes	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSA	NULL
results	NULL
showing	NULL
that	NULL
anti-ELK-1	NULL
antibodies	NULL
supershift	NULL
the	NULL
SRF-ETS	NULL
complex	NULL
on	NULL
the	NULL
SEE	NULL
site	NULL
.	NULL

U-937	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
*Â°P-labeled	NULL
wild-type	NULL
(	NULL
GABP	NULL
)	NULL
;	NULL
probe	NULL
(	NULL
LGH663/807	NULL
;	NULL
lanes	NULL
1	NULL
to	NULL
6	NULL
)	NULL
,	NULL
HCMV	NULL
SEE	NULL
probe	NULL
(	NULL
LGH814/815	NULL
;	NULL
lanes	NULL
7	NULL
to	NULL
12	NULL
)	NULL
,	NULL
and	NULL
wild-type	NULL
c-Fos	NULL
SRE	NULL
probe	NULL
(	NULL
LGH638/639	NULL
;	NULL
lanes	NULL
13	NULL
to	NULL
18	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
anti-GABPa	NULL
or	NULL
anti-ELK-1	NULL
antibodies	NULL
.	NULL

The	NULL
control	NULL
lanes	NULL
received	NULL
added	NULL
antibodies	NULL
without	NULL
protein	NULL
samples	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
5	NULL
,	NULL
9	NULL
,	NULL
11	NULL
,	NULL
15	NULL
,	NULL
and	NULL
17	NULL
)	NULL
or	NULL
received	NULL
added	NULL
protein	NULL
samples	NULL
without	NULL
antibodies	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
8	NULL
,	NULL
and	NULL
14	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Similar	NULL
antibody	NULL
supershift	NULL
experiments	NULL
using	NULL
U-937	NULL
nuclear	NULL
extracts	NULL
and	NULL
the	NULL
*Â°P-labeled	NULL
wild-type	NULL
HCMV	NULL
SEE	NULL
probe	NULL
(	NULL
LGH814/815	NULL
)	NULL
and	NULL
SCMV	NULL
SNE	NULL
probe	NULL
(	NULL
LGH218/219	NULL
)	NULL
.	NULL

The	NULL
controls	NULL
received	NULL
added	NULL
protein	NULL
sample	NULL
without	NULL
any	NULL
antibody	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
or	NULL
received	NULL
added	NULL
antibodies	NULL
without	NULL
protein	NULL
samples	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
.	NULL

F	NULL
,	NULL
free	NULL
probe	NULL
.	NULL

binding	NULL
and	NULL
c-Fos	NULL
SRE-related	NULL
SCMV	NULL
SNE	NULL
and	NULL
HCMV	NULL
SEE	NULL
motifs	NULL
that	NULL
are	NULL
likely	NULL
to	NULL
contribute	NULL
to	NULL
regulation	NULL
of	NULL
the	NULL
MIE	NULL
enhancers	NULL
of	NULL
HCMV	NULL
and	NULL
SCMV	NULL
(	NULL
Fig	NULL
.	NULL

12	NULL
)	NULL
.	NULL

Several	NULL
reports	NULL
have	NULL
focused	NULL
previously	NULL
on	NULL
the	NULL
isolated	NULL
multicopy	NULL
CRE	NULL
(	NULL
19-bp	NULL
)	NULL
elements	NULL
that	NULL
are	NULL
common	NULL
to	NULL
all	NULL
primate	NULL
CMV	NULL
MIE	NULL
enhancers	NULL
and	NULL
revealed	NULL
their	NULL
ability	NULL
to	NULL
respond	NULL
to	NULL
cAMP	NULL
induc-	NULL
RESPONSES	NULL
ANTIBODY	NULL
|	NULL
BINDING	NULL
SUPERSHIFT	NULL
TPA	NULL
SERUM	NULL
SRF-ETS	NULL
+4	NULL
00	NULL
``	NULL
+/-	NULL
+	NULL
+/-	NULL
_	NULL
no	NULL
ND	NULL
+/-++	NULL
+	NULL
++	NULL
+	NULL
FIG	NULL
.	NULL

10	NULL
.	NULL

Spatial	NULL
and	NULL
conformation	NULL
effects	NULL
of	NULL
SRF-ETS	NULL
interactions	NULL
.	NULL

The	NULL
model	NULL
shows	NULL
the	NULL
spatial	NULL
relationship	NULL
between	NULL
the	NULL
SRF	NULL
and	NULL
the	NULL
ETS	NULL
class	NULL
ELK-1	NULL
protein	NULL
binding	NULL
sites	NULL
on	NULL
the	NULL
four	NULL
SRE-related	NULL
motifs	NULL
indicated	NULL
at	NULL
the	NULL
left	NULL
.	NULL

Also	NULL
shown	NULL
are	NULL
their	NULL
responses	NULL
to	NULL
TPA	NULL
and	NULL
serum	NULL
induction	NULL
and	NULL
their	NULL
abilities	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
SRF-ETS	NULL
complex	NULL
and	NULL
to	NULL
form	NULL
ELK-1	NULL
antibody-supershifted	NULL
complexes	NULL
.	NULL

The	NULL
ELK-1	NULL
protein	NULL
contains	NULL
three	NULL
conserved	NULL
regions	NULL
designated	NULL
domains	NULL
A	NULL
(	NULL
for	NULL
DNA	NULL
binding	NULL
)	NULL
,	NULL
B	NULL
(	NULL
for	NULL
SRF	NULL
interaction	NULL
)	NULL
,	NULL
and	NULL
C	NULL
(	NULL
for	NULL
regulation	NULL
by	NULL
phosphoryla-tion	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
spaces	NULL
between	NULL
the	NULL
SRF	NULL
and	NULL
ETS	NULL
binding	NULL
sites	NULL
(	NULL
boxed	NULL
)	NULL
are	NULL
2	NULL
bp	NULL
in	NULL
the	NULL
SEE	NULL
and	NULL
SRE	NULL
motifs	NULL
but	NULL
3	NULL
bp	NULL
in	NULL
the	NULL
SNE	NULL
motif	NULL
.	NULL

The	NULL
spatial	NULL
effects	NULL
might	NULL
explain	NULL
the	NULL
antibody	NULL
supershift	NULL
results	NULL
.	NULL

Boldface	NULL
letters	NULL
indicate	NULL
sequence	NULL
differences	NULL
among	NULL
the	NULL
core	NULL
SRF	NULL
motifs	NULL
within	NULL
the	NULL
SEE	NULL
,	NULL
SNE	NULL
,	NULL
and	NULL
SRE	NULL
motifs	NULL
.	NULL

This	NULL
A/T-rich	NULL
core	NULL
appears	NULL
to	NULL
be	NULL
important	NULL
for	NULL
a	NULL
putative	NULL
unknown	NULL
factor	NULL
(	NULL
X	NULL
)	NULL
that	NULL
mediates	NULL
serum	NULL
responsiveness	NULL
(	NULL
28	NULL
)	NULL
.	NULL

ND	NULL
,	NULL
not	NULL
determined	NULL
.	NULL

ers	NULL
(	NULL
9	NULL
,	NULL
31	NULL
,	NULL
72	NULL
)	NULL
,	NULL
or	NULL
to	NULL
phytohemagglutinin	NULL
plus	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
31	NULL
,	NULL
55	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
directly	NULL
to	NULL
TPA	NULL
treatment	NULL
in	NULL
U-937	NULL
,	NULL
K-562	NULL
,	NULL
and	NULL
HL-60	NULL
cells	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
multicopy	NULL
classical	NULL
NFB	NULL
elements	NULL
present	NULL
in	NULL
the	NULL
human	NULL
MIE	NULL
and	NULL
IES	NULL
enhancers	NULL
(	NULL
but	NULL
not	NULL
in	NULL
the	NULL
simian	NULL
MIE	NULL
enhancer	NULL
)	NULL
were	NULL
found	NULL
to	NULL
respond	NULL
to	NULL
TPA	NULL
(	NULL
11	NULL
,	NULL
64	NULL
)	NULL
as	NULL
well	NULL
as	NULL
to	NULL
TNF-	NULL
Â«	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
there	NULL
are	NULL
also	NULL
several	NULL
consensus	NULL
AP-1	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
and	NULL
chimpanzee	NULL
CMV	NULL
MIE	NULL
enhancers	NULL
that	NULL
are	NULL
also	NULL
likely	NULL
to	NULL
respond	NULL
to	NULL
TPA	NULL
,	NULL
as	NULL
well	NULL
as	NULL
several	NULL
possible	NULL
diverged	NULL
AP-1-re-lated	NULL
sites	NULL
in	NULL
the	NULL
circopithecoid	NULL
simian	NULL
versions	NULL
,	NULL
but	NULL
none	NULL
have	NULL
been	NULL
studied	NULL
directly	NULL
.	NULL

Although	NULL
we	NULL
have	NULL
been	NULL
unable	NULL
to	NULL
demonstrate	NULL
any	NULL
serum	NULL
responsiveness	NULL
of	NULL
the	NULL
SCMV	NULL
ENH-A2	NULL
region	NULL
or	NULL
by	NULL
multimerized	NULL
SNEs	NULL
in	NULL
either	NULL
BALB/c	NULL
3T3	NULL
or	NULL
NIH	NULL
3T3	NULL
cells	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
,	NULL
there	NULL
are	NULL
many	NULL
other	NULL
potential	NULL
core	NULL
SRE-and	NULL
RSRF-like	NULL
motifs	NULL
in	NULL
all	NULL
primate	NULL
CMV	NULL
extended	NULL
MIE	NULL
control	NULL
regions	NULL
(	NULL
although	NULL
usually	NULL
without	NULL
overlapping	NULL
ETS	NULL
mo-tifs	NULL
)	NULL
,	NULL
and	NULL
therefore	NULL
the	NULL
possibility	NULL
of	NULL
serum	NULL
responsiveness	NULL
under	NULL
other	NULL
circumstances	NULL
or	NULL
through	NULL
the	NULL
SEE	NULL
motifs	NULL
remains	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

Evidence	NULL
against	NULL
the	NULL
possibility	NULL
of	NULL
a	NULL
role	NULL
for	NULL
NFB	NULL
family	NULL
proteins	NULL
(	NULL
5	NULL
,	NULL
80	NULL
)	NULL
in	NULL
the	NULL
TPA	NULL
responses	NULL
of	NULL
the	NULL
SNEs	NULL
comes	NULL
from	NULL
several	NULL
sets	NULL
of	NULL
results	NULL
.	NULL

First	NULL
,	NULL
there	NULL
was	NULL
a	NULL
decrease	NULL
in	NULL
activity	NULL
RESPONSE	NULL
BINDING	NULL
BASAL	NULL
tra	NULL
'	NULL
-	NULL
sRFETS	NULL
SREc	NULL
ETS	NULL
SRE	NULL
(	NULL
cFos	NULL
)	NULL
Ccrastarcqaci	NULL
@	NULL
@	NULL
@	NULL
re	NULL
++	NULL
++	NULL
+o	NULL
o	NULL
++	NULL
SREc	NULL
(	NULL
AF	NULL
)	NULL
-	NULL
-	NULL
++	NULL
SREE	NULL
(	NULL
AC	NULL
)	NULL
xx	NULL
xx	NULL
-	NULL
-	NULL
a	NULL
SNE	NULL
(	NULL
SCMV	NULL
)	NULL
-	NULL
++	NULL
++	NULL
+	NULL
+	NULL
AN	NULL
(	NULL
S+N	NULL
)	NULL
xxx	NULL
0	NULL
4/-	NULL
-	NULL
++	NULL
AS	NULL
(	NULL
SÂ°N+	NULL
)	NULL
RNS	NULL
-	NULL
-	NULL
-	NULL
_	NULL
AS/AN	NULL
buts	NULL
xx	NULL
x	NULL
=	NULL
=	NULL
=	NULL
=	NULL
S/nsN	NULL
-	NULL
-	NULL
+/-	NULL
++	NULL
+/-S/NFKB	NULL
-	NULL
-	NULL
++	NULL
h	NULL
SEE	NULL
(	NULL
HCMV	NULL
)	NULL
-	NULL
+	NULL
=	NULL
++	NULL
+	NULL
++	NULL
1	NULL
.	NULL

Measured	NULL
in	NULL
U-937	NULL
cells	NULL
2	NULL
.	NULL

Measured	NULL
in	NULL
HL-60	NULL
cells	NULL
FIG	NULL
.	NULL

11	NULL
.	NULL

Correlation	NULL
between	NULL
formation	NULL
of	NULL
SRF-ETS	NULL
complexes	NULL
and	NULL
functions	NULL
of	NULL
SNE-related	NULL
elements	NULL
.	NULL

x	NULL
,	NULL
position	NULL
of	NULL
mutated	NULL
nucleotides	NULL
.	NULL

VoL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
CI	NULL
{	NULL
_I	NULL
A1	NULL
uL	NULL
mie	NULL
iEs	NULL
_	NULL
us	NULL
FIG	NULL
.	NULL

12	NULL
.	NULL

Signal	NULL
transduction	NULL
pathways	NULL
and	NULL
HCMV	NULL
IE	NULL
gene	NULL
regulation	NULL
.	NULL

The	NULL
diagram	NULL
shows	NULL
several	NULL
different	NULL
pathways	NULL
(	NULL
arrows	NULL
)	NULL
and	NULL
their	NULL
target	NULL
cellular	NULL
mediator	NULL
proteins	NULL
(	NULL
circled	NULL
)	NULL
,	NULL
together	NULL
with	NULL
the	NULL
consensus	NULL
DNA	NULL
recognition	NULL
sequences	NULL
that	NULL
are	NULL
known	NULL
to	NULL
participate	NULL
in	NULL
the	NULL
control	NULL
of	NULL
HCMV	NULL
IF	NULL
gene	NULL
tran-scription	NULL
.	NULL

MIE	NULL
and	NULL
IES	NULL
refer	NULL
to	NULL
the	NULL
two	NULL
distinctive	NULL
HCMV	NULL
IFE	NULL
enhancers	NULL
that	NULL
drive	NULL
expression	NULL
of	NULL
the	NULL
transcripts	NULL
that	NULL
encode	NULL
the	NULL
IE1	NULL
and	NULL
IE2	NULL
(	NULL
MIE	NULL
)	NULL
or	NULL
the	NULL
US3	NULL
(	NULL
IES	NULL
)	NULL
proteins	NULL
,	NULL
respectively	NULL
.	NULL

Different	NULL
stimulants	NULL
(	NULL
rectangles	NULL
)	NULL
activate	NULL
different	NULL
pathways	NULL
.	NULL

The	NULL
dashed	NULL
lines	NULL
indicate	NULL
uncertainties	NULL
.	NULL

obtained	NULL
when	NULL
the	NULL
NFKB-like	NULL
series	NULL
IIIB	NULL
submotif	NULL
(	NULL
N	NULL
)	NULL
was	NULL
changed	NULL
into	NULL
a	NULL
classical	NULL
NFKB	NULL
site	NULL
;	NULL
second	NULL
,	NULL
we	NULL
previously	NULL
observed	NULL
a	NULL
lack	NULL
of	NULL
response	NULL
to	NULL
TNF-	NULL
Â«	NULL
of	NULL
both	NULL
the	NULL
oligomerized	NULL
SNE	NULL
and	NULL
the	NULL
intact	NULL
SCMV	NULL
MIE	NULL
,	NULL
reporter	NULL
genes	NULL
,	NULL
compared	NULL
with	NULL
stimulation	NULL
of	NULL
the	NULL
HCMV	NULL
version	NULL
(	NULL
11	NULL
)	NULL
;	NULL
and	NULL
third	NULL
,	NULL
there	NULL
was	NULL
a	NULL
lack	NULL
of	NULL
response	NULL
to	NULL
OA	NULL
by	NULL
both	NULL
the	NULL
isolated	NULL
SNE	NULL
motifs	NULL
as	NULL
shown	NULL
here	NULL
and	NULL
by	NULL
the	NULL
intact	NULL
SCMV	NULL
MIEs	NULL
region	NULL
as	NULL
shown	NULL
previously	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
latter	NULL
finding	NULL
is	NULL
comparable	NULL
to	NULL
the	NULL
positive	NULL
effects	NULL
of	NULL
OA	NULL
on	NULL
the	NULL
HIV	NULL
LTR	NULL
,	NULL
HCMV	NULL
MIE	NULL
,	NULL
and	NULL
HCMV	NULL
IES	NULL
enhancers	NULL
and	NULL
on	NULL
reconstituted	NULL
minimal	NULL
promoters	NULL
containing	NULL
oligomerized	NULL
copies	NULL
of	NULL
classical	NULL
HCMV	NULL
NFB	NULL
motifs	NULL
.	NULL

OA	NULL
is	NULL
a	NULL
phosphatase	NULL
inhibitor	NULL
that	NULL
specifically	NULL
inhibits	NULL
both	NULL
PP2A	NULL
at	NULL
50	NULL
%	NULL
inhibitory	NULL
concentrations	NULL
as	NULL
low	NULL
as	NULL
1	NULL
nM	NULL
and	NULL
PP1	NULL
at	NULL
10	NULL
to	NULL
15	NULL
nM	NULL
(	NULL
14	NULL
)	NULL
.	NULL

However	NULL
,	NULL
two	NULL
of	NULL
the	NULL
four	NULL
major	NULL
serine/threonine	NULL
protein	NULL
phosphatases	NULL
,	NULL
PP2B	NULL
and	NULL
PP2C	NULL
,	NULL
are	NULL
unaffected	NULL
by	NULL
levels	NULL
of	NULL
OA	NULL
as	NULL
high	NULL
as	NULL
1	NULL
M	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
OA	NULL
into	NULL
a	NULL
culture	NULL
medium	NULL
increases	NULL
the	NULL
overall	NULL
phosphorylation	NULL
levels	NULL
of	NULL
cellular	NULL
proteins	NULL
2.5-	NULL
to	NULL
3-fold	NULL
,	NULL
and	NULL
the	NULL
functions	NULL
of	NULL
several	NULL
proteins	NULL
such	NULL
as	NULL
elongation	NULL
factor	NULL
2	NULL
,	NULL
maturation-promoting	NULL
factor	NULL
,	NULL
p42	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
ERK-2	NULL
)	NULL
,	NULL
and	NULL
the	NULL
AP-1	NULL
transcription	NULL
factor	NULL
that	NULL
are	NULL
controlled	NULL
by	NULL
phosphorylation	NULL
are	NULL
affected	NULL
by	NULL
OA	NULL
(	NULL
81	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
several	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
OA	NULL
does	NULL
not	NULL
inhibit	NULL
protein	NULL
tyrosine	NULL
phos-phatase	NULL
,	NULL
acid	NULL
and	NULL
alkaline	NULL
phosphatases	NULL
,	NULL
inositol	NULL
triphos-phatase	NULL
,	NULL
PKA	NULL
or	NULL
PKC	NULL
,	NULL
and	NULL
the	NULL
Ca**/calmodulin-dependent	NULL
protein	NULL
kinases	NULL
but	NULL
that	NULL
it	NULL
does	NULL
lead	NULL
to	NULL
rapid	NULL
turnover	NULL
of	NULL
IxB	NULL
and	NULL
release	NULL
and	NULL
transport	NULL
of	NULL
active	NULL
NFKB	NULL
into	NULL
the	NULL
nucleus	NULL
(	NULL
76	NULL
)	NULL
.	NULL

Mechanism	NULL
of	NULL
SNE	NULL
or	NULL
SEE	NULL
transactivation	NULL
by	NULL
synergism	NULL
.	NULL

Transcriptional	NULL
transactivators	NULL
with	NULL
homologous	NULL
amino	NULL
acid	NULL
sequences	NULL
in	NULL
their	NULL
DNA	NULL
binding	NULL
domains	NULL
usually	NULL
constitute	NULL
a	NULL
gene	NULL
family	NULL
that	NULL
recognizes	NULL
similar	NULL
response	NULL
or	NULL
enhancer	NULL
core	NULL
motifs	NULL
.	NULL

Several	NULL
families	NULL
,	NULL
such	NULL
as	NULL
the	NULL
NFKkB/Re	NULL
!	NULL

l	NULL
family	NULL
(	NULL
5	NULL
,	NULL
80	NULL
)	NULL
,	NULL
glucocorticoid	NULL
receptors	NULL
,	NULL
and	NULL
the	NULL
ETS	NULL
(	NULL
51	NULL
)	NULL
,	NULL
CREB	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
OCT	NULL
families	NULL
have	NULL
been	NULL
extensively	NULL
studied	NULL
.	NULL

Not	NULL
only	NULL
do	NULL
the	NULL
members	NULL
of	NULL
the	NULL
same	NULL
family	NULL
often	NULL
interact	NULL
with	NULL
each	NULL
other	NULL
to	NULL
form	NULL
heterodimeric	NULL
complexes	NULL
,	NULL
but	NULL
members	NULL
from	NULL
different	NULL
families	NULL
can	NULL
interact	NULL
to	NULL
regulate	NULL
gene	NULL
expression	NULL
synergistically	NULL
or	NULL
antagonistically	NULL
.	NULL

A	NULL
directly	NULL
relevant	NULL
example	NULL
comes	NULL
from	NULL
studies	NULL
of	NULL
serum	NULL
induction	NULL
and	NULL
TPA	NULL
responses	NULL
through	NULL
the	NULL
SRE	NULL
motif	NULL
in	NULL
the	NULL
c-Fos	NULL
promoter	NULL
(	NULL
a	NULL
cellular	NULL
IE	NULL
growth	NULL
response	NULL
gene	NULL
)	NULL
.	NULL

This	NULL
reaction	NULL
requires	NULL
protein-protein	NULL
contacts	NULL
TPA	NULL
RESPONSES	NULL
OF	NULL
SRF/ETS	NULL
ELEMENTS	NULL
IN	NULL
CMV	NULL
8603	NULL
between	NULL
SRF	NULL
and	NULL
one	NULL
or	NULL
other	NULL
of	NULL
two	NULL
ETS	NULL
family	NULL
proteins	NULL
,	NULL
SAP-1	NULL
or	NULL
ELK-1	NULL
(	NULL
15	NULL
,	NULL
52	NULL
,	NULL
66	NULL
,	NULL
69	NULL
)	NULL
.	NULL

In	NULL
CMV	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
both	NULL
basal	NULL
enhancement	NULL
and	NULL
TPA-stimulated	NULL
activation	NULL
occurring	NULL
through	NULL
the	NULL
SEE	NULL
or	NULL
SNE	NULL
enhancer	NULL
motifs	NULL
,	NULL
which	NULL
appear	NULL
to	NULL
be	NULL
present	NULL
in	NULL
all	NULL
primate	NULL
CMV	NULL
MIE	NULL
enhancers	NULL
,	NULL
also	NULL
involve	NULL
synergistic	NULL
effects	NULL
between	NULL
two	NULL
essential	NULL
interacting	NULL
transcription	NULL
factors	NULL
,	NULL
SRF	NULL
and	NULL
ELK-1	NULL
(	NULL
Fig	NULL
.	NULL

11	NULL
)	NULL
.	NULL

This	NULL
arrangement	NULL
may	NULL
have	NULL
evolved	NULL
to	NULL
allow	NULL
differential	NULL
regulation	NULL
of	NULL
the	NULL
core	NULL
DNA-binding	NULL
(	NULL
SRF	NULL
)	NULL
and	NULL
transactivation	NULL
(	NULL
SAP-1	NULL
or	NULL
ELK-1	NULL
)	NULL
components	NULL
.	NULL

Furthermore	NULL
,	NULL
SRF	NULL
may	NULL
interact	NULL
with	NULL
different	NULL
ETS	NULL
family	NULL
members	NULL
to	NULL
allow	NULL
differential	NULL
responses	NULL
to	NULL
external	NULL
stimuli	NULL
such	NULL
as	NULL
TPA	NULL
or	NULL
serum	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
found	NULL
that	NULL
the	NULL
ELK-1	NULL
and	NULL
SAP-1	NULL
proteins	NULL
are	NULL
differentially	NULL
modified	NULL
by	NULL
Ras-dependent	NULL
and	NULL
Ras-inde-pendent	NULL
pathways	NULL
,	NULL
respectively	NULL
(	NULL
7	NULL
,	NULL
29	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
several	NULL
reports	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
ETS	NULL
consensus	NULL
sequences	NULL
adjacent	NULL
to	NULL
the	NULL
core	NULL
SRF	NULL
sites	NULL
in	NULL
the	NULL
c-Fos	NULL
SRE	NULL
are	NULL
required	NULL
for	NULL
TPA-mediated	NULL
but	NULL
not	NULL
for	NULL
serum-mediated	NULL
activation	NULL
(	NULL
24	NULL
,	NULL
28	NULL
,	NULL
37	NULL
)	NULL
.	NULL

The	NULL
serum-responsive	NULL
segment	NULL
of	NULL
the	NULL
SRF	NULL
protein	NULL
has	NULL
been	NULL
mapped	NULL
to	NULL
lie	NULL
within	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

Therefore	NULL
,	NULL
perhaps	NULL
some	NULL
as	NULL
yet	NULL
unidentified	NULL
cellular	NULL
factor	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
serum	NULL
induction	NULL
through	NULL
recognition	NULL
of	NULL
a	NULL
confor-mational	NULL
effect	NULL
on	NULL
SRF	NULL
after	NULL
binding	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Curiously	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
the	NULL
SCMV	NULL
SNE	NULL
motif	NULL
,	NULL
unlike	NULL
the	NULL
c-Fos	NULL
SRE	NULL
,	NULL
does	NULL
not	NULL
respond	NULL
significantly	NULL
to	NULL
serum	NULL
induction	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

The	NULL
reason	NULL
could	NULL
be	NULL
either	NULL
that	NULL
the	NULL
spacing	NULL
between	NULL
the	NULL
SRF	NULL
and	NULL
ELK-1	NULL
binding	NULL
sites	NULL
(	NULL
3	NULL
bp	NULL
instead	NULL
of	NULL
2	NULL
bp	NULL
in	NULL
the	NULL
c-Fos	NULL
SRE	NULL
)	NULL
prohibits	NULL
correctly	NULL
oriented	NULL
SRF-SAP-1	NULL
complexes	NULL
from	NULL
forming	NULL
or	NULL
that	NULL
the	NULL
different	NULL
A/T-rich	NULL
centers	NULL
of	NULL
the	NULL
SNE	NULL
and	NULL
SEE	NULL
core	NULL
motifs	NULL
(	NULL
CCATATATGG	NULL
)	NULL
and	NULL
in	NULL
the	NULL
c-Fos	NULL
SRE	NULL
(	NULL
CCATATTAGG	NULL
)	NULL
change	NULL
both	NULL
the	NULL
bound	NULL
SRF	NULL
conformation	NULL
and	NULL
its	NULL
interaction	NULL
with	NULL
the	NULL
unknown	NULL
factor	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
this	NULL
arrangement	NULL
constitutively	NULL
expressed	NULL
SRF	NULL
can	NULL
still	NULL
bind	NULL
to	NULL
the	NULL
DNA	NULL
to	NULL
prevent	NULL
chromatin	NULL
formation	NULL
and	NULL
allow	NULL
rapid	NULL
access	NULL
by	NULL
the	NULL
inducible	NULL
transactivators	NULL
.	NULL

It	NULL
is	NULL
not	NULL
yet	NULL
known	NULL
whether	NULL
the	NULL
HCMV	NULL
SEE	NULL
motif	NULL
,	NULL
which	NULL
is	NULL
more	NULL
similar	NULL
to	NULL
the	NULL
SRE	NULL
in	NULL
spacing	NULL
but	NULL
more	NULL
similar	NULL
to	NULL
the	NULL
SNE	NULL
in	NULL
the	NULL
core	NULL
SRF	NULL
binding	NULL
sequence	NULL
,	NULL
can	NULL
act	NULL
as	NULL
an	NULL
SRE	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

The	NULL
ETS	NULL
family	NULL
and	NULL
cell	NULL
type	NULL
specificity	NULL
.	NULL

Several	NULL
ETS	NULL
family	NULL
cDNAs	NULL
,	NULL
that	NULL
share	NULL
properties	NULL
with	NULL
TCF	NULL
,	NULL
including	NULL
SAP-1	NULL
,	NULL
ELK-1	NULL
,	NULL
and	NULL
NET/SAP-2	NULL
,	NULL
have	NULL
been	NULL
cloned	NULL
(	NULL
15	NULL
,	NULL
30	NULL
,	NULL
60	NULL
)	NULL
.	NULL

All	NULL
three	NULL
of	NULL
these	NULL
ETS	NULL
subfamily	NULL
proteins	NULL
contain	NULL
homologous	NULL
amino	NULL
acid	NULL
sequences	NULL
defined	NULL
as	NULL
A	NULL
(	NULL
ETS	NULL
DNA	NULL
binding	NULL
do-main	NULL
)	NULL
,	NULL
B	NULL
(	NULL
SRF	NULL
interaction	NULL
)	NULL
,	NULL
and	NULL
C	NULL
(	NULL
conserved	NULL
phosphorylation	NULL
sites	NULL
)	NULL
boxes	NULL
(	NULL
84	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
ternary	NULL
complex	NULL
requires	NULL
phosphorylation	NULL
of	NULL
the	NULL
C	NULL
box	NULL
of	NULL
the	NULL
TCF	NULL
either	NULL
through	NULL
mitogen-activated	NULL
protein	NULL
kinase-dependent	NULL
or	NULL
-independent	NULL
pathways	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
both	NULL
mitogen-activated	NULL
protein	NULL
kinase-dependent	NULL
and	NULL
-independent	NULL
pathways	NULL
target	NULL
ELK-1-	NULL
and	NULL
SAP-1-related	NULL
TCFs	NULL
,	NULL
respectively	NULL
(	NULL
7	NULL
,	NULL
29	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
GGAT	NULL
ETS	NULL
DNA	NULL
binding	NULL
motif	NULL
within	NULL
the	NULL
c-Fos	NULL
SRE	NULL
has	NULL
now	NULL
been	NULL
found	NULL
to	NULL
be	NULL
required	NULL
for	NULL
phorbol	NULL
ester	NULL
induction	NULL
but	NULL
not	NULL
for	NULL
serum	NULL
induction	NULL
(	NULL
24	NULL
,	NULL
28	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Instead	NULL
,	NULL
the	NULL
A/T-containing	NULL
central	NULL
sequence	NULL
of	NULL
the	NULL
core	NULL
SRE	NULL
and	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
the	NULL
SRF	NULL
appear	NULL
to	NULL
be	NULL
crucial	NULL
for	NULL
whole	NULL
serum	NULL
induction	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
ETS	NULL
family	NULL
genes	NULL
is	NULL
often	NULL
tissue	NULL
specific	NULL
(	NULL
4	NULL
,	NULL
67	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
ETS-1	NULL
is	NULL
expressed	NULL
at	NULL
a	NULL
high	NULL
level	NULL
in	NULL
the	NULL
thymus	NULL
but	NULL
at	NULL
a	NULL
low	NULL
level	NULL
in	NULL
the	NULL
lung	NULL
and	NULL
spleen	NULL
.	NULL

ELK-1	NULL
is	NULL
expressed	NULL
predominantly	NULL
in	NULL
the	NULL
lung	NULL
and	NULL
testis	NULL
,	NULL
and	NULL
PU1/SPI-1	NULL
is	NULL
expressed	NULL
primarily	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
macrophages	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
ETS-2	NULL
is	NULL
expressed	NULL
in	NULL
almost	NULL
every	NULL
cell	NULL
type	NULL
.	NULL

Furthermore	NULL
,	NULL
there	NULL
is	NULL
differential	NULL
regulation	NULL
of	NULL
expression	NULL
of	NULL
ETS	NULL
proteins	NULL
.	NULL

Resting	NULL
T	NULL
cells	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
the	NULL
ETS-1	NULL
but	NULL
low	NULL
levels	NULL
of	NULL
the	NULL
ETS-2	NULL
RNA	NULL
and	NULL
protein	NULL
,	NULL
although	NULL
activated	NULL
T	NULL
cells	NULL
dramatically	NULL
increase	NULL
the	NULL
ETS-2	NULL
RNA	NULL
and	NULL
protein	NULL
levels	NULL
,	NULL
with	NULL
8604	NULL
CHAN	NULL
ET	NULL
AL	NULL
.	NULL

a	NULL
significant	NULL
decrease	NULL
of	NULL
the	NULL
ETS-1	NULL
RNA	NULL
and	NULL
protein	NULL
levels	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Since	NULL
CMV	NULL
infection	NULL
is	NULL
highly	NULL
tissue	NULL
specific	NULL
and	NULL
shows	NULL
differential	NULL
permissiveness	NULL
in	NULL
cells	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
differentia-tion	NULL
,	NULL
it	NULL
is	NULL
very	NULL
likely	NULL
that	NULL
the	NULL
ELK-1	NULL
protein	NULL
that	NULL
is	NULL
involved	NULL
in	NULL
interacting	NULL
with	NULL
SRF	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
providing	NULL
tis-sue-specific	NULL
IE	NULL
gene	NULL
expression	NULL
.	NULL

Indeed	NULL
,	NULL
our	NULL
experiments	NULL
demonstrated	NULL
that	NULL
cell-type-specific	NULL
responses	NULL
to	NULL
TPA	NULL
occur	NULL
through	NULL
the	NULL
SNE	NULL
sites	NULL
,	NULL
because	NULL
Vero	NULL
cells	NULL
(	NULL
AGM	NULL
kidney	NULL
fi-broblasts	NULL
)	NULL
did	NULL
not	NULL
respond	NULL
to	NULL
TPA	NULL
,	NULL
whereas	NULL
monocyte	NULL
lineage	NULL
U-937	NULL
and	NULL
THP-1	NULL
cells	NULL
,	NULL
as	NULL
well	NULL
as	NULL
K-562	NULL
histiocytic	NULL
leukemia	NULL
cells	NULL
and	NULL
HL-60	NULL
cells	NULL
,	NULL
did	NULL
so	NULL
strongly	NULL
.	NULL

Our	NULL
EMSA	NULL
experiments	NULL
also	NULL
showed	NULL
that	NULL
the	NULL
SRF-ELK-1	NULL
ternary	NULL
complex	NULL
could	NULL
be	NULL
formed	NULL
on	NULL
the	NULL
SEE	NULL
motifs	NULL
with	NULL
U-937	NULL
,	NULL
K-562	NULL
,	NULL
HeLa	NULL
,	NULL
and	NULL
HL-60	NULL
cell	NULL
extracts	NULL
but	NULL
not	NULL
with	NULL
HF	NULL
,	NULL
Raji	NULL
,	NULL
BALB/c	NULL
3T3	NULL
,	NULL
or	NULL
Vero	NULL
cell	NULL
extracts	NULL
.	NULL

This	NULL
result	NULL
probably	NULL
implies	NULL
that	NULL
activation	NULL
by	NULL
virion	NULL
factors	NULL
in	NULL
primary	NULL
lytic	NULL
infection	NULL
in	NULL
HF	NULL
cells	NULL
represents	NULL
an	NULL
alternative	NULL
way	NULL
to	NULL
induce	NULL
MIE	NULL
transcription	NULL
and	NULL
that	NULL
the	NULL
TPA	NULL
responses	NULL
that	NULL
we	NULL
are	NULL
studying	NULL
here	NULL
are	NULL
more	NULL
likely	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
reactivation	NULL
from	NULL
a	NULL
quiescent	NULL
state	NULL
in	NULL
differentiating	NULL
or	NULL
activated	NULL
macrophages	NULL
and	NULL
T	NULL
cells	NULL
,	NULL
for	NULL
example	NULL
.	NULL

However	NULL
,	NULL
since	NULL
many	NULL
other	NULL
cis-acting	NULL
elements	NULL
also	NULL
contribute	NULL
to	NULL
the	NULL
overall	NULL
basal	NULL
and	NULL
inducible	NULL
MIE	NULL
enhancer	NULL
activity	NULL
,	NULL
it	NULL
will	NULL
be	NULL
difficult	NULL
to	NULL
test	NULL
the	NULL
overall	NULL
significance	NULL
of	NULL
the	NULL
SNE	NULL
sites	NULL
in	NULL
the	NULL
MIE	NULL
enhancer	NULL
background	NULL
until	NULL
we	NULL
are	NULL
able	NULL
to	NULL
find	NULL
a	NULL
cell	NULL
type	NULL
that	NULL
depends	NULL
predominantly	NULL
on	NULL
this	NULL
element	NULL
for	NULL
MIE	NULL
gene	NULL
regulation	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
This	NULL
study	NULL
was	NULL
funded	NULL
by	NULL
PHS	NULL
research	NULL
grants	NULL
ROI-A124576	NULL
and	NULL
ROLI-AI31454	NULL
to	NULL
G.S.H	NULL
.	NULL

from	NULL
the	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Disease	NULL
.	NULL

Y.-J.C.	NULL
and	NULL
Q.H	NULL
.	NULL

are	NULL
Ph.D.	NULL
candidates	NULL
within	NULL
the	NULL
Johns	NULL
Hopkins	NULL
Pharmacology	NULL
Training	NULL
Program	NULL
NIH	NULL
5T32	NULL
MOT7626	NULL
.	NULL

Y.-J.C.	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
a	NULL
scholarship	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Taiwan	NULL
,	NULL
Republic	NULL
of	NULL
China	NULL
.	NULL

We	NULL
thank	NULL
Pamela	NULL
Wright	NULL
for	NULL
technical	NULL
assistance	NULL
and	NULL
Sarah	NULL
Heag-gans	NULL
and	NULL
Wen-Ping	NULL
Tseng	NULL
for	NULL
assistance	NULL
in	NULL
preparation	NULL
of	NULL
the	NULL
manu-script	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Alcendor	NULL
,	NULL
D.	NULL
,	NULL
W.	NULL
Gu	NULL
,	NULL
J.-C.	NULL
Zong	NULL
,	NULL
I.	NULL
Waheed	NULL
,	NULL
R.-S.	NULL
Peng	NULL
,	NULL
Y.-J	NULL
.	NULL

Chan	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Hayward	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

2	NULL
.	NULL

Alcendor	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
P.	NULL
A.	NULL
Barry	NULL
,	NULL
E.	NULL
Pratt-Lowe	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Luciw	NULL
.	NULL

1993	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
rhesus	NULL
cytomegalovirus	NULL
immediate-early	NULL
gene	NULL
promoter	NULL
.	NULL

Virology	NULL
194:815-821	NULL
.	NULL

3	NULL
.	NULL

Bellas	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
N.	NULL
Hopkins	NULL
,	NULL
and	NULL
Y.	NULL
Li	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
NF-	NULL
Â«	NULL
B	NULL
binding	NULL
site	NULL
is	NULL
necessary	NULL
for	NULL
efficient	NULL
replication	NULL
of	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
of	NULL
ma-caques	NULL
in	NULL
primary	NULL
macrophages	NULL
but	NULL
not	NULL
in	NULL
T	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:2908-2913	NULL
.	NULL

4	NULL
.	NULL

Bhat	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
S.	NULL
Fujiwara	NULL
,	NULL
S.	NULL
Koizumi	NULL
,	NULL
R.	NULL
J.	NULL
Fisher	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1990	NULL
.	NULL

Reciprocal	NULL
expression	NULL
of	NULL
human	NULL
ETS1	NULL
and	NULL
ETS2	NULL
genes	NULL
during	NULL
T-cell	NULL
activation	NULL
:	NULL
regulatory	NULL
role	NULL
for	NULL
the	NULL
protooncogene	NULL
ETS1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:3723-3727	NULL
.	NULL

5	NULL
.	NULL

Blank	NULL
,	NULL
V.	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1992	NULL
.	NULL

NF-kappa	NULL
B	NULL
and	NULL
related	NULL
pro-teins	NULL
:	NULL
Rel/dorsal	NULL
homologies	NULL
meet	NULL
ankyrin-like	NULL
repeats	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

17:135-140	NULL
.	NULL

6	NULL
.	NULL

Boshart	NULL
,	NULL
M.	NULL
,	NULL
F.	NULL
Weber	NULL
,	NULL
G.	NULL
Jahn	NULL
,	NULL
K.	NULL
Dorsch-Hasler	NULL
,	NULL
B.	NULL
Fleckenstein	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1985	NULL
.	NULL

A	NULL
very	NULL
strong	NULL
enhancer	NULL
is	NULL
located	NULL
upstream	NULL
of	NULL
an	NULL
immediate	NULL
carly	NULL
gene	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
.	NULL

Cell	NULL
41:521-530	NULL
.	NULL

7	NULL
.	NULL

Buscher	NULL
,	NULL
D.	NULL
,	NULL
R.	NULL
A.	NULL
Hipskind	NULL
,	NULL
S.	NULL
Krautwald	NULL
,	NULL
T.	NULL
Reimann	NULL
,	NULL
and	NULL
M.	NULL
Baccarini	NULL
.	NULL

1995	NULL
.	NULL

Ras-dependent	NULL
and	NULL
-independent	NULL
pathways	NULL
target	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
network	NULL
in	NULL
macrophages	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:466-475	NULL
.	NULL

8	NULL
.	NULL

Chan	NULL
,	NULL
Y.	NULL
J.	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Hayward	NULL
.	NULL

1996	NULL
.	NULL

Two	NULL
distinct	NULL
upstream	NULL
regulatory	NULL
domains	NULL
containing	NULL
multicopy	NULL
cellular	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
provide	NULL
basal	NULL
repression	NULL
and	NULL
inducible	NULL
enhancer	NULL
characteristics	NULL
to	NULL
the	NULL
immedi-ate-carly	NULL
IES	NULL
(	NULL
US3	NULL
)	NULL
promoter	NULL
from	NULL
human	NULL
cytomegalovirus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70	NULL
:	NULL
5312-5328	NULL
.	NULL

9	NULL
.	NULL

Chang	NULL
,	NULL
Y.	NULL
N.	NULL
,	NULL
S.	NULL
Crawford	NULL
,	NULL
J	NULL
.	NULL

Stall	NULL
,	NULL
D.	NULL
R.	NULL
Rawlins	NULL
,	NULL
K.	NULL
T.	NULL
Jeang	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Hayward	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
palindromic	NULL
series	NULL
I	NULL
repeats	NULL
in	NULL
the	NULL
simian	NULL
cytomegalovirus	NULL
major	NULL
immediate-early	NULL
promoter	NULL
behave	NULL
as	NULL
both	NULL
strong	NULL
basal	NULL
enhancers	NULL
and	NULL
cyclic	NULL
AMP	NULL
response	NULL
elements	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:264-277	NULL
.	NULL

10	NULL
.	NULL

Chang	NULL
,	NULL
Y.	NULL
N.	NULL
,	NULL
K.	NULL
T.	NULL
Jeang	NULL
,	NULL
C.	NULL
J.	NULL
Chiou	NULL
,	NULL
Y.	NULL
J.	NULL
Chan	NULL
,	NULL
M.	NULL
Pizzorno	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Hayward	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
large	NULL
bent	NULL
DNA	NULL
domain	NULL
and	NULL
binding	NULL
sites	NULL
for	NULL
serum	NULL
response	NULL
factor	NULL
adjacent	NULL
to	NULL
the	NULL
NFI	NULL
repeat	NULL
cluster	NULL
and	NULL
enhancer	NULL
region	NULL
in	NULL
the	NULL
major	NULL
IE94	NULL
promoter	NULL
from	NULL
simian	NULL
cytomegalovirus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:516-529	NULL
.	NULL

J.	NULL
ViRoL	NULL
.	NULL

11	NULL
.	NULL

Chiou	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Y.	NULL
J.	NULL
Chan	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Hayward	NULL
.	NULL

Phorbol	NULL
ester	NULL
stimulation	NULL
induces	NULL
expression	NULL
from	NULL
multiple	NULL
response	NULL
elements	NULL
in	NULL
the	NULL
major	NULL
immediate-early	NULL
enhancer	NULL
regions	NULL
of	NULL
human	NULL
and	NULL
simian	NULL
cytomegalovirus	NULL
in	NULL
monocyte	NULL
and	NULL
lymphocyte	NULL
cell	NULL
types	NULL
and	NULL
can	NULL
lead	NULL
to	NULL
activation	NULL
of	NULL
the	NULL
full	NULL
lytic	NULL
cycle	NULL
in	NULL
non-permissive	NULL
U-937	NULL
cells	NULL
.	NULL

Submitted	NULL
for	NULL
publication	NULL
.	NULL

12	NULL
.	NULL

Chiou	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
J.	NULL
Zong	NULL
,	NULL
I	NULL
Waheed	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Hayward	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
and	NULL
mapping	NULL
of	NULL
dimerization	NULL
and	NULL
DNA-binding	NULL
domains	NULL
in	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
the	NULL
IE2	NULL
regulatory	NULL
protein	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:6201-6214	NULL
.	NULL

13	NULL
.	NULL

Christy	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
L.	NULL
F.	NULL
Lau	NULL
,	NULL
and	NULL
D.	NULL
Nathans	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
gene	NULL
activated	NULL
in	NULL
mouse	NULL
3T3	NULL
cells	NULL
by	NULL
serum	NULL
growth	NULL
factors	NULL
encodes	NULL
a	NULL
protein	NULL
with	NULL
``	NULL
zinc	NULL
finger	NULL
``	NULL
sequences	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:7857-7861	NULL
.	NULL

13a.Crawford	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
Fallon	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Hayward	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

14	NULL
.	NULL

Cohen	NULL
,	NULL
P.	NULL
,	NULL
S.	NULL
Klumpp	NULL
,	NULL
and	NULL
D.	NULL
L.	NULL
Schelling	NULL
.	NULL

1989	NULL
.	NULL

An	NULL
improved	NULL
procedure	NULL
for	NULL
identifying	NULL
and	NULL
quantitating	NULL
protein	NULL
phosphatases	NULL
in	NULL
mammalian	NULL
tissues	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

250:596-600	NULL
.	NULL

15	NULL
.	NULL

Dalton	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
R.	NULL
Treisman	NULL
.	NULL

1992	NULL
.	NULL

Characterization	NULL
of	NULL
SAP-1	NULL
,	NULL
a	NULL
protein	NULL
recruited	NULL
by	NULL
serum	NULL
response	NULL
factor	NULL
to	NULL
the	NULL
c-fos	NULL
serum	NULL
response	NULL
element	NULL
.	NULL

Cell	NULL
68:597-612	NULL
.	NULL

16	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebovitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

17	NULL
.	NULL

Dutko	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
and	NULL
M.	NULL
B.	NULL
Oldstone	NULL
.	NULL

1981	NULL
.	NULL

Cytomegalovirus	NULL
causes	NULL
a	NULL
latent	NULL
infection	NULL
in	NULL
undifferentiated	NULL
cells	NULL
and	NULL
is	NULL
activated	NULL
by	NULL
induction	NULL
of	NULL
cell	NULL
differentiation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

154:1636-1651	NULL
.	NULL

18	NULL
.	NULL

Fietze	NULL
,	NULL
E.	NULL
,	NULL
S.	NULL
Prosch	NULL
,	NULL
P.	NULL
Reinke	NULL
,	NULL
J.	NULL
Stein	NULL
,	NULL
W.-D.	NULL
Docke	NULL
,	NULL
G.	NULL
Staffa	NULL
,	NULL
S.	NULL
Loning	NULL
,	NULL
S.	NULL
Devaux	NULL
,	NULL
F.	NULL
Emmrich	NULL
,	NULL
R.	NULL
yon	NULL
Baehr	NULL
,	NULL
D.	NULL
H.	NULL
Kruger	NULL
,	NULL
and	NULL
H.-D.	NULL
Volk	NULL
.	NULL

1994	NULL
.	NULL

Cytomegalovirus	NULL
infection	NULL
in	NULL
transplant	NULL
recipients	NULL
:	NULL
the	NULL
role	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

Transplantation	NULL
58:675-680	NULL
.	NULL

19	NULL
.	NULL

Fish	NULL
,	NULL
K.	NULL
N.	NULL
,	NULL
A.	NULL
S.	NULL
Depto	NULL
,	NULL
A.	NULL
V.	NULL
Moses	NULL
,	NULL
W.	NULL
Britt	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Nelson	NULL
.	NULL

1995	NULL
.	NULL

Growth	NULL
kinetics	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
are	NULL
altered	NULL
in	NULL
monocyte-derived	NULL
macrophages	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:3737-3743	NULL
.	NULL

20	NULL
.	NULL

Forbes	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
C.	NULL
A.	NULL
Bonville	NULL
,	NULL
and	NULL
N.	NULL
L.	NULL
Dock	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
a	NULL
promoter	NULL
of	NULL
cell	NULL
differentiation	NULL
and	NULL
selected	NULL
hormones	NULL
on	NULL
human	NULL
cytomegalovirus	NULL
infection	NULL
using	NULL
an	NULL
in	NULL
vitro	NULL
cell	NULL
system	NULL
.	NULL

J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

162:39-45	NULL
.	NULL

21	NULL
.	NULL

Ghazal	NULL
,	NULL
P.	NULL
,	NULL
C.	NULL
DeMattei	NULL
,	NULL
E.	NULL
Giulietti	NULL
,	NULL
S.	NULL
A.	NULL
Kliewer	NULL
,	NULL
K.	NULL
Umesono	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Evans	NULL
.	NULL

1992	NULL
.	NULL

Retinoic	NULL
acid	NULL
receptors	NULL
initiate	NULL
induction	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
enhancer	NULL
in	NULL
embryonal	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:7630-7634	NULL
.	NULL

22	NULL
.	NULL

Ghazal	NULL
,	NULL
P.	NULL
,	NULL
H.	NULL
Lubon	NULL
,	NULL
B.	NULL
Fleckenstein	NULL
,	NULL
and	NULL
L.	NULL
Hennighausen	NULL
.	NULL

1987	NULL
.	NULL

Binding	NULL
of	NULL
transcription	NULL
factors	NULL
and	NULL
creation	NULL
of	NULL
a	NULL
large	NULL
nucleoprotein	NULL
complex	NULL
on	NULL
the	NULL
human	NULL
cytomegalovirus	NULL
enhancer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:3658-3662	NULL
.	NULL

23	NULL
.	NULL

Gonczol	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
W.	NULL
Andrews	NULL
,	NULL
and	NULL
S.	NULL
A.	NULL
Plotkin	NULL
.	NULL

1984	NULL
.	NULL

Cytomegalovirus	NULL
replicates	NULL
in	NULL
differentiated	NULL
but	NULL
not	NULL
in	NULL
undifferentiated	NULL
human	NULL
embryonal	NULL
carcinoma	NULL
cells	NULL
.	NULL

Science	NULL
224:159-161	NULL
.	NULL

24	NULL
.	NULL

Graham	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
M.	NULL
Gilman	NULL
.	NULL

1991	NULL
.	NULL

Distinct	NULL
protein	NULL
targets	NULL
for	NULL
signals	NULL
acting	NULL
at	NULL
the	NULL
c-fos	NULL
serum	NULL
response	NULL
element	NULL
.	NULL

Science	NULL
251:189-192	NULL
.	NULL

25	NULL
.	NULL

Hermiston	NULL
,	NULL
T.	NULL
W.	NULL
,	NULL
C.	NULL
L.	NULL
Malone	NULL
,	NULL
P.	NULL
R.	NULL
Witte	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
Stinski	NULL
.	NULL

1987	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
human	NULL
cytomegalovirus	NULL
immedi-ate-carly	NULL
region	NULL
2	NULL
gene	NULL
that	NULL
stimulates	NULL
gene	NULL
expression	NULL
from	NULL
an	NULL
inducible	NULL
promoter	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

61:3214-3221	NULL
.	NULL

26	NULL
.	NULL

Herrera	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
P.	NULL
E.	NULL
Shaw	NULL
,	NULL
and	NULL
A.	NULL
Nordheim	NULL
.	NULL

1989	NULL
.	NULL

Occupation	NULL
of	NULL
the	NULL
c-fos	NULL
serum	NULL
response	NULL
element	NULL
in	NULL
vivo	NULL
by	NULL
a	NULL
multi-protein	NULL
complex	NULL
is	NULL
unaltered	NULL
by	NULL
growth	NULL
factor	NULL
induction	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
340:68-70	NULL
.	NULL

27	NULL
.	NULL

Hilfinger	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
N.	NULL
Clark	NULL
,	NULL
M.	NULL
Smith	NULL
,	NULL
K.	NULL
Robinson	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Markovitz	NULL
.	NULL

1993	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
2	NULL
enhancer	NULL
in	NULL
monocytes	NULL
at	NULL
various	NULL
stages	NULL
of	NULL
differentiation	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:4448-4453	NULL
.	NULL

28	NULL
.	NULL

Hill	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
J.	NULL
Wynne	NULL
,	NULL
and	NULL
R.	NULL
Treisman	NULL
.	NULL

1994	NULL
.	NULL

Serum-regulated	NULL
transcription	NULL
by	NULL
serum	NULL
response	NULL
factor	NULL
(	NULL
SRF	NULL
)	NULL
:	NULL
a	NULL
novel	NULL
role	NULL
for	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:5421-5432	NULL
.	NULL

29	NULL
.	NULL

Hipskind	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
D.	NULL
Buscher	NULL
,	NULL
A.	NULL
Nordheim	NULL
,	NULL
and	NULL
M.	NULL
Baccarini	NULL
.	NULL

1994	NULL
.	NULL

Ras/	NULL
MAP	NULL
kinase-dependent	NULL
and	NULL
-independent	NULL
signaling	NULL
pathways	NULL
target	NULL
distinct	NULL
ternary	NULL
complex	NULL
factors	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:1803-1816	NULL
.	NULL

30	NULL
.	NULL

Hipskind	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
V.	NULL
N.	NULL
Rao	NULL
,	NULL
C.	NULL
G.	NULL
Mueller	NULL
,	NULL
E.	NULL
S.	NULL
Reddy	NULL
,	NULL
and	NULL
A.	NULL
Nordheim	NULL
.	NULL

1991	NULL
.	NULL

Ets-related	NULL
protein	NULL
Elk-1	NULL
is	NULL
homologous	NULL
to	NULL
the	NULL
c-fos	NULL
regulatory	NULL
factor	NULL
p62TCF	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
354:531-534	NULL
.	NULL

31	NULL
.	NULL

Hunninghake	NULL
,	NULL
G.	NULL
W.	NULL
,	NULL
M.	NULL
M.	NULL
Monick	NULL
,	NULL
B.	NULL
Liu	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
Stinski	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
promoter-regulatory	NULL
region	NULL
of	NULL
the	NULL
major	NULL
immediate-early	NULL
gene	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
responds	NULL
to	NULL
T-lymphocyte	NULL
stimulation	NULL
and	NULL
contains	NULL
functional	NULL
cyclic	NULL
AMP-response	NULL
elements	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:3026-3033	NULL
.	NULL

32	NULL
.	NULL

Ibanez	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
R.	NULL
Schrier	NULL
,	NULL
P.	NULL
Ghazal	NULL
,	NULL
C.	NULL
Wiley	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Nelson	NULL
.	NULL

1991	NULL
.	NULL

Human	NULL
cytomegalovirus	NULL
productively	NULL
infects	NULL
primary	NULL
differentiated	NULL
macrophages	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:6581-6588	NULL
.	NULL

33	NULL
.	NULL

Janknecht	NULL
,	NULL
R.	NULL
,	NULL
R.	NULL
Zinck	NULL
,	NULL
W.	NULL
H.	NULL
Ernst	NULL
,	NULL
and	NULL
A.	NULL
Nordheim	NULL
.	NULL

1994	NULL
.	NULL

Functional	NULL
dissection	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
Elk-1	NULL
.	NULL

Oncogene	NULL
9:1273-1278	NULL
.	NULL

34	NULL
.	NULL

Jeang	NULL
,	NULL
K.	NULL
T.	NULL
,	NULL
M.	NULL
S.	NULL
Cho	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Hayward	NULL
.	NULL

1984	NULL
.	NULL

Abundant	NULL
constitutive	NULL
expression	NULL
of	NULL
the	NULL
immediate-early	NULL
94K	NULL
protein	NULL
from	NULL
cytomegalovirus	NULL
(	NULL
Col-burn	NULL
)	NULL
in	NULL
a	NULL
DNA-transfected	NULL
mouse	NULL
cell	NULL
line	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

42214-2223	NULL
.	NULL

35	NULL
.	NULL

Jeang	NULL
,	NULL
K.-T.	NULL
,	NULL
and	NULL
W.	NULL
Gibson	NULL
.	NULL

1980	NULL
.	NULL

A	NULL
cycloheximide-enhanced	NULL
protein	NULL
in	NULL
cytomegalovirus-infected	NULL
cells	NULL
.	NULL

Virology	NULL
107:362-374	NULL
.	NULL

36	NULL
.	NULL

Jeang	NULL
,	NULL
K.	NULL
T.	NULL
,	NULL
D.	NULL
R.	NULL
Rawlins	NULL
,	NULL
P.	NULL
J.	NULL
Rosenfeld	NULL
,	NULL
J.	NULL
H.	NULL
Shero	NULL
,	NULL
T.	NULL
J.	NULL
Kelly	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Hayward	NULL
.	NULL

1987	NULL
.	NULL

Multiple	NULL
tandemly	NULL
repeated	NULL
binding	NULL
sites	NULL
for	NULL
cellular	NULL
nuclear	NULL
factor	NULL
1	NULL
that	NULL
surround	NULL
the	NULL
major	NULL
immediate-early	NULL
promoters	NULL
of	NULL
simian	NULL
and	NULL
VoL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59.	NULL
human	NULL
cytomegalovirus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

61:1559-1570	NULL
.	NULL

Johansen	NULL
,	NULL
F.	NULL
E.	NULL
,	NULL
and	NULL
R.	NULL
Prywes	NULL
.	NULL

1994	NULL
.	NULL

Two	NULL
pathways	NULL
for	NULL
serum	NULL
regulation	NULL
of	NULL
the	NULL
c-fos	NULL
serum	NULL
response	NULL
element	NULL
require	NULL
specific	NULL
sequence	NULL
elements	NULL
and	NULL
a	NULL
minimal	NULL
domain	NULL
of	NULL
serum	NULL
response	NULL
factor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:5920-5928	NULL
.	NULL

Karim	NULL
,	NULL
F.	NULL
D.	NULL
,	NULL
L.	NULL
D.	NULL
Urness	NULL
,	NULL
C.	NULL
S.	NULL
Thummel	NULL
,	NULL
M.	NULL
J.	NULL
Klemsz	NULL
,	NULL
S.	NULL
R.	NULL
McKercher	NULL
,	NULL
A.	NULL
Celada	NULL
,	NULL
C.	NULL
Van	NULL
Beveren	NULL
,	NULL
R.	NULL
A.	NULL
Maki	NULL
,	NULL
C.	NULL
V.	NULL
Gunther	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Nye	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
ETS-domain	NULL
:	NULL
a	NULL
new	NULL
DNA-binding	NULL
motif	NULL
that	NULL
recognizes	NULL
a	NULL
purine-rich	NULL
core	NULL
DNA	NULL
sequence	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1451-1453	NULL
.	NULL

(	NULL
Letter	NULL
.	NULL
)	NULL

Kondo	NULL
,	NULL
K.	NULL
,	NULL
H.	NULL
Kaneshima	NULL
,	NULL
and	NULL
E.	NULL
S.	NULL
Mocarski	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
cytomegalovirus	NULL
latent	NULL
infection	NULL
of	NULL
granulocyte-macrophage	NULL
progenitors	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:11879-11883	NULL
.	NULL

LaFemina	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Hayward	NULL
.	NULL

1986	NULL
.	NULL

Constitutive	NULL
and	NULL
retinoic	NULL
acid-inducible	NULL
expression	NULL
of	NULL
cytomegalovirus	NULL
immediate-early	NULL
genes	NULL
in	NULL
human	NULL
teratocarcinoma	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

58:434-440	NULL
.	NULL

LaFemina	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Hayward	NULL
.	NULL

1988	NULL
.	NULL

Differences	NULL
in	NULL
cell-type-specific	NULL
blocks	NULL
to	NULL
immediate	NULL
early	NULL
gene	NULL
expression	NULL
and	NULL
DNA	NULL
replication	NULL
of	NULL
human	NULL
,	NULL
simian	NULL
and	NULL
murine	NULL
cytomegalovirus	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

69:355-374	NULL
.	NULL

LaFemina	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
M.	NULL
C.	NULL
Pizzorno	NULL
,	NULL
J.	NULL
D.	NULL
Mosca	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Hayward	NULL
.	NULL

1989	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
acidic	NULL
nuclear	NULL
immediate-early	NULL
protein	NULL
(	NULL
IE1	NULL
)	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
in	NULL
stable	NULL
cell	NULL
lines	NULL
and	NULL
its	NULL
preferential	NULL
association	NULL
with	NULL
metaphase	NULL
chromosomes	NULL
.	NULL

Virology	NULL
172:584-600	NULL
.	NULL

LaMarco	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
C.	NULL
Thompson	NULL
,	NULL
B.	NULL
P.	NULL
Byers	NULL
,	NULL
E.	NULL
M.	NULL
Walton	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
of	NULL
Ets-	NULL
and	NULL
notch-related	NULL
subunits	NULL
in	NULL
GA	NULL
binding	NULL
protein	NULL
.	NULL

Science	NULL
253:789-792	NULL
.	NULL

LaMarco	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1989	NULL
.	NULL

Purification	NULL
of	NULL
a	NULL
set	NULL
of	NULL
cellular	NULL
polypeptides	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
purine-rich	NULL
cis-regulatory	NULL
element	NULL
of	NULL
herpes	NULL
simplex	NULL
virus	NULL
immediate	NULL
carly	NULL
genes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1372-1383	NULL
.	NULL

Lang	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
T.	NULL
Stamminger	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
86-kilodalton	NULL
IE-2	NULL
protein	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
is	NULL
a	NULL
sequence-specific	NULL
DNA-binding	NULL
protein	NULL
that	NULL
interacts	NULL
directly	NULL
with	NULL
the	NULL
negative	NULL
autoregulatory	NULL
response	NULL
element	NULL
located	NULL
near	NULL
the	NULL
cap	NULL
site	NULL
of	NULL
the	NULL
IE-1/2	NULL
enhancer-promoter	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:323-331	NULL
.	NULL

Lathey	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
S.	NULL
A.	NULL
Spector	NULL
.	NULL

1991	NULL
.	NULL

Unrestricted	NULL
replication	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
in	NULL
hydrocortisone-treated	NULL
macrophages	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:6371-6375	NULL
.	NULL

Lieberman	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
J.	NULL
M.	NULL
Hardwick	NULL
,	NULL
and	NULL
S.	NULL
D.	NULL
Hayward	NULL
.	NULL

1989	NULL
.	NULL

Responsiveness	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
NofI	NULL
repeat	NULL
promoter	NULL
to	NULL
the	NULL
Z	NULL
transactivator	NULL
is	NULL
mediated	NULL
in	NULL
a	NULL
cell-type-specific	NULL
manner	NULL
by	NULL
two	NULL
independent	NULL
signal	NULL
regions	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:3040-3050	NULL
.	NULL

Lieberman	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
J.	NULL
M.	NULL
Hardwick	NULL
,	NULL
J	NULL
.	NULL

Sample	NULL
,	NULL
G.	NULL
S.	NULL
Hayward	NULL
,	NULL
and	NULL
S.	NULL
D.	NULL
Hayward	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
zta	NULL
transactivator	NULL
involved	NULL
in	NULL
induction	NULL
of	NULL
lytic	NULL
cycle	NULL
gene	NULL
expression	NULL
in	NULL
Epstein-Barr	NULL
virus-infected	NULL
lymphocytes	NULL
binds	NULL
to	NULL
both	NULL
AP-1	NULL
and	NULL
ZRE	NULL
sites	NULL
in	NULL
target	NULL
promoter	NULL
and	NULL
enhancer	NULL
regions	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:1143-1155	NULL
.	NULL

Lin	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
Stinski	NULL
.	NULL

1992	NULL
.	NULL

Human	NULL
cytomegalovirus	NULL
contains	NULL
a	NULL
tegu-ment	NULL
protein	NULL
that	NULL
enhances	NULL
transcription	NULL
from	NULL
promoters	NULL
with	NULL
upstream	NULL
ATF	NULL
and	NULL
AP-1	NULL
cis-acting	NULL
elements	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:4434-4444	NULL
.	NULL

Lin	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
Baillie	NULL
,	NULL
J.	NULL
G.	NULL
Sissons	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Sinclair	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
YY1	NULL
binds	NULL
to	NULL
negative	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
human	NULL
cytomegalovirus	NULL
major	NULL
immediate	NULL
early	NULL
enhancer/promoter	NULL
and	NULL
mediates	NULL
repression	NULL
in	NULL
non-permissive	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22:2453-2459	NULL
.	NULL

Macleod	NULL
,	NULL
K.	NULL
,	NULL
D.	NULL
Leprince	NULL
,	NULL
and	NULL
D.	NULL
Stehelin	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
ets	NULL
gene	NULL
family	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

17:251-256	NULL
.	NULL

(	NULL
Review	NULL
.	NULL
)	NULL

Marais	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
Wynne	NULL
,	NULL
and	NULL
R.	NULL
Treisman	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
SRF	NULL
accessory	NULL
protein	NULL
Elk-1	NULL
contains	NULL
a	NULL
growth	NULL
factor-regulated	NULL
transcriptional	NULL
activation	NULL
domain	NULL
.	NULL

Cell	NULL
73:381-393	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
326:711-713	NULL
.	NULL

Nelson	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
C.	NULL
Reynolds-Kobler	NULL
,	NULL
and	NULL
B	NULL
.	NULL

A.	NULL
Smith	NULL
.	NULL

1987	NULL
.	NULL

Negative	NULL
and	NULL
positive	NULL
regulation	NULL
by	NULL
a	NULL
short	NULL
segment	NULL
in	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
cytomegalovirus	NULL
major	NULL
immediate-early	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:4125-4129	NULL
.	NULL

Niller	NULL
,	NULL
H.	NULL
H.	NULL
,	NULL
and	NULL
L.	NULL
Hennighausen	NULL
.	NULL

1990	NULL
.	NULL

Phytohemagglutinin-induced	NULL
activity	NULL
of	NULL
cyclic	NULL
AMP	NULL
(	NULL
cAMP	NULL
)	NULL
response	NULL
elements	NULL
from	NULL
cytomegalovirus	NULL
is	NULL
reduced	NULL
by	NULL
cyclosporine	NULL
and	NULL
synergistically	NULL
enhanced	NULL
by	NULL
cAMP	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:2388-2391	NULL
.	NULL

Norman	NULL
,	NULL
C.	NULL
,	NULL
M.	NULL
Runswick	NULL
,	NULL
R.	NULL
Pollock	NULL
,	NULL
and	NULL
R.	NULL
Treisman	NULL
.	NULL

1988	NULL
.	NULL

Isolation	NULL
and	NULL
properties	NULL
of	NULL
cDNA	NULL
clones	NULL
encoding	NULL
SRF	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
c-fos	NULL
serum	NULL
response	NULL
element	NULL
.	NULL

Cell	NULL
55:989-1003	NULL
.	NULL

Pizzorno	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Hayward	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
IE2	NULL
gene	NULL
products	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
specifically	NULL
down-regulate	NULL
expression	NULL
from	NULL
the	NULL
major	NULL
im-mediate-carly	NULL
promoter	NULL
through	NULL
a	NULL
target	NULL
sequence	NULL
located	NULL
near	NULL
the	NULL
cap	NULL
site	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:6154-6165	NULL
.	NULL

Pizzorno	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
M.	NULL
A.	NULL
Mullen	NULL
,	NULL
Y.	NULL
N.	NULL
Chang	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Hayward	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
functionally	NULL
active	NULL
IE2	NULL
immediate-early	NULL
regulatory	NULL
protein	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
is	NULL
an	NULL
80-kilodalton	NULL
polypeptide	NULL
that	NULL
contains	NULL
two	NULL
distinct	NULL
acti-vator	NULL
domains	NULL
and	NULL
a	NULL
duplicated	NULL
nuclear	NULL
localization	NULL
signal	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:3839-3852	NULL
.	NULL

Pizzorno	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
P.	NULL
O'Hare	NULL
,	NULL
L.	NULL
Sha	NULL
,	NULL
R.	NULL
L.	NULL
LaFemina	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Hayward	NULL
.	NULL

1988.	NULL
trans-activation	NULL
and	NULL
autoregulation	NULL
of	NULL
gene	NULL
expression	NULL
by	NULL
the	NULL
immedi-ate-carly	NULL
region	NULL
2	NULL
gene	NULL
products	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

62	NULL
:	NULL
1167-1179	NULL
.	NULL

TPA	NULL
RESPONSES	NULL
OF	NULL
SRF/ETS	NULL
ELEMENTS	NULL
IN	NULL
CMV	NULL
60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

82	NULL
.	NULL

83	NULL
.	NULL

84	NULL
.	NULL

85	NULL
.	NULL

86	NULL
.	NULL

8605	NULL
Price	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
A.	NULL
E.	NULL
Rogers	NULL
,	NULL
and	NULL
R.	NULL
Treisman	NULL
.	NULL

1995	NULL
.	NULL

Comparative	NULL
analysis	NULL
of	NULL
the	NULL
ternary	NULL
complex	NULL
factors	NULL
Elk-1	NULL
,	NULL
SAP-1a	NULL
and	NULL
SAP-2	NULL
(	NULL
ERP/NET	NULL
)	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:2589-2601	NULL
.	NULL

Rice	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
R.	NULL
D.	NULL
Schrier	NULL
,	NULL
and	NULL
M.	NULL
B.	NULL
Oldstone	NULL
.	NULL

1984	NULL
.	NULL

Cytomegalovirus	NULL
infects	NULL
human	NULL
lymphocytes	NULL
and	NULL
monocytes	NULL
:	NULL
virus	NULL
expression	NULL
is	NULL
restricted	NULL
to	NULL
imme-diate-carly	NULL
gene	NULL
products	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
81:6134-6138	NULL
.	NULL

Roberts	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
A.	NULL
Boundy	NULL
,	NULL
P.	NULL
O'Hare	NULL
,	NULL
M.	NULL
C.	NULL
Pizzorno	NULL
,	NULL
D.	NULL
M.	NULL
Ciufo	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Hayward	NULL
.	NULL

1988	NULL
.	NULL

Direct	NULL
correlation	NULL
between	NULL
a	NULL
negative	NULL
autoregulatory	NULL
response	NULL
clement	NULL
at	NULL
the	NULL
cap	NULL
site	NULL
of	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
type	NULL
1	NULL
IB175	NULL
(	NULL
alpha	NULL
4	NULL
)	NULL
promoter	NULL
and	NULL
a	NULL
specific	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
IE175	NULL
(	NULL
ICP4	NULL
)	NULL
protein	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

62:4307-4320	NULL
.	NULL

Ryan	NULL
,	NULL
W.	NULL
A.	NULL
,	NULL
Jr.	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
M.	NULL
Z.	NULL
Gilman	NULL
.	NULL

1989	NULL
.	NULL

Two	NULL
distinct	NULL
cellular	NULL
phosphoproteins	NULL
bind	NULL
to	NULL
the	NULL
c-fos	NULL
serum	NULL
response	NULL
clement	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:1785-1792	NULL
.	NULL

Sambucetti	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
J.	NULL
M.	NULL
Cherrington	NULL
,	NULL
G.	NULL
W.	NULL
Wilkinson	NULL
,	NULL
and	NULL
E.	NULL
S.	NULL
Mocarski	NULL
.	NULL

1989	NULL
.	NULL

NF-kappa	NULL
B	NULL
activation	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
enhancer	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
viral	NULL
transactivator	NULL
and	NULL
by	NULL
T	NULL
cell	NULL
stimulation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:4251-4258	NULL
.	NULL

Schrier	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Nelson	NULL
,	NULL
and	NULL
M.	NULL
B.	NULL
Oldstone	NULL
.	NULL

1985	NULL
.	NULL

Detection	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
in	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
in	NULL
a	NULL
natural	NULL
infection	NULL
.	NULL

Science	NULL
230:1048-1051	NULL
.	NULL

Schroter	NULL
,	NULL
H.	NULL
,	NULL
C.	NULL
G.	NULL
Mueller	NULL
,	NULL
K.	NULL
Meese	NULL
,	NULL
and	NULL
A.	NULL
Nordheim	NULL
.	NULL

1990	NULL
.	NULL

Synergism	NULL
in	NULL
ternary	NULL
complex	NULL
formation	NULL
between	NULL
the	NULL
dimeric	NULL
glycoprotein	NULL
p67SRF	NULL
,	NULL
polypeptide	NULL
p6ZTCF	NULL
and	NULL
the	NULL
c-fos	NULL
serum	NULL
response	NULL
element	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:1123-1130	NULL
.	NULL

Seth	NULL
,	NULL
A.	NULL
,	NULL
R.	NULL
Ascione	NULL
,	NULL
R.	NULL
J.	NULL
Fisher	NULL
,	NULL
G.	NULL
J.	NULL
Mavrothalassitis	NULL
,	NULL
N.	NULL
K.	NULL
Bhat	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
ets	NULL
gene	NULL
family	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

3:327-334	NULL
.	NULL

Sharrocks	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
F.	NULL
yon	NULL
Hesler	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Shaw	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
elements	NULL
determining	NULL
the	NULL
different	NULL
DNA	NULL
binding	NULL
specificities	NULL
of	NULL
the	NULL
MADS	NULL
box	NULL
proteins	NULL
and	NULL
RSRFCA4	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21:215-221	NULL
.	NULL

Shaw	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
H.	NULL
Schroter	NULL
,	NULL
and	NULL
A.	NULL
Nordheim	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
a	NULL
ternary	NULL
complex	NULL
to	NULL
form	NULL
over	NULL
the	NULL
serum	NULL
response	NULL
element	NULL
correlates	NULL
with	NULL
serum	NULL
inducibility	NULL
of	NULL
the	NULL
human	NULL
c-fos	NULL
promoter	NULL
.	NULL

Cell	NULL
56:563-572	NULL
.	NULL

Shore	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Sharrocks	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
transcription	NULL
factors	NULL
Elk-1	NULL
and	NULL
serum	NULL
response	NULL
factor	NULL
interact	NULL
by	NULL
direct	NULL
protein-protein	NULL
contacts	NULL
mediated	NULL
by	NULL
a	NULL
short	NULL
region	NULL
of	NULL
Elk-1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:3283-3291	NULL
.	NULL

Sinclair	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
J.	NULL
Baillie	NULL
,	NULL
L.	NULL
A.	NULL
Bryant	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Taylor-Wiedeman	NULL
,	NULL
and	NULL
J.	NULL
G.	NULL
Sissons	NULL
.	NULL

1992	NULL
.	NULL

Repression	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
major	NULL
immediate	NULL
carly	NULL
gene	NULL
expression	NULL
in	NULL
a	NULL
monocytic	NULL
cell	NULL
line	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

73:433-435	NULL
.	NULL

Stamminger	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Fickenscher	NULL
,	NULL
and	NULL
B.	NULL
Fleckenstein	NULL
.	NULL

1990	NULL
.	NULL

Cell	NULL
type-spe-cific	NULL
induction	NULL
of	NULL
the	NULL
major	NULL
immediate	NULL
early	NULL
enhancer	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
by	NULL
cyclic	NULL
AMP	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

71:105-113	NULL
.	NULL

Stein	NULL
,	NULL
J.	NULL
,	NULL
H.-D.	NULL
Volk	NULL
,	NULL
C.	NULL
Liebenthal	NULL
,	NULL
D.	NULL
H.	NULL
Kruger	NULL
,	NULL
and	NULL
S.	NULL
Prosch	NULL
.	NULL

1993	NULL
.	NULL

Tumour	NULL
necrosis	NULL
factor	NULL
alpha	NULL
stimulates	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
human	NULL
cytomegalovirus	NULL
major	NULL
immediate	NULL
carly	NULL
enhancer/promoter	NULL
in	NULL
immature	NULL
monocyte	NULL
cells	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

74:2333-2338	NULL
.	NULL

Stenberg	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
J.	NULL
Fortney	NULL
,	NULL
S.	NULL
W.	NULL
Barlow	NULL
,	NULL
B.	NULL
P.	NULL
Magrane	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Nelson	NULL
,	NULL
and	NULL
P.	NULL
Ghazal	NULL
.	NULL

1990	NULL
.	NULL

Promoter-specific	NULL
trans	NULL
activation	NULL
and	NULL
repression	NULL
by	NULL
human	NULL
cytomegalovirus	NULL
immediate-early	NULL
proteins	NULL
involves	NULL
common	NULL
and	NULL
unique	NULL
protein	NULL
domains	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:1556-1565	NULL
.	NULL

Stenberg	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
D.	NULL
R.	NULL
Thomsen	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
Stinski	NULL
.	NULL

1984	NULL
.	NULL

Structural	NULL
analysis	NULL
of	NULL
the	NULL
major	NULL
immediate-early	NULL
gene	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

49:190-199	NULL
.	NULL

Sun	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
S.	NULL
B.	NULL
Maggirwar	NULL
,	NULL
and	NULL
E.	NULL
Harhaj	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
of	NULL
NF-kappa	NULL
B	NULL
by	NULL
phosphatase	NULL
inhibitors	NULL
involves	NULL
the	NULL
phosphorylation	NULL
of	NULL
I	NULL
kappa	NULL
B	NULL
alpha	NULL
at	NULL
phosphatase	NULL
2A-sensitive	NULL
sites	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:18347-18351	NULL
.	NULL

Sundstrom	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
K.	NULL
Nilsson	NULL
.	NULL

1976	NULL
.	NULL

Establishment	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
human	NULL
histiocytic	NULL
lymphoma	NULL
cell	NULL
line	NULL
(	NULL
U-937	NULL
)	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
17:565-577	NULL
.	NULL

Taylor-Wiedeman	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
G.	NULL
Sissons	NULL
,	NULL
L.	NULL
K.	NULL
Borysiewicz	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Sinclair	NULL
.	NULL

1991	NULL
.	NULL

Monocytes	NULL
are	NULL
a	NULL
major	NULL
site	NULL
of	NULL
persistence	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
in	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

72:2059-2064	NULL
.	NULL

Taylor-Wied	NULL
J.	NULL
,	NULL
P.	NULL
Si	NULL
and	NULL
J.	NULL
Sinclair	NULL
.	NULL

1994	NULL
.	NULL

Induction	NULL
of	NULL
endog-enous	NULL
human	NULL
cytomegalovirus	NULL
gene	NULL
expression	NULL
after	NULL
differentiation	NULL
of	NULL
monocytes	NULL
from	NULL
healthy	NULL
carriers	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:1597-1604	NULL
.	NULL

Thanos	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1995	NULL
.	NULL

NF-kappa	NULL
B	NULL
:	NULL
a	NULL
lesson	NULL
in	NULL
family	NULL
values	NULL
.	NULL

Cell	NULL
80:529-532	NULL
.	NULL

Thevenin	NULL
,	NULL
C.	NULL
,	NULL
S.	NULL
J.	NULL
Kim	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Kehrl	NULL
.	NULL

1991	NULL
.	NULL

Inhibition	NULL
of	NULL
protein	NULL
phosphatases	NULL
by	NULL
okadaic	NULL
acid	NULL
induces	NULL
AP1	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:9363-9366	NULL
.	NULL

Thomsen	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
R.	NULL
M.	NULL
Stenberg	NULL
,	NULL
W.	NULL
F.	NULL
Goins	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
Stinski	NULL
.	NULL

1984	NULL
.	NULL

Promoter-regulatory	NULL
region	NULL
of	NULL
the	NULL
major	NULL
immediate	NULL
carly	NULL
gene	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
81:659-663	NULL
.	NULL

Treisman	NULL
,	NULL
R.	NULL
1986	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
protein-binding	NULL
site	NULL
that	NULL
mediates	NULL
transcriptional	NULL
response	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
to	NULL
serum	NULL
factors	NULL
.	NULL

Cell	NULL
46:567-574	NULL
.	NULL

Treisman	NULL
,	NULL
R.	NULL
1994	NULL
.	NULL

Ternary	NULL
complex	NULL
factors	NULL
:	NULL
growth	NULL
factor	NULL
regulated	NULL
transcriptional	NULL
activators	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

4:96-101	NULL
.	NULL

Wathen	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
Stinski	NULL
.	NULL

1982	NULL
.	NULL

Temporal	NULL
patterns	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
transcription	NULL
:	NULL
mapping	NULL
the	NULL
viral	NULL
RNAs	NULL
synthesized	NULL
at	NULL
immediate	NULL
carly	NULL
,	NULL
carly	NULL
,	NULL
and	NULL
late	NULL
times	NULL
after	NULL
infection	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

41:462-477	NULL
.	NULL

Weinshenker	NULL
,	NULL
B.	NULL
G.	NULL
,	NULL
S.	NULL
Wilton	NULL
,	NULL
and	NULL
G.	NULL
P.	NULL
Rice	NULL
.	NULL

1988	NULL
.	NULL

Phorbol	NULL
ester-induced	NULL
differentiation	NULL
permits	NULL
productive	NULL
human	NULL
cytomegalovirus	NULL
infection	NULL
in	NULL
a	NULL
monocytic	NULL
cell	NULL
line	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

140:1625-1631	NULL
.	NULL

